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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Advances in Total Colonic Aganglionosis

As defined in Louw’s paper in this
issue (page 397) total colonic agangli
onosis is that type of Hirschsprung’s
disease in which ganglion cells are
absent throughout the colon and a
greater or lesser part of the small in
testine. The condition accounted for
approximately 8% of the 217 cases of
Hirschsprung’s disease reported in his
article.
This disease, affecting as it does an
extremely long segment of the in
testine, presents a most difficult thera
peutic problem. In seeking its elucida
tion Professor Louw has carefully
analysed the data from his 17 patients
collected over a 21-year period.
The pitfalls in the interpretation of
roentgenographic findings are em
phasized and the radiologic features
specific to total colonic aganglionosis
are indicated. These include the “egg
on end” appearance of the inverted
lateral roentgenogram which should
raise one’s suspicion of the diagnosis.
Rectal manometry appears to be an
unreliable diagnostic procedure in pa
tients with total colonic aganglionosis
since it was characteristic of the dis
ease in only one of five patients.
Suction rectal biopsy as described
by Noblett1 has proved highly satis
factory in those cases in which its per
formance is possible. Attention is given
to the importance of increased cholin
esterase activity in confirming the com
plete absence of ganglion cells and an
increased number of large peripheral
nerves.
The histochemical demonstration of

increased acetylcholinesterase in the
myenteric plexus is well known in
Hirschsprung’s disease, but now Profes
sor Louw points out that the biochem
ically determined concentrations of
serum pseudocholinesterase and ery
throcyte acetylcholinesterase vary with
the length of the aganglionic segment.
They are higher in the long segment
disease and lower in the short segment
disease. This observation has provided
us with additional information concern
ing Hirschsprung’s disease and for the
first time has shown that the disease
has systemic effects that require fur
ther study.
Louw makes clear that the successful
management of total colonic agangli
onosis depends on early recognition of
the disorder, prompt decompression of
the obstructed bowel by ileostomy or
even jejunostomy, control of critical
fluid losses occasioned by the shortbowel syndrome, an appropriate defini
tive surgical operation and, finally, in
the postoperative period, management
of fluid losses and perianal excoriation
and a regimen leading to satisfactory
weight gain and growth.
The author’s choice of the best defi
nitive operation seems to have been
based upon experience gained from
this small series of different procedures
which resulted in 8 survivors among
17 patients. One survivor had a classic
Swenson abdominoanal pull-through
operation, another had a Duhamel ileorectal end-to-side anastomosis and a
third survivor had a typical Soave en
dorectal pull-through procedure.2 In all
three patients the treatment was com

plicated by recurrent enterocolitis and
severe perianal excoriation.
Since 1974 five survivors were sub
jected to the Lester Martin operation.3
This is essentially an extension of the
operation proposed by Duhamel for
total colonic aganglionosis, in which
an end-to-side anastomosis is created
between the ganglionic small intestine
and the aganglionic rectum in the re
trorectal space leaving the aganglionic
colon in situ. In its performance one
removes all the aganglionic colon ex
cept the descending colon and effects
a long side-to-side anastomosis between
the descending colon and a correspond
ing length of small bowel. This creates
a larger reservoir and absorptive sur
face.
It appears that if only half the cir
cumference of the bowel (180°) is
supplied with ganglia, this is suf
ficient to propel semiliquid bowel con
tents distally. The Lester Martin opera
tion sometimes results in alternating
constipation and diarrhea in the early
postoperative phase, but perianal exco
riation was much reduced in Professor
Louw’s series.
Loperamide hydrochloride, a non
narcotic antidiarrrheal drug, seems to
be a useful adjunct in postoperative
management.
Our understanding of this difficult
variation of Hirschsprung’s disease has
certainly been advanced by the in
formation contained in this detailed
analysis of carefully collected data.
However, all the factors concerned
in this fascinating variety of congenital
intestinal aganglionosis have not yet
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been discovered. To confuse the issue,
pathologists now refer to “hypoganglionosis” as an entity and pharmocologists
allude to a nonadrenergic inhibitory
system in the innervation of the in
testine, the absence of which gives rise
to the signs and symptoms of Hirsch
sprung’s disease!
It is hoped that some day, some
where, someone will put all this to

gether and that, for his current con
tribution, Professor J. H. Louw will be
included in the list of those who have
made the final solution possible.
H arvey E. B eardmore ,
FACS

m d , frcs [c ],

Department of pediatric general surgery,
The Montreal Children’s Hospital,
Montreal, PQ
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Compression Treatment for Burn Scars

The effectiveness of prolonged com
pression treatment of keloids and hy
pertrophic scars has been well estab
lished. Larson and associates1 and
others2-4 have reported fully the meth
ods used and results obtained from
this form of treatment. Complications
and failures of treatment with pro
longed compression3 have been due to
reluctance of patients to wear the com
pression apparatus, breakdown of the
skin and, presumably, failure of the
technique. In spite of these failures,
about 50% of patients are spared ex
tensive release and reconstructive pro
cedures, while others require only minor
surgery or none at all.
A compression treatment section was
established several years ago in the re
gional burn unit of the Hamilton Gen
eral Hospital. Personnel from this sec
tion were sent to Texas to learn the
technique that had proved most suc
cessful. Anyone who has used com
pression treatment knows that poor
technique and makeshift compression
garments will lead to as many compli
cations as good results. It took several
months to iron out the wrinkles in our
section, but compression treatment has
proved worth while and our results now
approximate those reported elsewhere.
In this issue of the Journal (page
380

450) Garcia-Velasco and colleagues de
scribe in detail compression treatment
of hypertrophic burn scars in children
and the use of a custom-made silicone
mask that is a valuable aid in the
treatment of patients with facial scar
ring. Probably more important is that
these authors have attempted to throw
additional light on the pathophysiol
ogy of scarring and to show the ef
fects of compression bandaging on it.
They demonstrate realignment of col
lagen bundles from the whorled ar
rangement present before treatment to
the linear grouping after treatment. A
decrease in chondroitin sulfate values
and decreased vascularity in the post
treatment group of patients is shown.
Prolonged compression appears to in
crease scar maturation in some patients,
and to force maturation in others in
whom it had been arrested. There can
be no doubt that microscopically, clin
ically and even biologically, the char
acteristics of a mature scar have been
almost, or possibly completely, attained.
Erie Peacock in the preface to “Sur
gery and Biology of Wound Repair”5
alluded to the fact that the gap between
laboratory and bedside needed to be
bridged to bring the two closer together.
This can, in part, be accomplished by
the publication of papers such as that
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of Garcia-Velasco and colleagues. So
much has yet to be done in the in
vestigation of scarring that I hope this
paper will encourage others to con
tribute to Canadian journals and there
by close that gap.
B arry L. C lark ,

m d , frcs [c ]

Chief of plastic surgery,
St. Joseph’s Hospital,
Hamilton, Ont.
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Introducing
our versatile new suture.

SURGILENE
polypropylene monofilament suture.
The best in
nonabsorbable polypropylene
monofilament sutures
•
•
•
•
•
•
•
•
•

It is stronger
Has longer flex life
Has less elasticity
Minimizes tissue drag... no sawing
Handles well
Has minimal tissue reaction, minimal scarring
Won't adhere to tissue
Maintains in vivo tensile strength
Comes in unique DIRECT DISPENSING packages

Ask your scrub nurse for "SURGILENE"
-you'll be glad you did.

SURGILENE®
Blue-Monofilament polypropylene
Sterile, NONABSORBABLE
Surgical Sutures, U.S.P.
® Registered Trademark

CORRESPONDENCE

Annular Pancreas
To the coeditors: Contrary to the com
ments made by Dr. O.G. Thurston in
his editorial entitled “Annular Pan
creas” (Can J Surg 21: 193, 1978), I
submit that the classification I set forth
in my paper (page 241) in the same
issue does indeed affect the type of sur
gical treatment offered to the patient.
I make the point that bypass proce
dures are indicated only in the extra
mural type of annular pancreas; in the
intramural type, surgical treatment is
directed towards the treatment of the
duodenal ulcer. I think this is made
clear in the final paragraph of my paper
and I draw this to the attention of the
readers of the Journal.
D.W.B. J ohnston ,

md , frcs [c], facs

Director of surgical studies,
Westminster Hospital,
London, Ont.
To the coeditors: In my editorial I
stated that some form of bypass proce
dure is indicated in both the extramural
and intramural types of annular pan
creas as described by Dr. Johnston. In
his letter and article Dr. Johnston cor
rectly points out that in the intramural
type of annular pancreas the surgical
treatment is directed towards treatment
of the duodenal ulcer. I submit that
this is true providing the annular pan
creas is bypassed by the surgical proce
dure on the ulcer, such as the gastrojejunal anastomosis performed on the
patient in his case 3. Would Dr. John
ston recommend a vagotomy and an
trectomy with a Billroth I anastomosis
for the treatment of such a patient? If
so, the role of the annular pancreas in
the pathogenesis of such a duodenal
ulcer is in doubt.
O lin G. T hurston , md , frcs [c]

Professor,
Department of surgery,
University of Alberta,
Edmonton, Alta.

Standards of Acceptance for
Surgical Procedures
To the coeditors: In theory, reviewers
of scientific papers enforce standards
for acceptance based on the aim of all
scientists— to report a true result. For
therapeutic trials a true result depends
on appropriate design (i.e., the results
382

should reveal real effects of treatment
of treatment. It is true that operative
by measures that minimize bias in se mortality will be reduced with experi
lecting patients and administering ther ence, but the proof of current benefit
apy). Acceptance of the results for to patients is necessarily derived from
publication implies merit, and without current experience. Our point is related
publication it is very difficult to estab to the quality of such proof.
lish a new treatment in practice. Thus,
We believe that the publication “fil
medical journals become the filter ter” is the place to maintain equally high
through which appropriately studied standards for all treatments. We request
modalities can go on to application but that the coeditors and reviewers of the
through which inappropriately studied Canadian Journal of Surgery consider
modalities should not be able to pass. an explicit policy of equal standards for
While this has been increasingly true trials of all modes of therapy.
for studies on medicinal agents it has
not been the case for those on new sur D avid H. Spodick, md , d sc
gical procedures and new applications of University of Massachusetts
established procedures. Most reviewers, W ilbert A ronow , md
abstract referees for scientific meetings University of California
and hospital research committees main
tain high standards for the design of Bernard Barber, ph d
medical therapeutic trials. Yet they do Columbia University
not impose equal standards upon the H enry Blackburn, md
design of surgical trials. However, this University of Minnesota
is not because such reliable trials can
D avid Boyd, md
not be devised.
Lahey Clinic, Boston
It has been shown that prospective,
controlled trials of surgical therapy, in C. R ichard C onti, md
cluding random allocation of patients, University of Florida
are feasible, although perhaps they are J ames P. LoG erfo , md
more complicated to perform than com University of Washington
parably designed trials of nonsurgical
therapy. But relatively few have been Bernard L own , md
done and these have followed rather than Harvard University
preceded the widespread introduction of VlRENDRA S. M aTHUR, MD
new operations. Yet to establish as early Baylor University
as possible that a treatment is truly ef H enry D. M cI ntosh , md
fective and exactly for whom it is in Watson Clinic, Lakeland, FL
dicated, the same principles must apply
to all therapies. Unless this is recog T homas A. P reston , md
nized, uncertainty will continue to US Public Health Service,
provoke protracted arguments over ap Seattle, WA
propriate operations for common di A rthur Selzer , md
seases such as peptic ulcer, breast car University of California
cinoma and coronary artery obstruc T imothy T akaro, md
tion. The years consumed and the heat Veterans Administration,
generated by disputants whose skill and Asheville, NC
intellect are undoubted testify to the
persistent problem of getting valid
evidence—to the detriment of our pa
Recurrent Spontaneous
tients. We believe this problem results
Pneumothorax
Concurrent
from the absence of appropriate stand
with Menses
ards for proof of the effectiveness of
new surgical treatments and new appli To the coeditors: Recurrent spontaneous
cations of existing surgical treatments. pneumothorax concurrent with menses
There is no scientific or humanistic is becoming increasingly recognized. I
reason why standards for acceptance have recently treated a patient with this
should not be the same for all types of condition and in reviewing the litera
treatment. Indeed, science and ethics ture I found 32 documented cases.
demand our best efforts to apply such Much controversy surrounds the cause
equal standards. Moreover, there is and treatment of this condition. I re
every reason for their application to port my experience for the benefit of
the very first clinical trial of any mode readers of the Journal.
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these apical bullae. The pneumothorax was
treated by excising the apical bullae and
oversewing the defect with chromic cat
gut. Gauze abrasion of both pleurae was
performed. The patient has had no recur
rence of pneumothorax and she continues
to menstruate regularly.

A 38-year-old woman, para 2, gravida 2,
was menstruating regularly. She had no
history of dysmenorrhea. About 4 hours
before vaginal bleeding started, she would
experience a pleuritic type pain on the right
side of the chest with a dry hacking cough
and moderate shortness of breath. The
first time she had these symptoms a chest
roentgenogram was done that showed
about 20% pneumothorax; unfortunately
the roentgenogram was interpreted as nor
mal. She had 24 such episodes at regular
monthly intervals before again seeking
medical assessment. At this time she was
suffering from severe shortness of breath
and was found to have a 50% pneumo
thorax. This was treated with tube thora
costomy. No evidence of endometriosis
was obtained by history or physical exam
ination. Laparoscopy was not done because
there were no notable physical findings.
During the next menstrual cycle, there
was again a right-sided pneumothorax. This
time a thoracotomy was performed. Dia
phragmatic defects, diaphragmatic fenes
tration, subpleural endometrioma and endometrioma involving the diaphragm were
sought. Only apical bullae were found.
When the pleural cavity was filled with
saline, the leak was seen to be coming from

Because Rogers, Saperstein and
Rosenfeld1 advocated that a diagnosis
of endometriosis could be confirmed by
laparoscopy and satisfactory treatment
achieved by suppression of ovulation,
the opinion of a gynecologist was
sought. Since there was no suggestion
of pelvic endometriosis, he believed that
laparoscopy was unwarranted. From my
experience I would take exception to
the treatment advocated by Rogers,
Saperstein and Rosenfeld although
some might regard it as a less traumatic
approach than thoracotomy.
No satisfactory explanation has yet
been made as to why the pneumothorax
almost always occurs on the right side.
The condition can sometimes be attri
buted to congenital diaphragmatic de
fects, either single or “fenestrated” .

There are a few reports of cases as
sociated with a subpleural endom etrio
ma but no evidence of endometriosis
was found in the tissue removed at oper
ation in my patient, nor was there any
diaphragmatic defect.
Although
recurrent
spontaneous
pneumothorax concurrent with menses
remains a relatively rare condition,
more than 30 cases have been reported.
The case presented here seems to be the
most typical presentation; no abnorm al
ities other than the usual apical bullae
were found. Because of the paucity of
documented cases, however, I believe
that this particular case report may be
useful as the condition becomes better
recognized and the search for its cause
continues.
A drian A . M in o r , b sc , m d , f r c s [c ]

The Peterborough Clinic,
Peterborough, Ont.
Reference
1. R ogers PM, S aperstein LM, R osen 
feld DL: Catamenial pneumothorax.
Am J Obstet Gynecol 118: 572, 1974

SESAP II Question

Items 465-468
(A)
(B)
(C)
(D)

Congenital aganglionic megacolon (Hirschsprung’s disease)
Psychogenic constipation
Both
Neither

465. Malnutrition and anemia
466. Rarely diagnosed in infancy
467. Roentgenogram of the colon with barium is usually diagnostic
468. Rectal ampulla loaded with feces

For each of the item numbers above select the appropriate lettered word or phrase. Y our answer should be
A
B
C
D

if
if
if
if

the
the
the
the

item
item
item
item

is
is
is
is

associated
associated
associated
associated

with (A) only,
with (B) only,
with both (A) and (B),
with neither (A) nor (B)

For the critique of Items 465-468 see page 453 of this issue.
(Reproduced by permission of the American College of Surgeons from SE SA P II Syllabus: Surgical Education and
Self-assessment Program N o. 2. F or enrolment in the Surgical Education and Self-assessment Program No. 2 please
apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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To control upper
gastrointestinal bleeding
due to stress ulcer,
hemorrhagic gastritis, stress
gastritis, bleeding gastric
erosions, duodenal and
gastric ulcers...

New

Tagamet
(cimelidine) injection

The 'Tagam et'effecl
The precise mechanism by which 'Tagamet' controls upper g.i. bleeding is not
understood, although several theories exist, of which these seem the most likely.

Significantly Inhibits Gastric Acid Secretion,
raising the pH of the stomach to inactivate pepsinogen (thereby decreasing pepsin which is
known to digest protein in an acidic environment) and possibly promoting clot formation.

■ May Decrease Gastric Mucosal Blood Flow
due to inhibition of acid secretion, allowing the body's hemostatic mechanism
to control bleeding.

■ May Prevent Further Damage to the Mucosa
by acid through blockade of histamine H2receptors, thereby encouraging
healing of the mucosal injury.

6 5 patients in whom other nonsurgical measures had failed, or
for whom surgical intervention
was considered impossible or
unduly hazardous, were
evaluated; the results are
reported in the adjacent table.1

Heavy
Moderate
Subacute/recurrent

C o m p le te

C o m p le te
Su ccess

P a rtia l
Su ccess

& P a r tia l

65%
52%
45%

15%
22%
25%

80%
74%
70%

Su ccess

F a ilu re

20%
26%
30%

1. Data on file, SK&F Medical Department

The H2Receptor Antagonist-A major clinical
advance for uncontrolled g.i. bleeding
SMITH KLINE S-FRENCH CANADA LTD.
Montreal, Quebec H4M 2L6

Tagamet®

DUODENAL ULCER. NON-MALIGNANT
GASTRIC ULCER. AND G ASTRO
ESOPHAGEAL REFLUX DISEASE

(cimetidine SK&F)
Tablets
Injection

Prescribing Inform ation
(Product Monograph available to practitioners on request)

ACTION
Cim etidine competitively inhibits the action of histamine
at the histamine Ho receptor, and thus represents a new
class of pharmacological agents, the histamine
H2 -receptor antagonists.
Cim etidine is not an anticholinergic agent. Studies have
shown that cimetidine inhibits both daytime and nocturnal
b asal gastric a cid secretion. Cimetidine also inhibits
gastric acid secretion stimulated by food, histamine,
pentagastrin, caffeine and insulin. Its ability to inhibit
gastric a cid secretion via this unique mechanism of action
permits a new approach to the treatment of acid-related
gastrointestinal disorders.
Cim etidine is absorbed rapidly after oral administration.
The plasm a half-life is approximately two hours. The
principal route of excretion is the urine.
The degree and duration of inhibition of basal and
stimulated gastric acid secretion are dose-related; the
data suggest that 8 0% or higher inhibition throughout a
2 4 hour period can be achieved by a dosage regimen of
3 0 0 mg four times daily given with meals and at bedtime.
Cim etidine 3 0 0 mg reduced total pepsin output as a result
of the d ecrease in volume of gastric juice. The drug had no
effect on the rate of gastric emptying or lower esophageal
sphincter (LES) pressure.

INDICATIONS AND CLINICAL USE
Tagamet® (cimetidine) is primary therapy for conditions
where the inhibition of gastric acid secretion is likely to be
beneficial, such as:
□
□
□
□
□

Duodenal ulcer
Non-malignant gastric ulcer
G astroesophageal reflux disease
M anagem ent of upper gastrointestinal hemorrhage
Pathological hypersecretion associated with ZollingerEllison Syndrome, systemic mastocytosis and multiple
endocrine adenomas.

CONTRAINDICATIONS
There are no known contraindications to the use of
'Tagam et' (cimetidine).

PRECAUTIONS
Use in P regn an cy : Nursing Mothers:
There has been no experience, to date, with use of
'Tagam et' (cimetidine) in pregnant patients. Reproduction
studies performed in rats, mice and rabbits have revealed
no evidence of impaired fertility or harm to the fetus due to
'Tagam et'. Studies have demonstrated that 'Tagamet'
crosses the p lacental barrier. It is also secreted in the milk
of animals. 'Tagam et' should b e used in pregnant or
lactating patients or women of child-bearing potential only
when, in the judgement of the physician, the anticipated
benefits outweigh the potential risks.
Use in Children
C linical exp erience in children is limited. Therefore,
’Tagam et' (cimetidine) therapy cannot be recommended
for children unless, in the judgement of the physician,
anticipated benefits outweigh the potential risks. In very
limited exp erience, 20-40 mg kg per day has been
administered in divided doses by mouth or intravenously.
Use in Im paired Renal Function
B ecause 'Tagam et' (cimetidine) is excreted by the kidney,
a reduced dosage should normally be administered to
patients with impaired renal function. (See DOSAGE AND
ADMINISTRATION)
Drug Interactions
Studies in animals revealed no pharmacological inter
action betw een 'Tagamet' and commonly used drugs. No
significant interactions have been observed in man.

ADVERSE REACTIONS
Mild and transient diarrhea, muscular pain, dizziness and
rash have been reported in a small number of patients
during treatment with 'Tagamet' (cimetidine). There have
been reports that a few patients have developed mild
nonprogressive gynecomastia during prolonged treatment.
No evidence of induced endocrine dysfunction was found,
and the condition remained unchanged with continuing
'Tagam et' treatment. Some increases in plasma creatinine
and serum transaminase have been reported.

OVERD OSAGE
In cases reported to date, involving oral ingestion of up to
10 gram s of 'Tagam et' (cimetidine), no untoward effects
have been noted, and recovery has been uneventful.
Treatm ent
The usual measures to remove unabsorbed material from
the gastrointestinal tract, clinical monitoring and
supportive therapy should be employed. Studies in animals
ind icate that assisted respiration may be of value and that
any tachycardia may be controlled by administration of a
B-blocker.

D O SA G E AND ADMINISTRATION
ADULTS:
(Experience with 'Tagamet' in children is limited and it has
not been evaluated in clinical studies—see PRECAUTIONS)
In c lin ical studies ’Tagamet' (cimetidine) has been used in
divided doses of up to 2 4 0 0 mg/day.
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The recommended adult oral dosage for duodenal ulcer,
non malignant gastric ulcer and gastroesophageal reflux
disease is 300 m g four times a day, with m eals and at
bedtime.
While healing with 'Tagamet' often occurs during the first
week or two, treatm ent should be continued for a t least
four weeks unless healing has been demonstrated by
endoscopic examination.
Some patients may require concomitant antacids until
symptoms disappear.

MANAGEMENT O F UPPER
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding of
sufficient magnitude as to require blood transfusions,
'Tagam et' should b e adm inistered parenterally,
preferably by intravenous injection or intermittent
infusion or, if necessary, by constant intravenous infusion
until 4 8 hours after active bleeding has stopped. At this
time an oral dosage regimen may be instituted and should
b e continued for at least 7 -10 days.
Recommended d osage for oral adm inistration:
3 0 0 mg every 6 hours.
Recommended dosage for intram uscular injection
adm inistration:
3 0 0 mg every 6 hours. Inject the entire contents of a 2 ml
ampul.
Recommended d osage for intravenous injection
adm inistration:
3 0 0 mg every 6 hours. Dilute ’Tagamet' in Sodium
Chloride Injection (0.9% ) (or other compatible i.v.
solution) to a total volume of 2 0 ml and inject over 1-2
minutes.
Recommended dosage for intermittent intravenous
infusion administration:
3 0 0 mg every 6 hours. Dilute 'Tagamet' 3 0 0 mg in 1 0 0 ml
of Dextrose Injection (5%) (or other compatible i.v.
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase dosage.
When this is necessary, the increases should be made by
more frequent administration of a 3 0 0 mg dose, but total
daily dosage should not exceed 2 4 0 0 mg.
Recommended dosage for constant intravenous
infusion administration:
2 mg/kg/hour. Dilute ’Tagamet' for injection in a
compatible i.v. solution, such as Sodium Chloride Injection
(0.9% ) or Dextrose Injection (5% or 10%). In some patients
it may be necessary to increase dosage. Dosage should
usually not exceed 4 mg/kg/hour.

DOSAGE ADJUSTMENT FOR PATIENTS WITH
IMPAIRED RENAL FUNCTION
Patients with severely impaired renal function have been
treated with ’Tagam et’. However, such usage has been
very limited. On the basis of this experience the
recommended dosage is 3 0 0 mg every 12 hours orally or
by intravenous or intramuscular injection. Should the
patient's condition require, the frequency of dosing may be
increased to every 8 hours or even further with caution. In
severe renal failure accumulation may occur and the
lowest frequency of dosing compatible with an adequate
patient response should be used. Hemodialysis removes
circulating cimetidine, therefore, the timing of dosage
should be adjusted to the dialysis schedule

PATHOLOGICAL HYPERSECRETORY
CONDITIONS
(e.g., Zollinger-Ellison Syndrome)
Recommended adult oral dosage:
3 0 0 mg four times a day with meals and at bedtime. In
some patients it may be necessary to administer 3 0 0 mg
doses more frequently to control symptoms. Dosage should
be adjusted to individual patient needs, but usually should
not exceed 2 4 0 0 mg per day. If intravenous administration
is required, the dosage schedule should be the same as
that recommended for control of upper gastrointestinal
bleeding.

SPECIAL CASES
In patients in whom control of gastric acid secretion is
desirable, the recommended oral dosage of ’Tagamet' is
3 0 0 mg four times a day, with meals and at bedtime. If
intravenous administration is required, the dosage
schedule should be the same as that recommended for
control of upper gastrointestinal bleeding.

STABILITY O F INJECTABLE FORM
'Tagam et' injection, when added to or diluted with most
intravenous solutions, such as Sodium Chloride injection
(0.9% ) or Dextrose injection (5% or 10% ), is stable for 4 8
hours at normal room temperature ’Tagamet' Injection
should not be refrigerated.

AVAILABILITY
Tablets:
Pale green circular biconvex film coated tablets, each
containing cimetidine 3 0 0 mg (monogrammed SKF T13).
Bottles of 10 0 tablets.
Injection:
Each 2 ml dose contains cimetidine HC1 equivalent to 3 0 0
mg of cimetidine, in Sterile Water for Injection. Preserved
with phenol, 0 .5 % . Ampuls of 2 ml, packaged in 10's.
C
l / r c
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Glimpses of Surgical History:
W for Witchcraft, Earliest
Basis of Medicine
D avid

A. E.

Sh eph a r d

WITCHCRAFT is a Jekyll-andHyde facet of man’s attempts to cure
disease. Witches have been regarded
as being of two types—those who,
positively, worked various wonders
and those who, negatively, used
drugs, poisons and other adverse
agents. Perhaps because witchcraft
has negative connotations—it is the
negative aspect of magic, which is
based on “marvellous physical pheno
mena" and “some occult controlling
principle of nature” (and who does
not pay heed to magic of this type?)
—its interest is perennial. In medi
cine we can note the great influence
o f witchcraft. The witch-doctor (or
medicine man or magician—they
were one) constituted the earliest
professional class in society; the
witch-doctor originally was not a
witch but one whose job was to
expel evil from a patient’s body;
and the first type of surgical opera
tion developed from man’s attempts
to drive out of the body “demons"
that were causing suffering in his
unfortunate fellows.
The earliest concept of disease
causation was a dual one: either
morbid material or influences were
projected into the body, or the soul
was abstracted from the body. Early
medicine men tried to counter par
ticularly the effects o f evil spirits
within the body. So they used suc
tion, cupping, vapour baths, incanta
tions—or they performed surgical
trephining. Witch doctors were thus
the earliest surgeons.
Medicine was once influenced by
all of man’s beliefs, of which witch
craft was the earliest. Ancient medi
cine was thus based on witchcraft.
Such a belief system may seem to
be the antithesis of our conviction
of the value of modern surgery, yet
in facilitating healing today’s sur
geons must still help their patients
deploy natural resources; surgeons,
one could say, must help their pa
tients rely on the “controlling prin
ciple of nature” that defines “magic”.
Even if one rejects any relation to
surgery of ineffable forces such as
“magic” or “witchcraft”, one can
at least see how far surgery has
developed out o f the witch-doctor's
technique of trephining. As for the
wiser surgeon, he or she is likely
to remain aware of the value of
such forces, whatever words are used
to define them.
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Pheochromocytoma in the Modern Context
N o r m a n C. D e l a r u e , m d , f r c s [ c ],* John D . M o r r o w , m d , F R C P [c],f
Ja m e s

H.

K e r r , m d , f r c p [c ]$ and R o n ald

C o l a p in t o , m d , f r c p [ c ]§

(3.8% ), multicentric tumours (3.8% )
and malignant change (11.5%) was
lower in this group of patients than
that usually reported. Abdominal
exploration remains the approach of
choice in most cases.
Treatment of the solitary
pheochromocytoma has become
straightforward. However, management
of the familial syndromes and the
malignant form of the disease still
requires careful scrutiny.

The hypertensive patient faces an
uncertain future. Therefore a search
for those cases in which the condition
is potentially curable is eminently
worth while and has become
increasingly productive because of the
specific diagnostic aids now available
and because of the present safety of
surgical intervention.
Detection and localization of a
pheochromocytoma allows a planned
surgical approach. Correction of hypo
volemia preoperatively ensures a safe
course postoperatively. The use of
blocking agents pre- and peroperatively
prevents the hazardous hypertensive
crises and arrhythmias that were a
part of early surgical experience.
Monitoring of central venous and arterial
pressures as well as the electrocar
diographic tracing during the operation
permits prophylactic therapy when
necessary.
On the basis of a series of 31
patients the authors compare many
aspects of the current management
with earlier experience of pheochromo
cytoma in the same institution. The
incidence of extra-adrenal lesions

Le patient hypertendu fait face a un
destin incertain. La recherche des cas
ou I'hypertension est potentiellement
guerissable est done eminemment
valable et est devenue de plus en plus
productive a cause de les aides
diagnostiques et specifiques maintenant
disponible et a cause de la securite
actuelle des interventions chirurgicales.
La detection et la localisation d’un
pheochromocytome permet de planifier
I'abord chirurgical. La correction de
I'hypovolemie avant I’operation assure
une evolution postoperatoire sure.
L'emploi d’agents bloquants, avant et
pendant la periode operatoire, previent
les crises hypertensives dangereuses
et les arythmies qui faisaient partie
des premieres experiences chirurgicales.
La surveillance des pressions veineuse
centrale et arterielle, ainsi que du
trace electrocardiographique pendant
I'operation permet un traitement
prophylactique quand cela est
necessaire.
S'appuyant sur une serie de 31
patients, les auteurs comparent plusieurs
aspects du traitement actuel du
pheochromocytome avec I'experience
anterieure enregistree dans le meme
hopital. L'incidence des lesions extra-
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surrenales (3.8% ), des tumeurs
polynodulaires (3.8% ) et des transfor
mations malignes (11.5% ) a ete plus
basse pour ce groupe de patients que
celle qui est habituellement signalee.
L'exploration adominale demeure la
voie d’abord de choix dans la plupart
des cas.
Le traitement du pheochromocytome
solitaire est devenu simple et direct.
Toutefois, le traitem ent du syndrome
familial et de la forme maligne de la
maladie exige toujours un examen
minutieux.

The pheochromocytoma syndrome is
clearly defined, resembling as it does
the alarm phase (Fig. 1) o f the stress
(or homeostatic) reaction as well as
presenting other characteristic features,
namely, hypertensive crises, sweating,
palpitation and diabetes. These symp
toms were noted in the 22 hypertensive
patients described in this series (Table
I).

Previous reports13 have detailed the
familial relationships o f the tumour, its
association with many other endocrine
conditions that are now commonly
recognized4 and the problems en
countered in managing the pheochro
mocytoma that is first recognized dur
ing pregnancy.5 In 1963 the value o f
peroperative monitoring o f blood pres
sure and cardiac action was emphasized,1
although central venous pressure re
cordings were not commonly used at
that time. The importance o f recogniz
ing and correcting hypovolemia pre
operatively was also noted— particularly
in patients with constriction o f peri
pheral vessels. Some o f these patients
were suffering from an Addisonian
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depletion of sodium (and blood volume)
as a result of either depression of
ACTH due to cortisol produced by the
tumour or a diminished response of the
adrenal cortex to ACTH brought about
by high concentrations of epinephrine.
When the tumour was excised and the
excess of norepinephrine thereby with
drawn, vessel walls lacking in sodium
content could not respond to the sharp
reduction in circulating catecholamines,
hence there was vasodilatation and
peripheral pooling. In these circum
stances essential treatment included the
administration of blood, sodium-con
taining fluid and steroids. Vasocon
strictors were relatively ineffective un
til blood volume and vessel reactivity
had been restored to normal. More
over, in an attempt to prevent the oc
currence of potentially hazardous peaks

HOMEOSTASIS
I ALARM PHASE
STRESS

♦
E P IN E P H R IN E

of systolic hypertension and of refrac
tory arrhythmias during manipulation
of the tumour at operation, the use
preoperatively of an a-blocking agent
(phenoxybenzamine hydrochloride) was
investigated. Initial experience encour
aged further study of the potential
value of this technique. Consequently,
the preoperative management of pa
tients suspected of harbouring a pheochromocytoma (i.e., a potentially cur
able disease) became increasingly so
phisticated, with respect to both diag
nostic considerations and the use of
a - and /3-blocking agents to minimize
intra- and postoperative complications.6
Patients

Our series comprised 31 patients
with a diagnosis of pheochromocytoma— 5 seen in the period 1950 to 1960,
15 in the period 1961 to 1970 and 6
between 1971 and 1975. The data from
five patients were excluded from the
study— in three instances because the
patient was lost to follow-up too soon
after resection of the lesion to permit
adequate review, in one because the
lesion was discovered at autopsy and
in one because no tumour was found at

Table 1— Symptoms in 22 Hypertensive
Patients

♦

PUP IL LA RY D I L A T A T I O N
B R O NCHIA L RELAXATION
SW EATING
C A R D I A C EFFECTS
Increased • Pulse Rafe
• C o n t r a c t i l it y
• I r r it a b il it y
G LY C O G E N O LY S IS
V A S C U L A R RE D IS TR IB U TI O N
(H O M EO STASIS II)
FIG. 1— Physiologic response to epi
nephrine.

Symptom
Headache
Sweating
Palpitations
Heat intolerance
Nausea and vomiting
Diabetes
Anorexia, w eight loss
Fatigue
B lurring of vision
Postural hypotension
Flushing
Irrita b ility
Constipation
Trem bling
Blanching
Epistaxis

No. of patients
22
16
10
10
9
9
8
7
6
5
3
3
3
2
2
1

operation. In the last instance the pa
tient’s preoperative vanillylmandelic acid
(VMA) value (11.1 mg/d [56 /zmol/d])
and the cathecholamine values (urinary
norepinephrine 322 /zg/d [1903 nmol/d]
and epinephrine 203 /zg/d [1108
nmol/d]) had supported the clinical
diagnosis in the presence of hyperten
sion. These values began to fall within
2 months of operation (VMA 8.6 mg/d
[43 /zmol/d], norepinephrine 57 /zg/d
[337 nmol/d], epinephrine 24 /zg/d
[131 nmol/d]) and 2 years later were
normal (norepinephrine 42 /zg/d
[248 nmol/d], epinephrine 10 /zg/d
[54.6 nmol/d]). The plasma
catechol
amine concentrations of venous blood
samples were also normal and localiza
tion of a possible lesion was therefore
impossible. Five years after operation
the patient was still normotensive. The
values in this patient may represent a
false-positive biochemical profile, but
this does not explain fully the accom
panying change from a hypertensive to
a normotensive state.
Data from the remaining 26 patients
form the basis of our report. There
were 16 women and 10 men with an
age range from 19 to 69 years (aver
age, 43 years). Twenty-two were hyper
tensive; 17 of them had typical par
oxysmal episodes. The duration of hy
pertension varied from 1 month to 20
years (average, 51 months).
Only one extra-adrenal lesion was
encountered (Table II) and this was
located in the para-aortic organ of
Zuckerkandl.7'8 The tumour was malig-

Table I I — Location of Lesions in 26 Patients
w ith Pheochromocytoma
Location
Adrenal
Right
Left
Bilateral
Extra-adrenal
Para-aortic

No. of patients
17
7
1
1

FIG: 2,~ Bila*eral multip,e pheochromocytomas. (a) Variegated appearance of right-sided lesion, (b) Lesions in right and
left adrenal glands, (c) Multiple lesions in left adrenal gland.
38 8
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nant and subsequently metastasized.
The one patient with bilateral adrenal
tumours (Fig. 2) was only 23 years of
age and had a remarkable family his
tory of pheochromocytoma. The father
was found to have bilateral adrenal tu
mours at autopsy and a brother, three
first cousins and an aunt had adrenal
tumours.
In 3 of the 26 patients the lesion
was detected during the investigation
of hypertension that developed during
pregnancy. One had a miscarriage preoperatively. In the second patient the
tumour was resected at 16 weeks’ gesta
tion, but an abortion occurred 1 month
after resection. The patient is alive and
well 14 years later. The third patient
who underwent cesarean section at 37
weeks’ gestation had resection of the
pheochromocytoma on the same occa
sion. At the time of writing both the
patient and the child are well 11 years
after the operation.

T Y R O S IN E

1

T Y R O S IN E
h y d r o x y la s e

DOPA

—

Refinements in Diagnostic Technique

Detection of Pheochromocytoma
The fact that catecholamines and
their metabolites are excreted in the
urine has permitted chemical demon
stration of the presence of a catechola
mine-secreting tumour (Fig. 3). How
ever, since only 2% to 4% of nore
pinephrine and epinephrine is excreted
directly, attention has been directed at
detecting the common metabolite VMA,
a larger proportion (40%) of which is
excreted. Although there were no
recognized false-negative reports in this
series, others9 have reported that the
frequency of false-negative results may
be as high as 25% to 30%. Conse
quently the reports that metanephrine
and normetanephrine measurements
were more accurate were evaluated
since larger amounts of these metabolic
by-products are excreted in the urine.
A sharp reduction (to 0% to 4% ) in

-------

c r-M E T H Y L T Y R O S IN E

( ty r o s in e h y d r o x y la s e in h ib it o r )
> 5 0 % in h ib it io n c a te c h o la m in e s y n th e s is

- — -------
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b io lo g ic a lly in e r t e n d - p r o d u c t
( a lth o u g h c h e m ic a lly a c tiv e )

D O P A M IN E
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FIG. 3—Metabolism of catecholamines and urinary metabolites.

Fig. 4a

false-negative reports has been obtained
so that this problem has been practical
ly eliminated.9 In eight patients in whom
a comparison was made, the average
preoperative concentrations of urinary
catecholamines (epinephrine 107 /rg/d
[584 nmol/d], range 26 to 263 [142 to
1435], and norepinephrine 1275 ftg/d
[7536 nmol/d], range 265 to 3718
[1566 to 21 977]) were considerably
lower than those recorded for the meta
bolites (metanephrine 679 /u.g/d [3700
nmol/d], range 231 to 2071 [1260 to
11 300] and normetanephrine 4631
fjtg/d [27 300 nmol/d], range 1857
to 11 912 [11 000 to 70 300]).
Not only do the higher concentra
tions make detection easier and there
fore more accurate, but also the wide
fluctuations ensure earlier detection of
residual or recurrent disease— a matter
of importance when the disease is
malignant in nature.
There were no false-negative results
in the 25 patients in whom estimations
were made preoperatively. Values de
creased to normal in the immediate
postoperative period in 14 of 16 pa
tients who had postoperative testing.
Two patients in whom postoperative
concentrations were elevated were
tested several years later and were
found to have metastatic disease. In
one woman the VMA values returned
to normal postoperatively but she re
mained hypertensive and catecholamine
values were actually higher than during
the preoperative period. This patient
also had bilateral renal artery stenosis
(Fig. 4) and died 8 months after oper
ation of a massive cerebrovascular
hemorrhage complicating the persist
ing hypertension (300/160 mm Hg).
There was no evidence of residual
pheochromocytoma at autopsy.
Localization of Pheochromocytoma
In view of the reported occurrence

Fig- 4b

Fig. 4c

FIG. 4— Localization of pheochromocytoma. (a) Intravenous pyelogram showing depression of right kidney by suprarenal
tumour, (b) Adrenal arteriogram showing right suprarenal tumour “blush”, (c) Renal arteriogram showing bilateral renal artery
stenosis.
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Table III—Roentgenographic Localization of Pheochromocytoma
Method

Table IV—Use of Preoperative “Blockade”

Normal

"Positive”

Not done

12

6

8

13

11

Intravenous pyelography (n = 18)
Arteriography (n = 15 )

2

Type of blocking agent

No. of patients

None

9

a

8

aandp

9*

*a-methyl paratyrosine was used in 1 patient.

of multiple lesions and lesions in extraadrenal locations, attempts to localize
the tumour preoperatively are worth
while in order to plan the appropriate
surgical approach, particularly if the
concentrations of norepinephrine are
much higher than those of epinephrine.
In this event an extra-adrenal location
is likely, since methylation of nore
pinephrine to epinephrine occurs pri
marily in the adrenal gland itself.
Certain risks are associated with ar
terial and venous catheterization. Hy
pertensive crises may occur following
arterial injection of the radiopaque
dye, although in our experience these
are readily controlled by the adminis
tration of phentolamine (2.5 to 5.0 mg
intravenously). During venography in
tramedullary hemorrhage may result
from manipulation of the catheter and
there is the danger of adrenocortical
atrophy due to pressure necrosis asso
ciated with the development of a medul
lary hematoma. For this reason we
prefer arteriography and have been
encouraged by having obtained “posi
tive” findings in 13 of 15 patients
(Table III). In only two cases were the
lesions not demonstrated.
Pheochromocytomas are generally
vascular and easily demonstrated.10’11
Usually an aortic “flush” will suggest
the presence of the tumour and is par
ticularly valuable in signalling the
presence of extra-adrenal lesions, spe
cifically the para-aortic paragangliomas
which are characteristically supplied by
a myriad of vessels arising directly from
the aorta.
Measurement of plasma catechola
mine values in blood samples taken
from different levels of the inferior
vena cava is useful primarily in the
search for possible sites of recurrent
or metastatic disease. In one case of a
malignant lesion in this series the
source of repeated elevated catechola
mine concentrations was discovered in
the right iliac fossa through the in
creased values found in blood samples
from this point.
Intravenous pyelography is also war
ranted because approximately one third
of the patients will have the character
istic depression of the ipsilateral kid
ney (Fig. 4a).
Although abdominal exploration (as
in 19 of our 26 patients) remains the
approach of choice because of the fre
quency of bilaterality and the possibil
390

ity of extra-adrenal location of pheo
chromocytomas, arteriographic localiza
tion of large adrenal lesions (Fig. 5)
has permitted utilization of a posterior
approach (provided that good visualiza
tion of the normal opposite adrenal
has been obtained), thereby ensuring a
smoother postoperative course. In three
patients the unilateral posterior ap
proach was used; all have done well
and are without evidence of residual
tumour. Thoracoabdominal extensions
of the incision (in four patients) are
occasionally advisable when dealing
with very large tumours.

FIG. 5— Adrenal arteriogram shows left
suprarenal tumour. In this patient right
adrenal was normal; aortic “flush” showed
no extra-adrenal lesion. Operation was by
unilateral posterior approach.

Refinements in Technical
Management

Preoperative Blocking of Catecho
lamines
The use preoperatively of both aand /3-blocking agents (Table IV) not
only ensures a fully expanded vascular
system but also minimizes large
fluctuations in blood pressure intraoperatively and the risk of intractable
cardiac arrhythmias. The effectiveness
of this prophylactic therapy increases
with the duration of treatment. Occa
sionally stabilization has been achieved
only after several weeks and operation
should preferably be deferred until this
objective has been realized. The
smoother peroperative course (Fig. 6)
that results from the use preoperatively
of a- and //-blocking agents can be
compared with the experience in the
cases treated earlier in this series, when
either no prophylactic measures were
used (Fig. 7) or an a-blocking agent
was used over the short term only (Fig.
8). In the more favourable situation re
sulting from use of a- and /3-blocking
agents the technical problems are great
ly simplified for the surgeon.
The regimen that has been most ef
fective is; phenoxybenzamine hydro
chloride, 10 mg tid or qid with staged

GLAND

200

mm

Hg

100

mm

Hg

REMOVED

UNBLOCKED PATIENTS
°-

and

p- BLOCKED PATIENTS

MG. 6 Comparison of fluctuations of blood pressure during surgical excision of
pheochromocytoma in patients receiving «- and ^-blocking agents and in those in whom
such agents were not used.
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increases to 40 mg qid if required, and
propranolol, 10 to 20 mg tid or qid
with staged increases up to 100 mg
qid if necessary.
For one patient in whom this regi
men produced incomplete stabilization,
a-methyl paratyrosine was added be
ginning with 250 mg qid and increas
ing to 500 mg qid. Although stabiliza
tion at a normotensive state ensued we
are not certain whether this additional
treatment was helpful or not because
a number of agents were being used.
Peroperative Care
During the operative procedure the
major responsibility devolves upon the
anesthetist.12 For example, anesthetic
agents that stimulate catecholamine or
histamine release are to be avoided.

FIG. 7— Peroperative fluctuations of
blood pressure in patient receiving no
blocking agent.

Halothane, although it is a potent
a-blocking agent that facilitates blood
pressure control, unfortunately stimu
lates production of epinephrine and
therefore increases the risk of arrhyth
mias. Opiates and d-tubocurare cause
histamine release and anectine, which
induces fasciculation, is also to be
avoided.
Monitoring of blood pressure (by
arterial line) permits its regulation by
continuous infusion of phentolamine (1
to 2 mg/mL) and avoids the spectacu
lar fall in blood pressure that follows
intravenous administration of a bolus
of phentolamine (2.5 to 5.0 mg) for
control of a hypertensive crisis.
The use of a central venous pressure
line will provide information on fluid
replacement requirements. Blood trans
fusion is indicated when a low central
venous pressure is associated with a low
blood pressure, whereas if the central
venous pressure is normal or elevated
when the blood pressure is low, vaso
pressors are required. Over-replacement
of fluid before vasomotor tone recovers
and possible production of edema are
thereby prevented.
Continuous electrocardiographic mon
itoring is advisable because of the fre
quency of sinus tachycardias. These
can be effectively corrected by pro
pranolol (0.5 to 1.0 mg intravenously)
if treatment is instituted promptly. With
the use of this precautionary step only
two frank arrhythmias were detected in
the entire series.
From the surgical standpoint, more

300 r
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efficient management by the anesthetist
permits easier technical mobilization of
the tumour, particularly when it is
large, thereby shortening the operative
procedure and lowering the frequency
of technical complications.
Results
Benign Disease
In this group of 26 patients, 23 of
the tumours were clinically benign (Ta
ble V). The single postoperative death
occurred early in our experience; the
patient had unrecognized hypovolemia
and a benign lesion that was associated
with prolonged peripheral vasoconstric
tion preoperatively. Cerebral edema de
veloped with tentorial herniation and
cerebellar coning as the result of post
operative vasodilatation and loss of
fluid through anoxic capillaries. This
death could have been prevented by
preoperative correction of the dimin
ished blood volume and the restoration
of a fully expanded vascular reservoir.
Sixteen of the patients with benign
tumours were normotensive postoperatively. In the 15 patients who have
been kept under surveillance the aver
age duration of observation now ex
ceeds 7 years. One patient was lost to
follow-up while still well. Two others
remained normotensive to death, which
resulted in one case from a cardiac
arrest 7 years later (there had been
demonstrable evidence of cardiac is
chemia preoperatively) and in the other
case from metastatic thyroid cancer
after 13 years. This last patient was
seen before we realized the significance
of medullary carcinoma of the thyroid
so that calcitonin studies were omitted.
Curative therapy was therefore
achieved in 18 of the 23 patients with
benign tumours. At the time of writing,
one additional patient remains normo
tensive while taking medication (methyldopa, 250 mg/d) after 16 years. In this
patient therapeutic control was impos
sible preoperatively. Moreover, a preoperative malignant retinopathy has not
progressed.
The other three patients with benign
tumours remained hypertensive follow
ing excision of the tumour. Reference
has already been made to the patient
with bilateral renal artery stenosis who

HCl

Tab le V— Incidence of M alignancy
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FIG. 8— Peroperative fluctuations of blood pressure in patient receiving short-term
(24-hour) a-blocking agent only.
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No. of patients

Benign
M alignant
H istologic (clin ica lly
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C lin ic a l course

22

Total

26
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died 8 months postoperatively of a
massive cerebrovascular accident when
blood pressure readings were as high
as 300/ 160 mm Hg, although the VMA
values were normal. One other patient
has moderate hypertension (130/100
to 140/ 110 mm Hg) but has been com
pletely asymptomatic for 14 years with
out treatment. The third patient also
has significant hypertension (188/105
mm Hg); he has required only diuretic
therapy during 5 years of follow-up
and the VMA (3.5 to 4.8 m g/d [17.7
to 24.2 yxmol/d]), epinephrine (8.5
/zg/d [46.4 nmol/d]) and norepine
phrine (32.6 to 170 /Ltg/d [192.7 to
1005 nmol/d]) values have remained
normal with the exception of one
isolated norepinephrine recording.

5000 i-

M a lignant Disease

Although pathology reports suggested
that four of the lesions were malignant
according to their histologic features,
only 3 of the 26 patients fulfilled the
necessary clinical criteria of malignant
change by demonstrating metastases in
the follow-up period. The fourth pa
tient has remained normotensive and
well for over 10 years.
Of the three patients with clinically
malignant disease (Table V) one died
of metastases to the central nervous
system after 1 year, having been hyper
tensive in the interim. The other two
warrant more detailed reporting be
cause they survived for long periods
following resection of the primary le
sion, despite the need for treatment
of symptomatic metastatic disease.
Case 1 (Fig. 9).-—This 54-year-old
woman was first seen in May 1968 be
cause of a 4-month history of hyperten
sion; her blood pressure was 240/140 mm
Hg. A pheochromocytoma was excised
and for 3 Vi years she remained normo
tensive. In January 1972 her blood pressure
was 190/110 mm Hg and the VMA ex
cretion value was 24 m g/d (121 u.mol/d).
Phenoxybenzamine hydrochloride, 10 mg
qid, was prescribed and her symptoms
were relieved. The location of recurrent
disease could not be discovered.
A month later roentgenography demon
strated a metastasis in the right ilium and
diabetes was diagnosed for the first time.
Radiotherapy (5000 rad over 5 weeks) was
administered.
In September 1975 a progressively en
larging mass was evident in the right
lower abdominal quadrant and the pa
tient complained of constipation. It was
thought that metastases were present in
the fourth lumbar vertebra and in the
liver. H er blood pressure was 220/125
mm Hg and the VMA excretion value
was 69.5 mg/d (351 u.mol/d). Venous
sampling showed high catecholamine con
centrations at the right iliac fossa. By
January 1976 the dose of phenoxybenza
mine hydrochloride was increased to 30
mg qid and of insulin to 50 units each
morning. In May of that year congestive
392

heart failure with dyspnea developed; her
blood pressure was 200/100 mm Hg and
the VMA excretion value 134 m g/d (677
u.mol/d). By August the edema of the feet
and ankles had increased. A venogram at
this time showed occlusion of the right
common iliac vein and the distal 4 to 5
cm of the inferior vena cava. Aorto
graphy failed to demonstrate other meta
static foci. The iliac mass was shown to
receive its main blood supply from the
right internal iliac artery. The vessel was
catheterized and pledgets of Gelfoam
were injected; a coiled wire vessel oc
cluder was introduced and placed 4 cm
from the origin of the artery, producing
complete occlusion. Subsequently the
urinary norepinephrine value fell from
3096 p.g/d (18 300 nm ol/d) to 1840
p.g/d (10 876 nmol/d).

EXCISION
PHEOCHROMOCYTOMA

FEB. SEPT. OCT

FIG. 9—Comparison of urinary excre
tion values of catecholamines and cate
cholamine metabolites in primary and
metastatic malignant adrenal disease.
---------- = norepinephrine, - - - - — epi
nephrine, ------------- = normetanephrine
(1968 to February 1972 o n ly ) ,------ -- =
metanephrine (1968 to February 1972
only). Content of norepinephrine was
44.6 Mg/g of tissue in primary tumour
and of epinephrine was 139.7 Mg/g.

FIG. 10— Sequential change in urinary
secretion values of catecholamines and
catecholamine metabolites in primary and
metastatic malignant extra-adrenal para
aortic pheochromocytoma (normal upper
limits: epinephrine 15 to 30 Mg/d [82 to
164 nmol/d], norepinephrine 50 to 90 Mg/d
[296 to 532 nmol/d]. ---------- — norepi
nephrine, - - - - — epinephrine,---------- —
normethanephrine (1970-71 only), - - - = metanephrine (1970-71 only). Primary
tumour (1966) content of norepinephrine
was 3.9 Mg/g and of epinephrine was
0.002 Mg/g. In extradural metastasis (1970)
content was 380 n_g/g of norepinephrine
and 35 y.g/g of epinephrine.
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The patient died on Sept. 30, 1976.
Autopsy revealed retroperitoneal exten
sion of the tumour, involvement of para
aortic lymph nodes, pulmonary metastases,
a single hepatic nodule and metastases in
the lumbar spine. There was a small
focus of recurrent tumour above the left
kidney.
Case 2 (Fig. 10).—A 19-year-old pa
tient who first came under our care in
December 1966 had had paroxysmal hy
pertension (blood pressure range, 130/90
to 200/100 mm Hg) for 4 months. The
VMA value was 32 m g/d (162 (xmol/d).
Arteriography demonstrated a para-aortic
lesion, which was excised. The patient re
mained normotensive for 3 years follow
ing the operation but in February 1970
had recurrence of headaches, sweating and
fatigue; blood pressure was 160/105 mm
Hg and the VMA excretion value 82 m g/d
(414 y.mol/d). Parethesias to the level of
the nipple line were present. Roentgeno
graphy disclosed evidence of osseous meta
stases at the T -l to T-3 levels and a
laminectomy was performed for residual
extradural tumour: radiotherapy was ad
ministered postoperatively. Afterwards the
blood pressure decreased to 138/85 mm
Hg and the VMA value to 11.7 m g/d
(59 (j.mol/d).
In September 1972 further radiotherapy
was necessary because of metastases in
the spinous process of C-3 and in the
shaft of the left femur. The patient re
mained free of symptoms and the blood
pressure was stationary at 140/90 mm Hg
until January 1977 when it was found to
be 150/105 mm Hg. A further rise to
170/120 mm Hg was discovered in Aug
ust of the same year when the patient
again noticed numbness of the left an
terior chest wall and complained of pain
on coughing. A myelogram showed total
obstruction at the T-8 level and therefore
irradiation to a total dose of 4000 rad
was administered. This partially relieved
the spinal block as demonstrated by a later
myelogram and reduced the paresthesias.

The possibility of the disease being
malignant should not therefore affect
surgical treatment of the primary le
sion regardless of its location, since
its removal is compatible with lengthy
survival, and worthwhile palliation for
prolonged periods can still be achieved
when metastatic disease has declared
its presence. Local radiotherapy is in
dicated for bony and soft tissue recur
rences, and, although not used in this
group of patients, chemotherapy with
vincristine and cyclophosphamide has
been reported to produce temporary
improvement in some cases.13
Multiple Endocrine Neoplasia
The presence of a possible genetic
or familial background for their disease
in some patients with pheochromocyto
ma was discussed in our original pub
lications on the subject.1-3 In the in
tervening 15 years we have encountered
several additional cases that reflect this
predisposition, although no patient has
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exhibited all the attributes of specific
multiple endocrine neoplasia (MEN)
syndromes. A review of this group of
26 patients has discovered the follow
ing associations:
Family History
1. Hypertension in five patients.
2. Diabetes in two patients.
3. Pheochromocytoma in six other
family members (in one of whom it
was bilateral) of one patient.
4. Multiple brain tumours in four
other family members of one patient.
Personal History
In patients with the MEN syndromes
in which the adrenal medulla may be
involved the primary association is with
medullary carcinoma of the thyroid
(type 2 syndrome). Pheochromocytoma
is frequently bilateral in this syndrome14
and is found most often when there is
a familial occurrence of medullary
thyroid cancer.15 Calcitonin estimations
can now be employed to detect thyroid
lesions of this type and in occult cases
in which the presence of the lesion is
suspected, glucagon or calcium infu
sions may be used to stimulate calci
tonin production. Recently the pentagastrin stimulation test has been found
to be more reliable than calcium infu
sion in demonstrating occult lesions.15
The relationship of pheochromocyto
ma to parathyroid hyperplasia or ade
nomas may be secondary or compen
satory in nature, representing reactive
stimulation of the parathyroid in an at
tempt to maintain normal calcium con
centrations in response to the calcium
lowering effect of calcitonin.
Any of the three components (adre
nal medulla, thyroid, parathyroid) of
the MEN syndromes may give rise to
the presenting symptoms in individual
patients. Furthermore, each pathologic
entity may begin as a hyperplastic reac
tion before tumours develop and the
hyperplastic reaction itself may be
capable of producing both symptoms
and signs.16 Fortunately it is now pos
sible to demonstrate the lesion at the
stage of hyperplasia in each instance.
An excess production of epinephrine
affecting the epinephrine/norepine
phrine ratio may reflect the presence
of adrenal medullary hyperplasia. In
creased serum calcitonin values follow
ing pentagastrin stimulation will identi
fy thyroid hyperplasia, and if infusion
of calcium does not suppress the para
thormone concentration, this constitutes
substantial evidence of parathyroid hy
perplasia.
There appears to be a consensus, in
view of the capacity of medullary car
cinoma of the thyroid to metastasize in
the occult stage, that total thyroidec
tomy is warranted if increased calci
tonin production is demonstrated. On
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the other hand, the parathyroid hyper
plasias do not usually present a
significant clinical problem and there
fore only frank adenomas require sur
gical excision.
Although some16'17 have advised
bilateral adrenalectomy for adrenal
medullary hyperplasia, the ultimate
biologic behaviour of this condition
cannot be clearly predicted. Admittedly,
pheochromocytoma and adrenal medul
lary hyperplasia, if present, are bila
teral in cases of MEN and if a frank
tumour exists bilateral resection is
probably warranted. However, unless a
tumour can be identified or disabling
symptoms are already present, a con
servative therapeutic approach would
seem advisable, since the risk of death
from hypertensive complications or
malignant disease can be avoided by
annual screening for developing dis
ease and increasing complaints.
The chronicity of the various disease
processes and the lengthy induction
period that precedes the development
of symptomatic disease can be illus
trated by the experience acquired in
the present series of cases. The follow
ing histories were obtained from in
dividual patients in the group:
1. Parathyroid adenoma 6 years prior
to resection of pheochromocytoma at
25 years of age in 1948. At last fol
low-up, 14 years after treatment of the
adrenal lesion, the patient was well and
completely asymptomatic.
2. Medullary thyroid cancer resected
by subtotal thyroidectomy 7 years be
fore excision of a pheochromocyto
ma in 1961 at 35 years of age. The
patient died of metastatic carcinoma of
the thyroid 13 years after treatment
of the adrenal lesion. He was normotensive at that time.
3. Thyroidectomy at 13 years of age.
A solitary pheochromocytoma was re
sected 36 years later in 1962. The pa
tient was well and normotensive 14
years after adrenal surgery. No descrip
tion of the histologic features of the
thyroid lesion was available but it
would be reasonable to infer that it
was a medullary carcinoma since it
occurred so early in life.
4. Resection of single pheochromocy
toma at 29 years of age. The initial
thyroid scan showed the presence of
a cold nodule. There were cafe-au-lait
spots, a history of neurofibromas and
a family history of hypertension. The
patient remained normotensive 1 year
after resection (1976). At that time re
peat thyroid scan was normal as were
serum calcium and calcitonin values.
5. Myxedema noted at 57 years of
age at the time of resection of an
adrenal tumour (1961). At last follow
up 4 years later the patient was re
ported to be completely well and nor
motensive.

6.
Adrenal cyst removed 8 years
before excision of an adrenal tumour
at age 49 years (1970). The patient was
normotensive and well 2 years after
the second operation. The pathologic
features of the adrenal cyst were not
recorded.18
Conclusions
The investigative techniques avail
able at present will identify and in
most cases accurately localize pheochromocytomas if they are present in
patients with hypertension. The search
is eminently worth while since curative
therapy may be accomplished in the
majority of patients. Approximately
four out of five patients with benign
tumours will remain normotensive postoperatively. With careful attention to
prophylactic measures serious hyper
tensive crises and arrhythmias can be
controlled during the operative mani
pulation and there should be no sig
nificant operative mortality.
Effective screening techniques are
now available for patients with a
family history of hypertension and
should be more fully utilized, particu
larly in young people and when several
family members have been hypertensive.
In addition, recognition of MEN
syndromes makes screening for asso
ciated disease in the thyroid (and para
thyroid) a practical and valuable aid
for the early recognition of hyperplastic
precursors and occult neoplastic le
sions.
The situation is not hopeless even
when the disease is malignant. Cellular
pleomorphism makes it unwise to ac
cept the diagnosis of a malignant lesion
on histologic grounds alone. Annual
screening of urine samples may detect
increasing concentrations of catechola
mine metabolites (metanephrine and
normetanephrine) as the first indicators
of recurrent (metastatic) disease. Long
term relief of hypertensive and meta
bolic symptoms can be provided with
phenoxybenzamine hydrochloride or
propranolol, or both. Radiotherapy (or
surgical excision when warranted) may
relieve disabling complaints of localized
disease. The place of systemic chemo
therapy remains to be established. Use
of these various therapeutic measures
is compatible with long-term survival
and worthwhile palliation in some pa
tients.
Recent evidence that adrenal medul
lary hyperplasia may not only be a
precursor of solitary or multiple pheochromocytomas, but may itself be
capable of producing substantial com
plaints, indicates the advisability of
screening for its presence in patients
in whom it is suspected or in whom
there is evidence of symptomatic mul
tiple endocrine neoplasia.
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It is evident that great advances
•have been made in the recognition
and management of adrenal medul
lary syndromes in the past 15 years.
Full utilization of these techniques will
obviate m any of the problems asso
ciated with such disease that plagued
both the physician and the patient in
the past.
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BOOK REVIEWS
CONGENITAL ADRENAL HYPER
PLASIA. Edited by Peter A. Lee, Leslie
P. Plotnick, A. Avinoam Kowarski and
others. 532 pp. Illust. University Park
Press, Baltimore, 1977. $37.50. ISBN
0-8391-0974-1.

This book is the product of a symposium
entitled “The Treatment of Congenital
Adrenal Hyperplasia: A Quarter of a
Century Later”, which was held at the
Johns Hopkins Hospital in October 1975.
It presents contributions from over 50
international investigators and is divided
into seven general areas: historical aspects;
pathophysiology; hormone measurement
in diagnosis and management; long range
follow-up; surgical correction and sexual
maturation; psychological, intellectual and
educational aspects; and detection of the
heterozygous state and prenatal diagnosis.
Each section is well presented and in
cludes current references to the experience
of several large groups dealing with con
genital adrenal hyperplasia (CAH). Bongiovanni deals briefly with the nature of
the enzymatic defects in the biosynthesis
of cortisol, whereas the mechanism of
action of ACTH is described at length.
I would have preferred that the emphasis
be reversed. A welcome feature is the
chapter by Josso on the mullerian in
hibitory factor (anti-miillerian hormone).
However, the section on the androgen in
sensitivity syndromes is out of place in a
text dealing with CAH and androgen
excess.
The recent advances in hormone meas
urement that led to improvement in diag
nosis and management are well presented;
the usefulness of the determination of to
tal blood cortisol (TBC) and 17-hydroxyprogesterone (17-OHP) by radioimmuno
assay is pointed out. The sections dealing
with long-range follow-up at sexual ma
turity provide important information on
the long-term prognosis for fertility, preg
nancy and normal spermatogenesis in
adults who have received cortisone therapy
for over 25 years. However, these sections
suffer because the experience of several
different clinics is reported. Often the
results are comparable but occasionally the
presentation of conflicting data leaves no
clear direction for the management of
particular patients.
Surgical correction is dealt with rather
briefly, but interesting information is pro
vided on the follow-up of 84 patients who
had undergone primary surgical interven
tion, 25 (30%) of whom required a second
operation.
The editors include a discussion of the
pathophysiology of salt loss and the im
plications with regard to normal growth
and development and hormone replacement.
The psychosocial aspects of management
are well presented and there is an excel
lent discussion on patient education by
Rosenbloom. The manual on CAH for
parents and patients will prove practical
and useful.
In the final section of the book the
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editors deal more with the future than
with the present or past. They review the
current state of the art as it applies to
prenatal diagnosis and detection of the
heterozygous state. Little progress has
been made in the use of modern assay
methods to detect the fetus with
CAH. Unfortunately, these methods can
only be used late in gestation, by which
time the virilization in females has al
ready been established. Antenatal diag
nosis might, however, lead to improved
therapy in the newborn and neonatal death
could be prevented. Owing to the rela
tively high gene frequency the detection
of the heterozygous state is important for
genetic counselling. Current research is
involved with attempts to determine the
heterozygote by utilizing the determination
of TBC and 17-OHP before and after
ACTH stimulation. To date, these meth
ods have not been entirely successful.
The text is too complex for medical
students. However, it will be of value
to residents and practitioners in the vari
ous related specialties, including endocrin
ology, gynecology, reproductive physiology
and genitourinary surgery.
H arvey G uyda

Department of endocrinology,
The Montreal Children’s Hospital,
Montreal, PQ
SCIENTIFIC
FOUNDATIONS
OF
UROLOGY. Vol. 1. Renal Disorders,
Infections and Calculi. Edited by David
Innes Williams and Geoffrey D.
Chisholm. 374 pp. Illust. William
Heinemann Medical Books Ltd., Lon
don; Year Book Medical Publishers Inc.,
Chicago, 1976. $27.25. ISBN 0-81514821-6.
SCIENTIFIC
FOUNDATIONS
OF
UROLOGY. Vol. II. Urogenital Tract,
Oncology and the Urological Arma
mentarium. Edited by David Innes Wil
liams and Geoffrey D. Chisholm. 474
pp. Illust. William Heinemann Medical
Books Ltd., London; Year Book Med
ical Publishers Inc., Chicago, 1976.
$29.35. ISBN 0-8151-4822-4.

The scientific method has greatly improved
the efficacy of the treatment of urologic
disease. The material presented in these
two volumes forms the framework of cur
rent scientific urology within which the
clinician must work. The scope of scienti
fic urology is expanding rapidly and the
authors, for lack of space, have had to
omit a great deal of material. For example
embryology, although it is vital to the
understanding of genital anomalies, had
to be sacrificed.
The first volume includes discussions of
the anatomy and physiology of the kidney
of renal failure, renal hypertension, renal
transplantation, urinary tract infection,
urolithiasis, tissue response and tissue
replacement and genetics. This volume will
continued on page 419
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Total Colonic Aganglionosis
J.H. Louw,

CH M , FRCS, FACS*

clinique a la consultation etait
extremement variable.
Le diagnostic precoce depend d'une
connaissance clinique de cette maiadie
chez les nouveaux-nes ayant une
obstruction intestinale, une diarrhee,
ou les deux a la fois. L’indice radiologique le plus important a ete la
retention du barium pendant 24 heures.
Les resultats des etudes manometriques
ont ete trompeurs. La biopsie par
aspiration du rectum a offert la seule
methode sure de diagnostic, bien que
la determination de I’activite cholinesterasique dans I'echantillon de biopsie
et dans le serum du patient ait ete
d’une certaine aide.
Deux patients sont decedes avant
I'operation et deux sont morts d’une
aganglionose totale du colon et de
I'intestin grele. Huit patients ont
survecu a I'ileostomie initiale et a
I’anastomose subsequente. De toutes
les interventions utilisees, I'operation
de Lester Martin s'est averee la plus
satisfaisante.

This study is based on 17 neonates
suffering from total colonic
aganglionosis. The male:female ratio
was 2:3 and there was a significant
familial occurrence. The ages on
admission varied between 1 and 90
days. The clinical presentation was
extremely variable.
Early diagnosis depends on clinical
awareness of the condition in neonates
who have intestinal obstruction or
diarrhea, or both. The most important
radiologic indication was retention of
barium for 24 hours. Results of
manometric studies were misleading.
Suction biopsy of the rectum provided
the only sure method of diagnosis,
although determination of cholinesterase
activity in the biopsy specimen and in
the patient's serum was of some value.
Two patients died before operation
and two died from total colonic and
small intestinal aganglionosis. Eight
patients survived both the initial
ileostomy and subsequent pull-through
operation. Of the various procedures
utilized, the Lester Martin operation
has proved to be the most satisfactory.

During the 21-year period July 1, 1956
to June 30, 1977 we treated 217 pa
tients suffering from Hirschsprung’s
disease at the Red Cross War Memorial
Children’s Hospital, Cape Town (i.e.,
approximately 10 patients per year).
Seventeen (8%) of these patients had
total colonic aganglionosis and they
form the basis of this paper.
The incidence of Hirschsprung’s dis
ease in populations of Western Euro

Cette communication se ref ere a 17
patients souffrant d'aganglionose totale
du colon. Le rapport des patients males
et femelles etait de 2:3 et une incidence
familiale significative a ete decelee.
Les ages lors de I’hospitalisation
variaient entre 1 et 90 jours. Le tableau

pean origin has been calculated at about
0.02% or 1 in 5000 births.1,2 In Cape
Town, where we have seen an average
of 10 patients with this disease per
year, our mean annual birth rate is
20 000, that is, the incidence is 0.05%
or 1 in 2000 births. The overall sex
ratio of three males to one female is
somewhat less than the four to one
ratio reported in other large series,2"5
but can be accounted for by the fact
that 21% of our patients had long seg
ment disease and total colonic agan
glionosis in which female patients are
more frequently affected.1"3,6,7
The occurrence of short segment dis
ease in three quarters of the patients
(Table I) is similar to that reported by
Swenson, Sherman and Fisher5 and
others,6 while the 15% incidence of
long segment disease is about half-way
between the extremes of 8% and 26%
reported by others.2 An incidence of
8% for total colonic aganglionosis is
also in keeping with the findings of
others, who report 2 % 3 to 13%8 with
an average of 6% .6
The male preponderance of four to
one in the classical short segment dis
ease (Table I) has now been well
established. The less evident predo
minance of males in the other types is
in keeping with reports from many
authors,2’3,6’7 with the notable exception
of Swenson, Sherman and Fisher,5 who
found no variation with the length of
the aganglionic bowel in their series of
501 patients. Our ratio of two males to

From the Red Cross War Memorial
Children’s Hospital, Cape Town,
South Africa
T a b le 1— Sex, F a m ilia l

Fred G. McLeod Lecture presented at the
10th annual meeting of the Canadian
Association of Paediatric Surgeons,
Vancouver, BC, Jan. 25, 1978

S h o rt s e g m e n t
d is e a s e

*Professor and head, department of
surgery, University of Cape Town
medical school

N o. o f p a tie n ts
M a le : fe m a le ra tio
No. o f s ib lin g s
A g e on a d m is s io n
Range
M ean

Reprint requests to: Dr. J.H. Louw,
Department of surgery, University of
Cape Town Medical School,
Observatory 7925, South Africa
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171
4:1
2
1 d - 13 y r
114 y r
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29
2:1
1
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T o ta l c o lo n ic
a g a n g lio n o s is
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1:1 .5
6
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12 d
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three females in total colonic agan- has been controlled with loperamide
glionosis is similar to that reported by hydrochloride.
Prevot and colleagues6 from Nancy.
A ge on A dm ission
The familial occurrence of Hirsch
sprung’s disease has been noted by
It is not surprising that symptoms
many workers1-’-6-7 and is of consider severe enough to necessitate hospitaliza
able theoretical and practical interest. tion correlate with the length of the
In our series as a whole there were aganglionic segment, that is, the longer
nine cases in which siblings were af the segment the earlier the onset of
fected, an incidence of 4.1%, which symptoms and the greater their urgency
corresponds to the 4% occurrence do (Table I). However, it is well known
cumented by geneticists.1-’-7 However, that this correlation is not absolute.’
only five families were involved because Among our cases one third with short
two pairs of siblings and one family segment disease presented with urgent
of three are included among our cases. symptoms on the first or second day of
On the other hand, there was an addi life, and in 50% of our neonatal cases
tional case with well-documented evi the disease was of the short segment
dence of older siblings dying of sus type.9 On the other hand, in 25% of
pected Hirschsprung’s disease without those with long segment disease and
histologic proof, and one pair of in 15% of those with total colonic
siblings had a cousin with proven aganglionosis, the initial symptoms were
aganglionosis.
so mild that they were overlooked, or
The length of the aganglionic seg first became manifest after weeks or
ment has an important bearing on the even months.9
familial occurrence, the long and total
The lack of a constant relation be
segment cases being at greater risk.1-7 tween the extent of aganglionosis and
In our cases the incidence was 1.2%
severity of symptoms is further il
for short segment disease, 3.4% for lustrated by our patients with total
long segment disease, and as high as colonic aganglionosis (Fig. 1). Only two
35% for total colonic aganglionosis infants were admitted on the first day
(27% on a familial basis). If we com — one with only colon involved and the
bine our cases of long segment disease other with involvement of colon plus
and total colonic aganglionosis the in 5 cm of small bowel. On the other
cidence was 15% (11% on a familial hand, in an infant with involvement of
basis) which corresponds with Pas colon and 20 cm of small bowel ad
sag e's1 calculation that the risk in long mission was delayed for 13 days, while
segment disease plus total colonic one of those with total colon and smallaganglionosis is 10%.
bowel involvement was admitted on the
We have had only one patient who
10th day. Of special note is the infant
had an affected twin. He suffered from with involvement of colon plus 5 cm
long segment disease and she from of ileum who was admitted on the 30 th
total colonic aganglionosis. In the day; she had been completely asymp
literature there are only a few accounts tomatic for the first 2 weeks of life
of the disease occurring in twins, either but then diarrhea and vomiting devel
dizygous or monozygous.1 Our series oped and she was treated at home for
includes one family in which two fe the next 2 weeks. Of even greater inmale siblings suffered from total colonic
aganglionosis and a younger first cou
sin had short segment disease. Passarge1
found that 10% to 15% of the propo
siti in his study had first cousins who
were affected. There were no affected
parents in our study. Our first suc
cessfully treated patient with Hirsch
sprung’s (short segment) disease is now
25 years old and married, but she has
not yet had children. An affected
parent who had an affected child has
been described at least four times and
there are several reports of suspected
but unproven parental disease.1
We have records of an Australian
family seen by us for check-up during
a visit to South Africa early in 1977.
The mother had short segment disease,
which was treated in Sydney, and two
of her children had total colonic
aganglionosis, also treated there. They
FIG. 1— Extent o f aganglionic bowel
are now 14 and 11 years of age and
and age (in days) at time of admission.
well, apart from loose stools, especially Figures
in parentheses indicate age (in
in the younger child, but this symptom days) on admission elsewhere.
398

VOLUME 21, NO. 5, SEPTEMBER 1978

/

terest is the infant with involvement of
colon plus 10 cm of ileum who remained
completely asymptomatic for 3 months
(I shall refer to him again).
It should be emphasized that in
babies with total colonic aganglionosis
the delay in admission was by no means
always due to lack of symptoms, but
in many cases resulted from failure
to suspect the fcondition because of its
protean clinical manifestations. Indeed,
in retrospect, 15 of our 17 patients had
suggestive symptoms during the first
2 days of life.
Sym ptom s

The frequency of the various symp
toms is shown in Table II, from which
it is evident that distension and vomit
ing were the most common. Surprising
ly, four of the infants passed their first
meconium stool before they were 24
hours old. In three of them it was re
lated to the development of enteroco
litis, but the fourth had no suspicious
symptoms for 3 months and then pre
sented with acute peritonitis due to a
perforated appendix. In this connection
Swenson, Sherman and Fisher9 have
reported that 95% of infants with
Hirschsprung’s disease fail to pass a
stool within 24 hours.
More important than the frequency
of occurrence of each individual symp
tom was the combination of complaints
(Table III). In seven patients the char
acteristic triad of constipation or de
layed passage of the first stool, disten
sion and bile-stained vomiting was
present, and in three more diarrhea oc
curred as well.
Also of importance was the vari
ability in the onset of the symptoms
Table II—Symptoms in 17 Patients

Symptom
Absolute constipation
Delayed passage of first stool
Distension
Vomiting
Diarrhea
Other

No. of
patients
10
3
15
14
6
1

Table II I—Combinations of Symptoms
Symptoms
Constipation + distension +
vomiting
Delayed stool + distension +
vomiting
Constipation + distension
Delayed stool + vomiting
Constipation - f distension +
vomiting + diarrhea
Vomiting + diarrhea + distension
Other

No. of
patients
5
2
2
1
3
3
1
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months. An infant admitted on the
fourth day also had an inappropriate
operation; she survived but also had a
stormy passage until appropriate de
compression was carried out at 5
months. Then there was an infant in
whom an inappropriate operation was
done elsewhere when she was 5 days
old. She remained partially obstructed
until the appropriate operation was
done on the 26th day. Thus in a group
of seven with symptoms urgent enough
to demand admission within 5 days,
there were four survivors. If we in
clude in this group the infant, previ
ously referred to, admitted on the first
day who died without surgery within
12 hours, we are left with four sur
vivors out of eight—a truly serious
situation.

and the presentation of the disease. At
one extreme was an infant admitted at
the age of 1 day with the classical triad
of symptoms and a barium enema ap
pearance suggestive of total colonic
aganglionosis. He collapsed soon after
admission and died within 12 hours
before corrective surgery could be car
ried out. At the other extreme was the
child who remained asympomatic for
3 months and then suddenly developed
an ucute illness with vomiting, restless
ness, pyrexia and collapse. He was op
erated on within 24 hours of the onset
and found to have total colonic agan
glionosis complicated by acute per
forated appendicitis and peritonitis. He
failed to rally postoperatively and died
3 days later.
Between these extremes was an in
fant who remained asymptomatic for
2 weeks and then had diarrhea and
vomiting with later distension. She was
admitted to hospital only 2 weeks later.
Hirschsprung’s disease was suspected
but the barium enema was misinter
preted, which led to a further delay of
6 days. Then repeat roentgenography
revealed retained barium, but soon
afterwards she had upper gastrointes
tinal bleeding and collapsed and died
within a few hours. At autopsy total
colonic aganglionosis and a perforated
duodenal ulcer with peritonitis were
found.
Finally, there is the variability in the
severity and course of the disease (Ta
ble IV). This is well illustrated by the
remaining 14 patients, in all of whom
symptoms commenced during the first
2 days of life.

Surgery in Second Week
In two infants admitted on the fourth
day, the symptoms were mild enough
to postpone surgery until the second
week. One succumbed from total colon
ic and total small intestinal aganglio
nosis, while the other survived. The
same applies to two infants admitted at
the ages of 10 days and 13 days re
spectively. The mortality in this group
was also 50% but was due entirely to
total colonic and total small intestinal
aganglionosis.
Surgery in Third Week
In one infant admitted on the fifth
day the symptoms were so mild that
surgery was deferred until the third
week, and he survived. The same holds
for another infant admitted on the 12th
day. Thus the survival rate was 100%.

Surgery in First Week

Later Initial Surgery

In only three patients were the
symptoms severe enough to demand
immediate admission within the first 2
days of life. All three were operated
upon during the first week of life, but
only one survived. Two were admitted
on the third day and were also operated
upon within the first week. One sur
vived despite an inappropriate opera
tion but had a very stormy course until
the proper operation was done at 13 Vi

An infant admitted at 5 days of age
was in complete remission after 2
weeks’ hospitalization and remained
asymptomatic until the age of 414
months, when she was operated upon.
She survived this operation as well as
a later definitive procedure, but died
at home at the age of 314 years. In ad
dition, there were the two patients ad
mitted much later and already referred

Table IV— V ariability in Severity and Course
Tim ing of operation (no. of patients/survivors)
Later

Age on admission, d

1st week

2nd week

3rd week

1-2
3
4
5
10-13

3/1
2/1*
1/1*
1/1*

—

—

—

—

—

—

Total

—

7/4

2 f/l

—

—

1 / lt

2 f/ l

1/1
1/1

4/2

2/2

1/1

—

—

’ Operation inappropriate; correct operation at 13VJ mo, 5 mo and 26 d (with survival),
f l each had total colonic and total sm all intestinal aganglionosis.
fComplete remission until 414 mo.
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Total
3/1
2/1
3/2
3/3
3/2
14/9

to. They were aged 30 days and 90
days respectively; both died.
These various cases serve to illus
trate the crux of total colonic agangli
onosis, namely, that while it is usually
a highly lethal disease unless promptly
treated, it occasionally does tend to
remain asymptomatic, or to remit, and
patients with the disease may withstand
incorrect surgical procedures for pro
longed periods.6-10 These idiosyncrasies
no doubt account for the apparent late
onset or prolonged survival of some
untreated or incorrectly treated cases
reported in the literature.11 There are
many reports of infants with total co
lonic aganglionosis who first presented
at up to 12 weeks of age,6,8’12 and occa
sional reports of first presentation in
adolescence13’14 and even in adults.15
However, in all of them there was a
history of “bowel trouble” during the
neonatal period. Our patient who re
mained entirely asymptomatic until the
age of 3 months is, therefore, unique.
Indeed, this infant had been under our
personal observation since birth because
two older siblings suffered from Hirsch
sprung’s disease, one with short segment
disease and the other with total colonic
aganglionosis. At the age of 214
months he was seen for a check-up and
found to be perfectly well. Two weeks
later acute appendicitis developed,
which has been recorded as a com
plication of total colonic agangliono
sis.16’17 Unfortunately he died despite
appendectomy and ileostomy.
Diagnosis
Clinical Features
The keynote to early diagnosis is a
clinical awareness of the possibility of
total colonic aganglionosis in every in
fant who presents with signs and symp
toms of neonatal intestinal obstruction
or diarrhea, or both. Delay in the pas
sage of the first meconium stool is
usually, but not always, present, while
abdominal distension is a constant sign
although it may be intermittent at
first.6 Rectal examination reveals a
narrow rectal ampulla but rarely pro
vokes the efflux of liquid stools which
is so often seen in short segment di
sease and even in long segment disease.
The presence of certain complica
tions should also suggest the diagnosis.
Early perforations are less frequent in
long segment than in short segment
disease but do occur; for example, a
cecal perforation occurred in one of
our patients at the age of 3 days.
More frequently, perforations tend to
occur after inappropriate surgery, espe
cially if an ostomy is established in a
zone of aganglionosis and does not
function. This occurred in three of our
patients— in one after two laparotomies,
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in another after cecostomy and in the
third after ileostomy (instead of jejunostomy).
Another complication is acute appen
dicitis as occurred in one patient who
presented at 3 months. It should be
noted that acute appendicitis com
plicating total colonic aganglionosis has
been reported by a number of work
ers16'17 including Swenson, Sherman and
Fisher.5 Indeed, it is a good rule to
suspect total colonic aganglionosis in
any young infant in whom acute ap
pendicitis develops.
The family history can provide useful
information especially when a history of
Hirschsprung’s disease can be elicited in
a sibling or close relative. Death of a
previous child with alimentary symp
toms of unknown etiology may also be
significant.

into the terminal ileum (Fig. 4); a tran
sitional zone into dilated ileum (Fig. 5),
which may be misinterpreted as an ileal
intussusception; retention of barium
throughout the colon for 24 hours18'20
(Fig. 6) and longer. Unfortunately, false
transitional zones in the sigmoid (Fig. 7)
or transverse colon may appear,20 and
misled us in two of our cases. One of
these patients had a juvenile polyp at
the site of apparent transition, and this
might have caused the confusion.
Operative Findings

When colonic aganglionosis is sus-

FIG. 5— Barium enema showing reflux
into narrowed terminal ileum which dilates
into transitional zone.

Radiologic Findings

Hirschsprung’s disease should be sus
pected in all infants with a history of
intermittent vomiting and diarrhea who
have multiple fluid levels on the plain
roentgenogram.18 An inverted lateral ro
entgenogram that shows a deficiency of
rectal gas and dilated small bowel, giv
ing an “egg on end” appearance, should
increase the suspicion19 (Fig. 2). After a
barium enema the colon usually appears
normal in calibre, unlike the microcolon
of atresias and meconium ileus. In addi
tion, the following special features
should be sought:20 reduction in the
length of the colon, especially at the
flexures and the loops of sigmoid and
transverse colon (Fig. 3); an irregular
contour with areas of abnormal rip
pling (Fig. 4); free and rapid reflux

FIG. 3— Barium enema showing fore
shortening of sigmoid and transverse
colon.
FIG. 6— Barium enema showing reten
tion of barium in whole colon after 24
hours.

FIG. 2— Inverted lateral roentgenogram
showing lack of gas in rectum and “egg
on end” appearance. Apex of “egg” points
to pelvis.
400

FIG. 4— Barium enema showing ir
regular colon from enterocolitis, and free
reflux into dilated ileum.
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FIG. 7— Barium enema showing false
transitional zone in sigmoid colon.
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pected on the basis of clinical and
radiologic findings, laparotomy is in
dicated to establish the diagnosis and
determine the extent of the disease by
histologic studies of biopsies taken at
various levels during the operation. At
laparotomy variable lengths of the small
bowel are distended and hypertrophied,
and mechanical obstruction must first
be excluded. Total colonic aganglionosis
should be suspected when there is
marked dilatation of the small intestine
in association with a ribbon-like fore
shortened colon. In one of our cases
the condition was misdiagnosed as
Ladd’s syndrome, in a second as an in
ternal hernia, and in yet another as
meconium ileus. The typical cone of the
transitional zone can often be detected
in the ileum, but there may be false
cones in the transverse or sigmoid
colon. Two of our patients had false
cones.

The extent of the disease cannot be
determined from the macroscopic ap
pearance alone. In more than half of
the reported cases and in one third of
our own the extent was misjudged.
Frozen sections from multiple biopsies
are therefore mandatory and a rapid,
nonspecific cholinesterase stain21 has to
be used to distinguish immature from
absent ganglia (Fig. 8). However, his
tologic abnormalities may be misinter
preted in frozen sections, especially in
total colonic aganglionosis, and this was
unfortunately so in one of our patients.
Manometry
In the neonate who presents with
acute symptoms preoperative mano
metry is obviously out of the question.
Even in older infants with mild symp
toms the technical difficulty is such that
the investigation is seldom of value.
However, it should be performed later
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after an ostomy has been established or
occasionally preoperatively in older in
fants and children who present late. We
have used the method described by
Boston and Scott.22 Normally the in
ternal sphincter relaxes when rectal
pressure is increased.23 In classical
Hirschsprung’s disease there is fail
ure of relaxation.23 We performed
rectal manometry in five of our patients
with total colonic aganglionosis, and in
only one was a response as in Hirsch
sprung’s disease obtained (Fig. 9). The
behaviour of the other four was normal
(Fig. 10), although the relaxation of
the internal sphincter was less complete.
A particularly instructive case was the
patient who remained asymptomatic un
til the age of 3 months, when he pre
sented with acute appendicitis. At the
age of 2Vi months rectal manometry
had been done and had produced an
apparently normal response (Fig. 11). In
retrospect, a barium enema should have
been the mode of investigation.
Rectal Biopsy
We have been using the Noblett for
ceps24 for suction biopsy for some years
and it has proved to be highly satis
factory. However, even suction biopsies
are not possible in the acutely ill neo
nate, hence we have used this method of
investigation in only six of those who
have survived their “ostomies”. The
tissue was first stained by the MeierRuge modification25 of Karnovsky’s
method26 for cholinesterase activity.
From all six patients positive results
were obtained indicating increased choli
nesterase activity (Fig. 12), and on his
tologic examination all showed complete
absence of ganglia and an increased

ii r;.. *'/./<# /. f f l
FIG. 8— Two small-bowel biopsies stained by rapid nonspecific cholinesterase
method showing normal ganglia on left and large peripheral nerve but no ganglia on
right (reduced by 37% from X125).
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FIG. 9— Results of rectal manometry in patient with total colonic aganglionosis
showing relaxation of internal sphincter when rectal pressure is increased— similar to
response in short and long segment Hirschsprung’s disease.
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FIG. 10— Results of rectal manometry
in case of total colonic aganglionosis
showing relaxation o f internal sphincter
when rectal pressure is increased— similar
to response in normal subjects.
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number of large peripheral nerves (Fig.
13).
Cholinesterase Activity
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FIG . 11— Results of rectal manometry in case of total colonic aganglionosis
showing apparently normal response.
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FIG. 12— Rectal suction biopsy, stained
by Meier-Ruge modification of Karnovsky’s cholinesterase method, showing large
nerve fibrils with increased cholinesterase
activity (reduced by 47% from X63).

Controls

Hirschsprung’s
Disease

FIG. 14— Quantitative biochemical as
say of acetylcholinesterase in rectal biopsy
specimens. T indicates total colonic agan
glionosis. R = rate units.

30

It is well known that the local con
centration of acetylcholinesterase in the
myenteric plexus is increased in the
affected segment of gut in Hirsch
sprung’s disease. This can be demon
strated histochemically by means of the
Meier-Ruge stain, or biochemically as
first shown by Boston and Scott from
Newcastle-upon-Tyne.27 While a post
graduate fellow at the Red Cross War
Memorial Children’s Hospital in 1976,
Victor Boston extended this work, and
since then we have continued it still
further. As far as tissue acetylcholin
esterase activity is concerned, the pre
vious findings have been confirmed in
12 index cases and 10 control cases
(Fig. 14).
Further elaboration of the work has
included measurement of the serum
pseudocholinesterase and erythrocyte
acetylcholinesterase values in 12 pa
tients with proven Hirschsprung’s di
sease and in 10 controls28 (Fig. 15). The
patients with Hirschsprung’s disease in
cluded five with total colonic aganglio
nosis. Three of these had already un
dergone a Lester Martin procedure but
were included because in all three there
remained in situ almost 50% of the
aganglionic large bowel. As shown in
Fig. 15, there is a significant difference
between the index cases and the con
trols. In the former the mean serum
pseudocholinesterase value was 11.7
units and in the controls it was 5.0
units. The mean erythrocyte acetylcholi
nesterase value in the two groups was
1.39 units and 0.73 units, respectively.
The difference between the means is
statistically significant, but there is over
lap between index cases and controls
with respect to both serum and erythro-
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FIG . 13— Rectal suction biopsy showing
large nerve fibrils and absence of ganglia
(hematoxylin and eosin, reduced by 44%
from X 45).
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FIG. 15— Serum measurements in patients with Hirschsprung’s disease and in control
subjects.
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cyte cholinesterase activity. In general,
the longer the segment involved by the
disease, the greater is the serum and
erythrocyte activity. Of interest was the
reduction of serum pseudocholinesterase
activity following a Lester Martin pro
cedure done in the patient marked with
a circle in Fig. 15. While this prelimin
ary study does not clearly separate the
index and control groups, it has pro
vided useful additional information on
Hirschsprung’s disease, and it has also
demonstrated for the first time that the
disease has systemic effects that require
further study. (Since this paper was
prepared four more cases of Hirsch
sprung’s disease and five more control
subjects have been investigated and the
findings have been similar.)

Management
The successful management of total
colonic aganglionosis depends on early
recognition of the disorder, prompt de
compression of the obstructed bowel
by ileostomy or jejunostomy depending
on the extent of the aganglionic bowel,
control of the critical fluid losses as
sociated with ileostomy and the shortbowel syndrome, appropriate definitive
surgery, and control of fluid losses, ex
coriation, etc. thereafter.
The problems associated with early
recognition have already been outlined,
and resulted in no operation being car
ried out in two of our patients (Table
V). One, only 18 hours old, was mori
bund with enterocolitis on admission. A

Table V— D etails of Two Patients Not Operated Upon
Patient
no.

History

Segment

D ied ,d

7

Colon + 5 cm
ileum

Admitted day 1 with
enterocolitis

2

11

Colon + 5 cm
ileum

1st symptom day 14,
admitted day 30

36

Table V I— Patients with Inappropriate In itial Surgery
Patient
no.
4
9
8
3
6
10

13
16

Segment

Corrective
operation

In itial surgery

Colon
small
intestine
Colon
Colon + 150 cm
ileum
Colon + small
intestine
Colon + 1 5 0 cm
ileum
Colon

Colon + 10 cm
ileum
Colon + 150 cm
ileum

Ladd’s operation, 10 d
Jejunostomy, 29 d
Laparotomy, 2 d
Laparotomy, 8 d
Laparotomy, 2 d

Outcome

—

Died, 29 d

21 d

Died, 22 d

16 d

Died, 25 d

—

Died, 22 d

Ileostom y, 3 d

17 d

Died, 35 d

Cecostomy, 3 d
Transverse colostomy, 1 mo
Closure colostomy, 6 mo
Transverse colostomy, 654 mo
Transverse colostomy, 4 d

1354 mo

A live and w ell,
8 yr

5 mo

Ileostomy, 5 d

26 d

Alive and w ell,
3 yr
Alive and w ell,
14 mo

Jejunostomy, 12 d

Table V II— D efinitive Surgery -1957-1971
Patient
no.
1
2
5

6*
10*

Segment

Operation

Age at
operation

Colon + 50 cm
ileum
Colon -f- 20 cm
ileum
Colon + 5 cm
ileum
Colon + 1 5 0 cm
ileum
Colon

Swenson’s

5 mo

Died, 354 y r

Swenson’s

2 mo

Duhamel

354 mo

A live and w ell,
19 yr
A live and w ell,
17 yr
Died, 35 d

Duhamel

17 d

Soave

1354 mo

'Inappropriate initial surgery.
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Outcome

A live and w ell,
8 yr

barium enema suggested total colonic
aganglionosis, but the infant died with
in 24 hours before surgery was possible.
Another, whose symptoms commenced
at the age of 14 days, was admitted
when she was 30 days old. Agangliono
sis was suspected but the barium enema
was misinterpreted and she died 6 days
later without having been operated on.
More important are eight patients in
whom the condition was not properly
recognized at operation, with the result
that inappropriate operations were per
formed (Table VI). In three infants the
diagnosis was completely missed. One
had a Ladd’s procedure performed, one
was thought to have an internal
hernia and, at a later operation, adhe
sions, and the third was operated upon
elsewhere. The first patient succumbed
to total colonic and small intestinal
aganglionosis and could not have been
saved. The other two died despite later
appropriate surgery. In five patients
the extent of the disease was misjudged
and the ostomy made through agan
glionic bowel. One succumbed to total
colonic and small-bowel aganglionosis
and could not have been saved, one
died despite corrective surgery 2 weeks
later, and three survived but had very
stormy courses until appropriate surgery
was carried out 13 Vi months, 5 months
and 26 days later. Fluid losses contri
buted greatly to the deaths of the three
patients who had later corrective proce
dures.
With regard to fluid and electrolyte
losses, it should be mentioned that in
the early days (1957 to 1961) we were
forced to perform the definitive proce
dure fairly soon because of problems
with the ileostomies. Thus, in our first
four patients the pull-throughs were
done 2 weeks, 6 weeks, 3 months and
2 weeks after the ileostomies and con
sequently all were subjected to defi
nitive surgery at an early age (Table
VII). These infants had extremely
stormy postoperative courses because of
diarrhea and excoriation. One died 2 Vi
weeks after a Duhamel operation, and
another 3 years after a Swenson’s oper
ation. The other two required repeated,
lengthy periods of hospitalization dur
ing the first 3 years of their lives, but
are now well at 19 years and 17 years
of age.
Since that time we have managed to
cope with the fluid losses by means of
hyperalimentation, and definitive sur
gery has been postponed for 7 to 17
months. However, a patient who had a
Soave pull-through procedure at 13 Vi
months had to be hospitalized for most
of the succeeding 2 years. He is now 8
years old and somewhat retarded.
Since 1974 we have adopted the Les
ter Martin procedure for total colonic
aganglionosis29 (Table VIII), and al-
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age of 3 months with acute appendicitis
and died of sepsis and fluid loss. Final
ly, one patient survived for 314 years
after a Swenson’s operation but had
repeated attacks of severe enterocolitis.

Table V III— Patients Who Underw ent a Lester M artin Procedure
P atien t
no.
12
13*
14
15
16*

Segment
Colon +
ileum
Colon +
ileum
Colon +
ileum
Colon
Colon +
ileum

Age at
operation, mo

Outcome

10 cm

15

A live and w ell, 3 yr

10 cm

16

Alive and w ell, 3 yr

30 cm

13

A live and w ell, 214 yr

150 cm

9
7

Alive and w ell, 19 mo
A live and w ell, 13 mo

Survivors
There were eight survivors in all of
whom the early postoperative period
posed problems because of fluid losses
(Table X). Recurrent enterocolitis and
perianal excoriation occurred in the
three who had a Soave, Swenson’s, or
Duhamel procedure, but these compli
cations improved with time. In recent
years loperamide hydrochloride30 has
proved a great help, and the diarrhea
is less severe in the five children who
underwent a Lester Martin procedure.

"Inapprop riate in itial surgery.

Table IX — Summary of Results— Deaths
No. of
patients
No operation
Total colonic and total small intestinal aganglionosis
Inappropriate in itial surgery
No d e fin itiv e operation
Duham el procedure
Ileostom y
C orrect in itia l surgery— Swenson’s procedure

2
1
1
1*

To tal

9

References

2
2

‘ Survived 3% yr.

though there have been early post
operative problems with alternating
constipation and diarrhea, these have
been less severe than those encountered
after the Swenson’s, Duhamel and
Soave operations. Anal excoriation in
particular has been much less, but it is
still too soon to assess the long-term
results. As shown in Fig. 16, the small

intestine anastomosed to the aganglionic
left colon becomes considerably dilated
and acts as a reservoir. This may pose
problems if too much colon is retained
or a spastic internal sphincter inter
feres with emptying.
Summary of Results

Deaths
Nine of our 17 patients died (Table
IX). Two were not operated upon— one
because of the moribund condition of
the infant on admission and the other
because the diagnosis was missed de
spite a suspicious barium enema. In two
with total colonic and total small in
testinal aganglionosis the deaths were
unavoidable. In three the extent of the
aganglionic segment was misjudged and
the infants died later despite corrective
surgery. One patient presented at the

Table X— Summary of Results -S urvivors
No. of
patients

FIG. 16— Barium enema after Lester
Martin procedure for total colonic aganglionosis showing gross dilatation of an
astomosed ileum.
404

Inappropriate initial surgery
(Soave)
(Lester M a rtin )

1
2

Correct in itia l surgery
(Swenson’s)
(D uham el)
(Lester M a rtin )

1
1
3

Total

8
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Staging Laparotomy for Hodgkin’s Disease in Children
D avid P. G ir v a n ,

R e s o rt to la p a ro to m y fo r th e staging
o f H o d g k in ’s d is e a s e has been
c o n tro v e rs ia l b e c a u s e o f it s q u e s tio n a b le
a d van tag e o v e r n o n s u rg ic a l staging
m eth o d s. T he re c e n t c o n c e rn over
s p le n e c to m y and s u b s e q u e n t over
w h e lm in g in fe c tio n h a s added to th is
debate.
The a u th o r re v ie w s e x p e rie n c e w ith
H o d g k in ’s d is e a s e in 34 p a tie n ts w h o se
a g e s ra n g e d fro m 6 to 18 y e a rs.
S e v e n te e n p a tie n ts u n d e rw e n t staging
la p a ro to m y a fte r t h e ir d is e a s e had
been sta g e d b y sta n d a rd n o nop erative
m e th o d s; th e d u ra tio n o f fo llo w -u p w a s
fro m 2 to 7 y e a rs . In 7 of th e s e 17
p a tie n ts th e s ta g e o f th e ir d is e a s e
w a s ch a n g e d a s a r e s u lt of th e lapa
ro to m y fin d in g s . C o m p lic a tio n s have
been la te s e p tic e m ia re s u ltin g in death
in o n e p a tie n t and su b a c u te bow el
o b s tru c tio n n o t re q u irin g reop eration
in tw o p a tie n ts .

m d , m cl sc , f r c s [ c ], fa cs

In th e a u th o r's o p in io n sta g in g
la p a ro to m y in c h ild re n w ith H o d g k in ’s
d is e a s e is a v a lu a b le m eans o f d e c id in g
on th e ir s u b s e q u e n t therapy.
Le re c o u rs a la la p aro to m ie p o u r la
c la s s if ic a t io n du s ta d e c lin iq u e d e la
m a la d ie de H o d g k in a p re te a c o n tro v e r s e
a c a u s e d e s a v a n ta g e s d is c u ta b le s de
c e tte m e th o d e su r le s m e th o d e s non
c h ir u r g ic a le s d e c la s s ific a tio n .
L 'in q u ie tu d e re c e n te e xp rim e e au s u je t
de la s p le n e c to m ie e t d e s in fe c tio n s
in c o n trd la b le s su b s e q u e n te s e s t v e n u e
s 'a jo u te r a c e debat.
L e s a u te u rs e tu d ie n t une e x p e rie n c e
p o rta n t s u r la m a la d ie de H o d g k in ,
c h e z 34 p a tie n ts d o n t I’age v a r ia it e n tre
6 e t 18 an s. D ix -s e p t p a tie n ts o n t s u b it
une la p a ro to m ie d e s tin e e a e t a b lir
le sta d e d e la m a la d ie ap res q u e
c e lu i-c i e u t e te d e te rm in e par le s
m e th o d e s n o n o p e ra to ire s h a b itu e lle s ;
la d u re e d e la p e rio d e de s u rv e illa n c e
u lte rie u re a e te de 2 a 7 ans. C h e z 7
d e s 17 p a tie n ts le s ta d e de le u r m a la d ie
a e te c h a n g e p a r s u ite d e s r e s u lta ts
la p a ro to m ie s . L e s c o m p lic a tio n s
o b s e rv e e s o n t e te une s e p tic e m ie
ta rd iv e e n tra in a n t la m o rt c h e z un
p a tie n t e t u n e o b s tru c tio n in te s tin a le
su b -a ig u e qui n ’a p a s n e c e s s ity
d 'o p e ra tio n , c h e z d e u x pa tien ts.

e n fa n ts s o u ffra n t de m a la d ie d e H o d g k in
e s t un m o y e n v a la b le de d e c id e r de
la c o n d u ite su b se q u e n te du tra ite m e n t.

The prognosis of Hodgkin’s disease has
improved greatly over the last 10 to
15 years as a result of the systematic
application of modern diagnostic and
therapeutic advances. One of the more
controversial diagnostic measures has
been the use of staging laparotomy.
Splenectomy has been an integral part
of this procedure along with liver biop
sy and multiple intra-abdominal lymphnode biopsies. Failure of routine tests
to detect occult tissue involvement,
particularly in the abdomen, together
with negative findings in patients sus
pected of having Hodgkin’s disease, has
been a strong argument in favour of
staging laparotomy. Since this is a
diagnostic and not a therapeutic proce
dure, the morbidity and mortality must
be kept to a minimum. The reported
frequency of complications has varied
considerably.1-3 The risk of overwhel
ming infection in patients who have
undergone splenectomy has been of
particular interest. There has been dis
agreement as to whether or not the
pediatric patient is at particular risk.
In this communication we review our
experience with staging laparotomy in
the pediatric patient.
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Patients and Methods

During the 11-year period from Jan.
1, 1965 through Dec. 31, 1975, 34
patients with Hodgkin’s disease were
assessed and treated at this institution.
Of these 18 were boys and 16 were
girls. The ages of the children ranged
from 6 to 18 years (median, 14 years)
(Fig. 1). Seventeen of these patients
underwent staging laparotomy and
form the basis of this report. We noted
the age at diagnosis, the mode of pre
sentation, the preoperative clinical
stage of the disease, and the methods
of diagnosis and the success rate fol
lowing the various diagnostic proce
dures. We scrutinized the changes in
staging subsequent to laparotomy and
the survival and morbidity associated
with the surgical procedures. We re
viewed possible causes of overwhelming
infection secondary to splenectomy and
the possible means of preventing such
infection.
Presentation
Thirty patients had cervical and su
praclavicular lymphadenopathy as the
presenting complaint. Two patients had
inguinal lymphadenopathy and two pa
tients had evidence of spinal cord com
pression. Systemic symptoms of weight
loss, fever and night sweats were
present in 11 of the children at the
time of diagnosis.
Clinical Staging
The protocol used in our unit to
determine preoperatively the clinical
stage of Hodgkin’s disease includes ob
taining a detailed history and perform
ing physical examination with special
reference to any systemic symptoms. A
complete hematologic investigation is
carried out as well as tests of liver func
tion, serum protein electrophoresis and
immunography; blood urea nitrogen

and serum creatinine concentrations are
determined. Chest roentgenography is
supplemented by whole lung tomo
graphy if mediastinal or hilar nodes
are involved. Lower limb lymphangi
ography is performed by the standard
technique. A hepatosplenoscan and
bone scans are obtained routinely. In
travenous pyelography and skeletal
surveys are done only for specific in
dications. Needle biopsy of the bone
marrow is done. The stage of the dis
ease was determined according to the
classification of Carbone and associ
ates.1 Of the 17 patients who had a
staging laparotomy 9 were classified as
stage IA or IIA, 4 as stage IIB, 2 as
stage IIIA and 2 as stage IIIB after
completion of their clinical staging.
Only 14 of the 17 patients had lym
phangiography but all patients under
went liver-spleen scans and liver func
tion tests.
Operative Procedure
Following completion of the clinical
staging the case is discussed at a con
ference of the physicians concerned
and a decision is reached regarding the
desirability of a staging laparotomy.
Laparotomy is performed through an
extended midline incision and involves
the removal of the spleen and any ob
vious hilar nodes. A wedge biopsy of
the liver is performed along with
needle biopsies of the depths of both
the right and left lobes. Biopsy is done
of lymph nodes that appear affected
or suspicious on lymphangiography and
of any nodes suspicious on palpation.
Metallic clips are placed at all sites of
node biopsies. Roentgenologic facilities
are available to confirm that suspicious
nodes have been removed. The iliac,
portal and mesenteric areas are in
spected and any suspicious nodes are
removed. In women of child-bearing
age an oophoropexy is performed. No
antibiotics or drains are used.
Results

FIG. 1— Age distribution of 34 patients
with Hodgkin’s disease.
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In 8 of the 17 patients who under
went a staging laparotomy the stage
was changed from the preoperative
one based on the clinical findings.
In five cases the stage was upgraded,
in two cases from stage IIA to IIIA,
in two from IIB to IIIB and in
one from IIIB to IVB. In three cases
the stage was downgraded, in one case
from IVA to IIA, in one from IIIA to
IA and in one from IIIB to IIB.
Correlation of the stage with the
preoperative lymphangiograms disclosed
four cases of false-positive lymphangi
ograms but no false-negative result. In
30% of the cases there was false
negative correlation between the liverspleen scan, results of liver function
tests and the findings at laparotomy.

There were four instances of unsus
pected Hodgkin’s disease of the spleen
and one case of liver involvement.
Survival and Complications
There was immediate survival of all
patients. Only one late death occurred
in the 17 patients who underwent stag
ing laparotomy. This was in a 16-yearold boy with stage IIIA disease estab
lished at laparotomy at which time un
suspected splenic involvement was
found. He underwent a full course of
above-diaphragm irradiation followed
by a second 4-week course of belowdiaphragm irradiation. At follow-up
examination the mediastinal mass had
increased in size as determined radiologically and the boy complained of
pruritus. The development of recurrent
disease was suspected so chemotherapy
with a combination of nitrogen mustard,
vincristine, procarbazine and prednisone
was instituted. Two months later an
influenza-like illness developed one
morning and the boy was admitted to
the local hospital in the early afternoon.
He died at 5:00 pm on the same day.
Streptococci were cultured from his
blood.
Six other patients have died of dis
seminated disease. Two of these had
undergone a laparotomy.
In two patients there were three
episodes of small-bowel obstruction, all
relieved by conservative treatment with
nasogastric suction. These patients have
been well, one for 3 and one for 5
years. Two patients had unexplained
fever and were thoroughly investigated
in hospital; all cultures showed no
growth of organisms and both patients
are alive and well at the time of writ
ing. One boy suffered from vomiting
for approximately 6 months after his
staging laparotomy; he was fully in
vestigated and no cause could be found.
He has remained well for almost 3
years. In one patient a stitch granuloma
drained intermittently but caused no
major difficulty. One patient who
initially was treated with chemotherapy
was well for 5 years. She was then
suspected of having intra-abdominal
recurrence so a staging laparotomy was
carried out and an oophoropexy per
formed. Afterwards chemotherapy was
continued. A year later there was an
other localized abdominal recurrence
and she was considered a candidate for
local radiotherapy. At examination it
was evident that one ovary had be
come detached from behind the uterus.
The patient refused to submit to radia
tion treatment until this ovary had
been reattached and accordingly this
was done.
Discussion

If optimal treatment is to be given

VOLUME 21, NO. 5, SEPTEMBER 1978 / THE CANADIAN JOURNAL OF SURGERY

to patients with Hodgkin’s disease, then
accurate staging is important. Precise
knowledge of organ involvement is es
sential in planning the administration
of radiotherapy or chemotherapy. At
the same time, overtreatment should be
avoided to minimize the likelihood of
excessive irradiation or the side effects
of chemotherapy. Thus, a major ar
gument for staging laparotomy is
the possibility of more accurately
locating intra-abdominal disease or de
termining its absence and therefore
providing more accurate specific treat
ment, be it irradiation or chemother
apy. Our experience with 17 children
who underwent staging laparotomy has
confirmed the value of this procedure.
In eight patients the staging was
changed from the preoperative classi
fication. In four of the five patients
in whom the staging was advanced
more extensive treatment was given.
Full abdominal irradiation was given
because of unsuspected splenic involve
ment in two cases and chemotherapy
rather than irradiation was given in
two cases because a stage IIIB classifi
cation had been made. In one patient
who was upgraded from stage IIIB to
stage IVB the treatment regimen was
not altered but important prognostic
information was obtained. Of equal im
portance is the fact that three patients
were assigned to a lower stage and
hence required considerably less treat
ment. Two patients who otherwise
would have been given chemotherapy
were found to have above-diaphragm
disease only and received more localized
radiotherapy. One patient who would
have received extensive irradiation to
the abdomen for stage IIIA disease re
ceived more limited irradiation to the
upper abdomen when found to have
stage IA disease. In only one patient in
our series did abdominal disease devel
op in a patient who previously was
considered free of abdominal disease.
This 15-year-old boy had recurrent ab
dominal disease 14 months after a stag
ing laparotomy and died 2 years later.
Because some series have reported a
higher frequency2 we may need a longer
period of follow-up to exclude com
pletely the development of abdominal
disease.
Our series confirms, as have other
reviews,1'5 that there may be no corre
lation between lymphangiography, liver
and spleen scans and liver function
tests in an appreciable number of cases.
Twenty-eight percent of our lymphangiograms gave false-positive results
although we had no false-negative re
sults. Other series have reported the
greater likelihood of false-positive than
of false-negative results. The results of
liver-spleen scans and liver function
tests can be quite misleading. Five of

the 17 patients with Hodgkin’s disease
involving the spleen or liver had liver
function tests and scans that gave nor
mal results. The diagnosis of stage IV
disease should be based on histologic
evidence alone and not on serum find
ings or radioisotope scans, a conclusion
supported by others.5'6
The strongest opponents of staging
laparotomy argue that the mortality
and morbidity of the procedure out
weigh the useful data obtained for the
subsequent treatment of these persons.
In our series we had no operative deaths
but one patient died of overwhelming
septicemia 10 months after splenec
tomy. Our morbidity statistics are com
parable to those of several other series
and none of the complications serious
ly influenced the patient’s future man
agement or survival. Higher incidences
of postoperative difficulties have been
reported2 resulting in abandonment of
staging laparotomy or limitation of it
to selected cases.
The risk of overwhelming sepsis in
patients who have undergone splenec
tomy is the principal concern at present.
In 1952 King and Schumaker7 drew at
tention to the increased susceptibility of
young infants to serious bacterial in
fection following splenectomy. Since
then there has been considerable con
troversy over whether such a risk does
exist. At present it seems that splenec
tomy does increase susceptibility to in
fection in certain individuals. The fre
quency of infection varies considerably
with the indication for the operation.
It is lowest when the spleen is removed
because of trauma and tends to be
highest when the organ is removed for
congenital hemolytic anemia, thalasse
mia, portal obstruction, immune defi
ciency or malignant disease.8,9 Hodgkin’s
disease certainly falls into the last two
categories since in many of the patients
the immune system is depressed or im
paired because of the primary disease
and also because of concomitant radio
therapy or chemotherapy, or both. The
Children’s Cancer Study Group re
viewed 200 children under 19 years of
age with Hodgkin’s disease who under
went staging laparotomy and splenec
tomy.10 There were 20 episodes of septi
cemia and meningitis in 18 children
and 10 died. Almost all of them had
fulminating infections resulting in
death within hours. It is significant that
78% of these young patients had re
ceived both chemotherapy and radia
tion therapy. All of the infections oc
curred within 3 years of the splenec
tomy. A number of other authors have
shown that the chance of infection is
greatest within the first 2 to 3 years
after splenectomy although some cases
have occurred at later intervals.8,10 That
the very young child is at increased
risk was shown by King and Schu-
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maker’s original paper7 and is supported
by more recent series.8,11 It appears that
splenectomy should be avoided in in
fants under 2 years of age and per
haps up to 5 years of age. It is inter
esting that our case of septicemia was
very similar to those seen in the Chil
dren’s Cancer Study Group series, the
boy having died 10 months after opera
tion and after having received both
chemotherapy and irradiation.
A number of factors have been im
plicated in the increased susceptibility
to overwhelming infection. Splenectomv
has been shown to decrease the phago
cytic mass. While the liver and other
areas of the reticuloendothelial system
can affect phagocytosis, the efficiency
of this process is much reduced in the
absence of the spleen.11"13 It has been
suggested that a substance found in
splenic tissue, termed tuftsin, may act
upon leukocytes to stimulate phagocy
tosis.14 Weitzman and associates13
showed that the number of antibodies
to Hemophilus influenzae was sub
stantially reduced in patients treated
for Hodgkin’s disease. Splenectomy and
radiotherapy when used alone had lit
tle effect but chemotherapy alone or
combined with splenectomy depressed
antibody titres, as did combined treat
ment of chemotherapy and irradiation.
They also showed that IgM concentra
tions were greatly reduced in patients
who received chemotherapy and that
this effect was accentuated by splenec
tomy. IgM appears to facilitate the
removal of organisms and it is well
known that normal concentrations are
not attained until 2 years of age. As
mentioned above, a general alteration
in the immunity of the patient either
from underlying malignant disease or
the combination of chemotherapy and
radiotherapy may play a role and ag
gravate the problems initially induced
by the splenectomy.
We must consider whether the risk
of overwhelming infection can be pre
vented or at least reduced. Physicians’
knowledge of this complication must
be increased. The high-risk group ap
pears to be patients under 5 years of
age and particularly those under 2
years. Fortunately, few such young
children suffer from Hodgkin’s disease
and in our series there were no chil
dren under 2 years of age. The first
3 to 4 years following splenectomy ap
pear to be the period of greatest risk
although sepsis and death have oc
curred after many years have elapsed.
Those patients who receive chemo
therapy, especially if it is combined
with radiotherapy, appear to be at the
greatest risk and should be under very
careful surveillance. Patients or, in the
case of a child, the family should be
instructed to seek attention early if an
infection or high fever develops. Some
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authors have suggested that patients
should be provided with a supply of
antibiotics to be taken at the first
sign of infection until medical atten
tion can be obtained.15
There is m uch debate at present on
whether antibiotics should be pre
scribed prophylactically. It has been
advised that patients who have had a
splenectomy should take penicillin daily
for 2 to 3 years.8’10 Although pneumo
coccus has been the organism most
frequently isolated, H. influenzae, strep
tococci and occasionally enteric organ
isms have also been isolated. N ot only
may the prophylactic antibiotic selected
be the wrong one fo r the particular
infection but resistance to the antibiotic
may develop. The number of strains of
the various organisms may make com
plete coverage almost impossible. In
fections have been confirmed in children
receiving prophylactic antibiotics.3-16
Patient compliance is also unreliable;
there is no assurance that the child will
remember to take his medication or
that the parents will give it to him
regularly. A future possibility may be
the immunization of these high-risk pa
tients with bacterial vaccines15 but at
present these are not generally avail
able.
O ur own policy has been to insist
that children take phenoxymethyl peni
cillin, 125 m g twice daily by mouth,
for 3 years after the staging laparotomy.
This is particularly necessary in chil
dren who have received chemotherapy.
The patient, his parents and his family
physician are all instructed to seek
medical attention without delay if signs
of a respiratory illness or unexplained
fever appear.
Summary
We have presented our findings in
34 patients under the age of 18 years
with the diagnosis of Hodgkin’s disease.
In 17 the stage of the disease was de
termined at laparotomy when splenec
tomy was performed. Morbidity was
low and the only related death was
attributable to septicemia 10 months
after the laparotomy. We have dis
cussed the role of the spleen in body
defence mechanisms and the possible
alterations in these mechanisms induced
by its removal and augmented by irra
diation or chemotherapy, or both. Over
whelming infection is the major com
plication to be avoided as it carries a
high m ortality in the splenectomized,
immune-depressed patient.
We believe that staging laparotomy
is a valuable diagnostic procedure in
young people with Hodgkin’s disease.
It reveals occult disease and thus allows
earlier and more exact treatment. In
other cases it prevents excessive irradia
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tion to regions shown not to be in
volved by the disease. As this is a
diagnostic and not a therapeutic pro
cedure the m ortality and morbidity
m ust be kept to a minimum.
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A Critical Look at Delayed Intestinal Motility
in Gastroschisis
S.Z. R ubin, mb, frcs [c], frcs ( edin ),* D.J. M artin, MD, FRCP[C]f
and S.H. E in , md, frcs[c], faap$

The motility of the gastrointestinal
tract after the accepted management
of gastroschisis by using a Silon pouch
and gradually reducing the herniated
intestine is compared with the intestinal
motility after primary reduction and
closure of the defect.
Since 1970, 46 children with gastro
schisis have been treated at the
Hospital for Sick Children, Toronto.
Twenty-seven were treated with a Silon
pouch. Eleven died after an average
postoperative survival of 17 weeks;
not one had bowel motility that allowed
oral feeding. Among the 16 survivors
an average of 10 weeks elapsed
between operation and the institution
of full oral feeding.
Seventeen children were treated by
forceful stretching of the abdominal
cavity, primary replacement of the
eviscerated intestines and closure of
the defect. Tw o died in the early
postoperative period of conditions
unrelated to the gastroschisis or to the
procedure. The average period between
operation and full oral intake of food
was only 4 weeks. In addition, two
neonates were admitted after primary
closure was done at the referring
hospital.
Roentgenograms obtained postoperatively in 24 of the patients showed
the “ typical" dilated loops with air

fluid levels in patients treated with a
Silon pouch.
The authors' findings indicate that
primary reduction and closure of the
defect has a distinct advantage over
use of a Silon pouch in the treatment
of gastroschisis.
La motilite du tractus gastrointestinal,
apres recours au traitement courant
du gastroschisis par I’utilisation de
la poche Silon et la reduction
progressive des intestins hernies, a
ete comparee avec la motilite intestinale
obtenue apres reduction primaire et
fermeture de I'anomalie.
Depuis 1970, 46 enfants ayant un
gastroschisis ont ete traites au
Hospital for Sick Children de Toronto.
Vingt-sept ont ete traites a I'aide de
la poche Silon. Onze sont morts apres
une survie postoperatoire moyenne de
17 semaines; aucun n'avait une motilite
intestinale permettant I'alimentation
par voie orale. Chez les 16 survivants,
il s'est ecoule en moyenne 10 semaines
entre I’operation et I’instauration d'une
alimentation complete par voie orale.
Dix-sept enfants ont ete traites
par dilatation forcee de la cavite
abdominale, restauration primaire des
intestins evisceres et la fermeture
de I'anomalie. Deux sont morts dans
la periode postoperatoire immediate
dans des circonstances n’ayant aucun
rapport avec le gastroschisis ou
■’intervention chirurgicale. La periode
moyenne s'etant ecoulee entre
I’operation et I’alimentation complete
par voie orale n’a ete que de 4 semaines.
De plus, deux nouveaux-nes ont ete
hospitalises apres qu'une fermeture
primaire eut ete realisee a I’hopital
d’ou ils furent diriges.
Les radiographies obtenues apres
I’operation chez 24 patients ont montre
I'anse dilatee “ typique” , avec des
niveaux d'air et liquide des patients
traites avec une poche Silon.
Les resultats obtenus par les auteurs
indiquent que la reduction primaire
et la fermeture de I’anomalie presentent
un avantage marque sur I'emploi de
la poche Silon dans le traitement d'un
gastroschisis.

Gastroschisis1 is a congenital condition
in which a baby is born with its un
covered intestine herniated through an
anterior abdominal wall defect. The
increasing incidence of gastroschisis2
has drawn the attention of pediatric
surgeons to this condition, which calls
for immediate operation.
Despite improved treatment and the
widespread application of total paren
teral nutrition (TPN), the major prob
lems of sepsis3'5 and delayed intestinal
motility3'6,7 still account for a significant
morbidity and mortality.
The clinical problem of sepsis has
already been studied.5 In this paper we
examine the delay in intestinal motility
associated with gastroschisis.

Patients and Methods
During the period Jan. 1, 1970 to
Dec. 31, 1977, 46 neonates with gastro
schisis were treated at the Hospital for
Sick Children, Toronto. After delivery
of the baby the exposed intestine was
covered with petrolatum- or salinesoaked gauze and was supported by a
plastic film or a linen binder fastened
around the abdomen. A nasogastric
tube was passed to which intermittent
suction was applied. The babies were
nursed in an incubator in the reversed
Trendelenberg position. A catheter was
inserted intravenously for the infusion
of solutions of glucose. Electrolyte and
blood-gas
abnormalities were corrected.
From the departments of surgery and
At operation 27 babies had exposed
radiology, The Hospital for Sick Children,
loops of bowel covered with a Silon
Toronto, Ont.
pouch (American Medical and Surgical
Presented at the 10th annual meeting
Research Corp., Haverford, PA). The
of the Canadian Association of
other 19 newborns were treated by
Paediatric Surgeons, Vancouver, BC,
forceful stretching of the abdominal
Jan. 25, 1978
wall to allow primary reduction of the
*Formerly chief resident, division of
eviscerated
intestine and closure of
general surgery, The Hospital for Sick
the defect. No special attempt was made
Children, Toronto
to close the abdominal wall in layers.
t Staff radiologist, department of radiology,
The
thick exudate (“peel”) covering the
The Hospital for Sick Children
intestine was not removed. Gastro
tStaff surgeon, division of general
stomy, ileostomy or ileotomy to decom
surgery, The Hospital for Sick Children
press the bowel was avoided. The
nasogastric tube was left in place to
Reprint requests to: Dr. S.Z. Rubin,
permit gastrointestinal decompression.
Ste. 138, North York General Hospital,
4001 Leslie St., Willowdale, Ont.
As soon as the infant’s condition was
M2K 1E1
stable TPN was started.
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Intestinal transit was gauged clinical
ly by the type and amount of naso
gastric drainage, the degree of ab
dominal distension, the presence of
peristalsis and the passage of stools, and
radiologically by plain abdominal films
and by roentgenograms obtained after a
barium meal. Adequate intestinal func
tion was indicated by tolerance to gas
trointestinal feeding and ability to dis
pense with TPN.
Results

According to the initial operation,
the neonates were assigned to one of
three categories: those whose defect
was closed in stages with Silon, those
who underwent primary closure at our
institution and those whose primary
closure was performed at the referring
hospital.
Eleven of the 27 neonates treated
by use of a Silon pouch died (Table
I). The mean birth weight of the
survivors was 2.29 kg and the mean
birth weight of the babies who died
was 2.41 kg. Eighteen proven cases of
bacterial or monilial sepsis were re
corded. Sixty-four operative procedures
were performed on these 27 babies.
The average age at which complete
gastrointestinal feeding of the 16 sur
vivors was possible was 46 days. No
baby who died was ever weaned from
TPN and the mean age at death was
67 days.
Seventeen, infants were treated by
primary closure at our institution (Ta

ble I); their mean birth weight was
2.43 kg. Two died in the early post
operative period. One infant died on
the sixth postoperative day of acute
aspiration and the other on the second
postoperative day of an intraventricular
hemorrhage; neither death was directly
related to the surgical procedure. Each
infant in this group of 17 required only
one operation. The mean age at which
the 15 survivors had adequate intestinal
function was 32 days.
Two neonates had primary closure
of the defect performed at the refer
ring hospital (Table I). Each weighed
2.4 kg and both survived in spite of
proven bacterial sepsis. One infant re
quired four abdominal procedures, in
cluding drainage of an intraperitoneal
abscess; adequate intestinal function
was achieved on the 76th postoperative
day. The other baby had two operations
and full gastrointestinal feeding was
possible by the 128th postoperative day.
Twenty-four of the infants in the
study had postoperative abdominal
roentgenography (Table II). The degree
of intestinal dilatation was noted and
the patients were classified accordingly.
There were 13 infants whose films
demonstrated moderate to severe in
testinal dilatation of longer than 7
days’ duration; 11 had been treated
with Silon while the other 2 had under
gone primary closure at the referring
hospital. There were four infants whose
roentgenograms showed mild intestinal
dilatation of longer than 7 days’ dura
tion, but films taken later showed nor

Table 1— Data of 46 Neonates Treated for Gastroschisis by Use of Silon
Pouch or Primary Reduction and Closure

mal bowel-gas patterns and barium
follow through.
D iscussion

Prolonged postoperative ileus is as
sociated with all methods of correction
of gastroschisis.3'6'7 Intraoperative at
tempts to decompress the bowel by
colotomy, ileotomy or gastrotomy in
crease the morbidity without beneficially
affecting the postoperative course.5 The
“peel” covering, and firmly adherent
to, the herniated intestine and mesent
ery may contribute to the prolonged
ileus. The surgeon should not attempt
to remove the “peel” at operation
because of the risk of hemorrhage and
occasionally of bowel perforation.
Temporary delay in gastrointestinal
function is now managed by TPN,
which is an important factor in re
ducing mortality.3'6'8
The clinical signs of abnormal bowel
motility are abdominal distension, lack
of peristaltic sounds, a large volume of
nasogastric aspirate and the inability
to tolerate any enteral feeding. Passage
of meconium or green, mucus-contain
ing stool often indicates normal colonic
function, even though small-bowel
peristalsis is ineffective.
In 24 infants these clinical signs
were of sufficient severity or duration
to warrant abdominal roentgenography.
The most striking feature was the
dilatation of the loops of bowel. Fre
quently most of the bowel was uniform
ly involved, but at times some loops
were disproportionately dilated (Fig. 1).
Air fluid levels were seen and the wide
separation of the intestinal loops at
tested to the thickness of their walls
(Fig. 2). Under any other circum
stances these appearances would have

Primary closure
Use of
Silon pouch
(n = 27)

Data
Survivors
Deaths
Birth weight, kg
Survivors
Deaths
Age at cessation of TPN, d
Survivors
Deaths

At the Hospital for
Sick Children
(n = 17)

At referring
hospital
(n = 2)
2

16
11

15
2

2.29
2.41

2.43
2.00

2.4

46
67

32

102

—

—

Table II -R esults of Roentgenography in 24 Neonates
Dilatation
Degree

Duration, d

Moderate-severe
Mild
Mild-normal

> 7
> 7
< 7

*Primary closure at referring hospital.
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Silon
11
1
2

Primary
closure
2*
3
5

FIG. 1— Abdominal roentgenogram
showing dilated loops in right upper
quadrant and loops of normal calibre in
left lower quadrant— example of localized
dilatation.
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been regarded as evidence of obstruc
tion, but barium studies demonstrated
no mechanical obstruction (Fig. 3),
only inert bowel with poor peristaltic
activity. Occasionally, ineffective peri
stalsis producing a to-and-fro move
ment of the barium was observed. It
became clear that the amount of ef
fective peristaltic activity was inversely
related to the degree of dilatation of
the loops of bowel (i.e., the most dilated
loops had the least activity). As the
condition improved, so the calibre of
the loops diminished. In many cases,
the infant was able to tolerate oral
feedings before the intestinal loops re
turned to normal size. Even in infants
with similar roentgenographic appear
ances initially, there were wide varia
tions in the speed of recovery of useful
peristalsis. When the dilatation appeared
localized, resection of this portion of
bowel did not result in improved motil
ity. Although the roentgenograms were
typical and had prognostic value, they
did not localize the intestinal disease.
Forty-four neonates were managed
identically except for the method of
reduction of the hernia. During the
initial years of the study staged closure
with Silon was considered the optimal
treatment. In the later years primary
closure became the treatment of choice;
in only one patient was Silon applied

because the surgeon was unable to
achieve primary closure. There was no
statistical difference in the mean birth
weights of the two groups.
In our experience the use of artificial
material to cover the exposed intestine
was frequently associated with both local
and systemic infection. There were,
however, no intraperitoneal abscesses.
None of the 11 babies treated by use
of a Silon pouch who died ever at
tained intestinal function. In one un
fortunate infant dilated inert loops of
small bowel persisted for 1 year before
he finally died. Although sepsis may
contribute to delayed intestinal motility,
application of a Silon pouch is asso
ciated with such a delay even in the
absence of infection.
Those neonates who were managed
by primary closure demonstrated a
more rapid return of intestinal func
tion than those who were managed by
staged closure with Silon. It is con
ceivable that the earlier restoration of
the normal intraperitoneal milieu at
tained by primary closure results in the
more rapid disappearance of the “peel”
and an earlier return of normal bowel
function.
The delayed successful outcome in
the two infants who had primary
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Summary and Conclusion

Over a period of 7 years, 46 neonates
with gastroschisis were studied. Twentyseven were treated by staged closure
using Silon and 19 by primary closure
of the defect. A delay in the restoration
of normal intestinal motility was ob
served. In such infants serial roent
genography revealed an abnormal in
testinal pattern, which was related to
the degree of disordered intestinal
motility and was not influenced by
pharmacologic agents. The delay in
restoring normal intestinal motility was
a major cause of morbidity and mortal
ity. The frequency of delayed intestinal
motility was increased by staged closure
using a Silon pouch.
This study indicates that primary
closure of gastroschisis in a properly
equipped pediatric surgical and neo
natal centre will substantially reduce
the occurrence of delayed intestinal
motility in gastroschisis.
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Fine Needle Aspiration Biopsy
in the Management of Palpable Breast Lesions
L. D eschenes , m d , fr c s [c ], J. F abia , md , sd ( h y g ), A. M eisels , m d , f r c p [c ],
B.V. T oth , md , J.C. G agnon , md , H. S avard, m d and L.M. Sh ir ley , md

de lesions solides, 384 ont eu 405
biopsies chirurgicales. Le diagnostic de
cancer a ete porte pour 118 lesions.
De ces lesions, la cytologie en avait
considere 92 (7 8 % ) comme malignes et
13 (1 1 % ) comme suspectes; 9 (7 .6 % )
avaient faussement ete trouvees benignes. L'examen cytologique avait
correctement identifie 237 (8 3 % ) des 287
lesions histologiquement benignes. II
n’y a pas eu d'examen cytologique
faussement positif.
Les 243 patientes atteintes de kystes
ont ete soumises a 572 ponctions
cytologiques pour diagnostic et traitement. Quatre lesions ont ete excisees
et trouvees benignes a l'examen
histologique.
La ponction cytologique a I'aiguille
fine est un outil de grande valeur.
C'est un examen sans complication,
simple, rapide, facilement accepte par
les patientes et qui peut etre repete
au besoin. Sa valeur predictive positive
est excellente (100% dans notre serie).
Des resultats cytologiques negatifs
doivent etre ignores si la lesion est
cliniquement suspecte.

During a 34-month period 2050 fine
needle aspiration biopsies of solid
or cystic palpable breast lesions
were performed.
Of the 1182 patients with solid
lesions, 384 underwent 405 surgical
procedures. Carcinoma was the his
tologic diagnosis of 118 lesions. Of these,
aspiration cytology had identified 92
(7 8 % ) as malignant; in 13 (1 1 % ) a
malignant condition was suspected; 9
(7 .6 % ) had been falsely assessed as
benign. Cytology reports were
accurate in 237 (8 3 % ) of the 287
histologically confirmed benign lesions.
There were no false-positive reports.
The 243 patients with cystic lesions
underwent 572 aspirations for diagnosis
and as treatment. Four lesions were
excised and found to be benign.
Needle aspiration biopsy is a most
valuable tool. It is safe, simple, quick,
repeatable and easily accepted by
patients. Its positive predictive value is
excellent (100% in our series). Cytology
reports negative for malignant change
should be disregarded if cancer is
suspected clinically.
Du 1er janvier 1975 au 31 octobre 1977,
un total de 2050 ponctions cytologiques
a I'aiguille fine ont ete faites pour
des lesions mammaires palpables,
solides ou kystiques.
Parmi les 1182 patientes porteuses

Needle biopsy of tumours was first de
scribed more than half a century ago.1
Fine needle aspiration of breast lesions
is a modification of the original tech
nique. It was initiated in the early
1930s at the Memorial Hospital for
Cancer and Allied Diseases in New
York by Martin and Ellis2,3 and has
gained wide acceptance in Europe,
mostly in Sweden4'7 and France,8'10 and
in some medical centres in the United
States.11'14 Only one large study has been
reported from Canada— that o f Smith
and colleagues15 published in 1959.
We have found biopsy by fine nee
dle aspiration to be a most valuable
tool in the management of breast le
sions and report our experience.

From the breast clinic and the department
o f pathology, Hopital dtt Saint-Sacrement,
and the department o f social and pre
ventive medicine, Laval University,
Quebec, PQ
Presented in part at the 47th annual
meeting o f the Royal College of
Physicians and Surgeons of Canada,
Vancouver, BC, Jan. 27, 1978
Reprint requests to: Dr. Luc Deschenes,
Hopital du Saint-Sacrement, 1050
chemin Ste-Foy, Quebec, PQ G1S 4L8
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Patients and Methods

This study includes all fine needle
aspiration biopsies performed on pal
pable breast lesions in women from
Jan. 1, 1975 to Oct. 31, 1977. During
this period 2050 such biopsies were
done on 1331 patients.
T ech nique o f A spiration C y to lo g y

The technique is well known.4,0 We
use a 20-gauge needle and a 10-mL
disposable syringe with a special han
dle which permits single-handed aspira
tion while the tumour is immobilized
by the fingers of the other hand. No
local anesthesia is required.
The smear is spread on four slides.
Two slides are stained according to the
Papanicolaou method and two accord
ing to the Giemsa method.
C y to lo g ic Grading

As suggested by Webb,16 cytologic
findings are divided into four cate
gories: malignant, suggestive of malig
nancy (suspicious), benign, inadequate.
Malignant smears are those in which
unmistakable malignant cells pre
dominate.6,18 Suspicious smears contain
some cells with morphologic anomalies
suggestive of cancer, but benign cells
coexist and suspicious clusters are a
minority.10 Inadequate smears are char
acterized by the absence o f representa
tive cellular elements,0'10 they are
acellular or contain only cells from
fibrofatty tissue. (Details o f the cyto
logic findings from this series o f pa
tients will be published elsewhere.)
A ccu ra cy o f A spiration C y to lo g y

The accuracy o f a diagnostic test is
judged by its ability to detect the
presence or absence of the disease un
der study. It is measured by its sen
sitivity, specificity and predictive val
ues.
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The sensitivity of aspiration cytology
indicates the probability that a lesion
will be labelled as malignant by the test
given that it is truly malignant (i.e.,
found to be malignant on histologic
examination).
The specificity is the probability that
a lesion will be labelled as benign by
the test given that it is truly benign
(i.e., found to be benign on histologic
examination).
The predictive value of a positive
test is the probability that a lesion is
truly malignant given that it is so la
belled by the test. The predictive value
of a negative test indicates the probality that a lesion is truly benign given
that it is so labelled by the test.

while 2.3% were labelled as suspicious.
Only four lesions (two cytologically
suspicious and two benign) required
surgical excision and were found to be
benign by their histologic character
istics.
Of the 1478 aspirates from solid
lesions, 6.2% were labelled malignant,
2.8% suspicious and 72.7% benign.
The proportion of inadequate smears
was rather high — 18.3%. The 1182
patients with solid lesions can be as
signed to one of two groups: those
who did not have surgery and those
who did. The 798 patients in the first
group were and are still being care
fully followed up. The 384 patients in
the second group underwent surgery in
405 instances.
Cytologic and histologic reports for
these 405 lesions are compared in Ta
ble II. Breast carcinoma was the his
tologic diagnosis for 118 lesions in 111
patients. Seven patients had bilateral
malignant tumours, synchronous in four
instances, metachronous in three.
Cytology identified as malignant 92
of the 118 histologically proven can
cers. It therefore had a sensitivity of

Results

The results of aspiration biopsy on
each type of lesion (solid or cystic) are
shown in Table I. Of the 1331 patients,
1182 had solid lesions and 243 had
cystic lesions (94 had both solid and
cystic lesions).
Of the 572 aspirates from cystic le
sions, 96.5% were assessed as benign

Table 1 -R esults of 2050 Fine Needle Aspiration Biopsies (1331 Patients)
Type of lesion
Cytology report

Solid, no. (and

%)

Cystic, no. (and

%)

Total, no. (and

Benign
Suspicious
M alignant
Inadequate

1074 (72.7)
42 (2.8)
92 (6.2)
270 (18.3)

552 (96.5)
13 (2.3)
0 (0 )
7 (1.2)

1626 (79.3)
55 (2.7)
92 (4.5)
277 (13.5)

Total

1478 (100.0)

572 (100.0)

2050 (100.0)

%)

Table II -Comparison of Cytology and Histology Reports for 405 Solid Lesions
of the Breast in 384 Patients
Histology report
Cytology report
Malignant
Suspicious
Benign
Inadequate
Total

Malignant, no. (and

%)

Benign, no. (and

%)

Total, no.

92 (78.0)
13 (11.0)
9 (7.6)
4 (3.4)

0 (0)
16 (5.6)
237 (82.6)
34 (11.8)

92
29
246
38

118 (100.0)

287 (100.0)

405

0.78. It also identified 13 lesions as
suspicious. Nine lesions (7.6%) were
assessed as benign. Of the 287 lesions
diagnosed as benign by histologic meth
ods (in 273 patients), 237 were so
classified by aspiration biopsy. The
specificity of aspiration biopsy was
therefore 0.83. Aspiration smears were
inadequate in 3.4% of the 118 his
tologically malignant lesions and in
11.8% of the histologically benign le
sions. In the absence of any false
positive statements, the positive pre
dictive value of cytology in our series
was 1. With nine false-negative state
ments, its negative predictive value was
0.96.
Of the 16 cytologically suspicious
lesions subsequently found to be
benign at histologic examination, 4
were fibroadenomas, 11 were cases of
mammary dysplasia and 1 was an in
traductal papilloma.
Recorded clinical impressions and
cytology reports for the 118 histologic
ally proven breast carcinomas are com
pared in Table III. Of the 20 cases
clinically assessed as benign, 10 had
aspiration smears positive for malig
nancy. Results of mammography were
considered suspicious in 4 of these 10
patients and benign in 5. One patient
was pregnant and did not have a ro
entgenogram. These 10 women who
had a median age of 44.0 years and a
mean age of 46.1 ± 9.2 years were
significantly (P = 0.0016) younger than
the other 101 cancer patients who had
a median age of 59.2 years and a mean
age of 58.6 ± 11.8 years.
The age distribution of the 111 con
firmed cancer patients and of all the
1220 patients with lesions assessed as
benign appear in Fig. 1. As expected,
cancer patients are appreciably older
(mean age, 57.5 ± 11.8 years) than
women with benign lesions (mean age,
38.6 ± 12.6 years).
Discussion

Our results are very similar to those
reported elsewhere.8,10 Fine needle
aspiration biopsy is simple, quick, re
peatable and readily accepted by
patients. Its excellent positive predictive
value in malignant cases in our series

Table III— Comparison of Clinical and Cytology Reports for the 118 Breast Cancers Confirmed
by Histology (111 Patients)
C lin ical report
Cytology report

Suspicious

Benign

Total no.

Malignant
Suspicious
Benign
Inadequate

82
8
5
3

10
5
4
1

92
13
9
4

Total

98

20

118
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F I G . 1— Age distribution of patients
with malignant disease superimposed on
that of patients with benign conditions.
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biopsy in diagnosis of palpable le
foreseen are hospitalized whereas the
sions of the breast. Critical review of
3479 consecutive biopsies. Acta Radiol
others have their surgical biopsy as
[Ther] (Stockh) 7: 241, 1968
outpatients.
5. Zajicek J, C aspersson T, J akobsson
Aspiration cytology appears to be
P, et al: Cytologic diagnosis of mam
particularly useful for detecting cancer
mary tumors from aspiration biopsy
in younger patients in whom clinical
smears. Comparison of cytologic and
histologic findings in 2,111 lesions and
assessment may be influenced by age;
diagnostic use of cytophotometry.
it is also useful in pregnant women. It
Acta Cytol (Baltimore) 14: 370, 1970
is the most adequate method of assess
6. Zajicek J: Cytology of Aspiration
ing recurrent, inflammatory or inoper
Biopsies, Part I: Cytology of Supra
diaphragmatic Organs (Monographs in
able breast cancers.
Clinical Cytology, Vol. 4), S. Karger,
The only complication encountered
Basel, 1974 pp 1-29 and 136-194
occasionally is a hematoma.6 At Stock
7. H ennig K, J ohansson H, R imsten
holm’s Radiumhemmet where aspiration
A, et al: X-ray and fine-needle biopsy
biopsy has been routinely performed
in diagnosis of non-palpable breast
for over 20 years, no sign of local
lesions. Acta Cytol (Baltimore) 19: 7,
1975
malignant seeding has ever been ob
8. C ornillot M, V erhaeghe M: Con
served in that institution’s very large
frontation clinique et cytologique dans
series of breast cancers.6 With regard
les tumeurs du sein. Cancerologie 2:
to distant dissemination, aspiration
204, 1955
9. C ornillot M, V erhaeghe M, C apbiopsy seemed to have no effect on the
pelaere P, et al: Place de la cytolo15-year survival rates of the carefully
matched though not randomized pa
tients with breast cancer studied at
New York’s Memorial Hospital for
continued from page 394
Cancer and Allied Diseases.17
Although the possibility of false therefore be of interest to the nephrologist
negative results must always be kept as well as the urologist. The second vol
in mind, needle biopsy is also of great ume will be of interest not only to the
value in the management of benign le urologist but to the endocrinologist and
sions. When associated with clinical oncologist as well. The authors deal main
ly with the neoplastic diseases, but they
findings not indicative of a malignant
have also included sections on the storage
condition, benign smears relieve the and transport of urine, the prostate, the
anxiety of both patient and physician.
genital tract and fertility, the urologic
Aspiration cytology allows for a more armamentarium and anesthetic problems
reliable follow-up of such conditions
with urologic patients.
These books are intended for urologic
as mammary dysplasia.
In the large French and Swedish surgeons and will be of special help to
cancer centres, fine needle aspirations those in training; they complement, but
are performed by the cytologist.6’10 In do not compete with, the numerous ex
our situation, that of a breast clinic in cellent textbooks of urology now avail
able. While the text deals with the clinical,
a general hospital, it is the clinician
diagnostic and operative aspects of the
who does the aspiration. The syringe topic, the authors have stressed patho
is then handed over to the cytotechni- physiology, the newer aspects of histocian who immediately performs the pathology and oncology and the scientific
necessary procedures. Experience in basis of the technology employed in the
performing the aspiration reduces the development of endoscopic instruments.
Although there are 52 contributing au
proportion of false-negative and inade
thors, the books are amazingly uniform.
quate results.6'16
Up to the present we have adhered They are well edited and largely free of
rhetoric. They are highly recommended.
to the “established routine of frozen
section”,15 satisfied to have, and to be W.E. C ollins
able to compare, two sources of micro
Professor of surgery (urology),
scopic diagnosis. Now, however, the
Faculty of medicine,
time may have come to forgo surgical University of Ottawa,
biopsy for cytologically malignant le Ottawa, Ont.
sions. Frozen sections remain man
SURGERY IN THYROID DISEASE.
datory, of course, for cytologically
The Place of Total Thyroidectomy.
negative lesions if cancer is suspected
Samuel L. Perzik. 273 pp. Illust. Strat
ton Intercontinental Medical Book Cor
on clinical grounds.
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versial. It is based on the author’s per
sonal experience of over 1700 thyroidec
tomies, more than half of which were to
tal. The first section deals with the
indications for surgery. Part II is an atlas
of thyroid surgery with very compre
hensive notes and a great deal of prac
tical detail on operative and postoperative
management. Part III is made up of 79
questions and answers; these cover most
of the controversial points in thyroid
surgery and help reinforce Perzik’s argu
ments. In Part IV the author provides a
comprehensive analysis of his cases. There
is some unavoidable repetition.
The main thesis is that a total thyroidec
tomy can be performed as safely as the
subtotal operation. The results recorded
here present a strong case in support of
this position.
The complication rate after a second
thyroid operation is 10 times greater than
after the first. Therefore, total removal
of the thyroid gland in patients with
nodular goitre, Hashimoto’s thyroiditis
and Graves’ disease would seem to be a
reasonable procedure. Retention of a por
tion of the thyroid gland is not an ef
fective method of avoiding late onset of
hypothyroidism. Total removal of the
gland and immediate institution of thyroid
replacement therapy might therefore be
more effective.
Dr. Perzik recommends that the distal
1 to 2 cm of the recurrent laryngeal nerve
be identified at the cricotracheoesophageal junction; this is a point where the
nerve is angulated during surgery when
the gland is rotated and traction applied.
poration, New York; Longman Canada It is precisely at this location that injury
usually occurs. Parathyroid glands should
Limited, Don Mills, 1976. $20.75.
not be sought but their presence should
ISBN 0-88372-090-6.
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Expanded Polytetrafluoroethylene Prosthetic Grafts for
Blood Access in Patients on Dialysis
J.L. Wellington , mb , frcs[c]

T he d if f ic u lt ie s in m a in ta in in g v a s c u la r
a c c e s s in p a tie n ts on lo n g -te rm hem od ia ly s is a re w e ll re c o g n ize d . The a u th o r's
e x p e rie n c e w ith b o v in e g r a fts in s u c h
c a s e s had be e n th a t la te fa ilu r e fro m
s e p s is o r th ro m b o s is w a s c o m m o n , a s
re p o rte d in th e lite ra tu re b y o th e rs . In
M a y 1976 th e e xpa nde d p o ly te tr a flu o ro 
e th y le n e (PTFE) p r o s th e s is b e c a m e the
s u b s titu te o f c h o ic e a s a v a s c u la r graft.
In th e la s t 18 m o n th s t h e s e g ra fts
h a ve b e e n p la ce d a s su b c u ta n e o u s
a rte r io v e n o u s f is t u la s in 22 p a tie n ts .
T h re e e a rly fa ilu r e s o c c u rre d a s a re s u lt
o f g ra ft th ro m b o s is b u t o n e g ra ft w a s
sa lv a g e d b y th ro m b e c to m y u s in g a
F o g a rty c a th e te r. T w o la te fa ilu r e s
o c c u rre d , o n e a fte r 3 and a n o th e r a fte r
6 m o n th s. A l l o th e r g ra fts a re fu n c tio n 
ing s a tis fa c to rily .
E xp a n d e d PTFE g ra fts p ro v id e s a t is 
fa c to ry v a s c u la r a c c e s s fo r m a in te n a n c e
h e m o d ia ly s is in s e le c te d p a tie n ts an d
th e ir u s e m a y prove to be th e p ro c e d u re
o f c h o ic e f o r h e m o d ia ly s is in s m a ll
c h ild re n .
L e s d if f ic u lt e s de m a in te n ir un a c c e s
v a s c u la ire c h e z le s p a tie n ts ay a n t
re c o u rs a I'h e m o d ia ly se a lo n g te rm e
s o n t b ie n re c o n n u e s. L 'e x p e rie n c e de
I’a u te u r d a n s c e s c a s , a v e c d e s g r e ffe s
d e v a is s e a u x de b o e u f a m o n tre q u e le s
d e fa illa n c e s ta r d iv e s a ttrib u a b le s a
I’ in fe c tio n o u a la th ro m b o s e s o n t
fre q u e n te s , t e l que s ig n a le p a r d 'a u tre s
a u te u rs d a n s la litte ra tu re . En m a i 1976,

22 p a tie n ts. T ro is e c h e c s im m e d ia ts so n t
su rv e n u s a la s u ite d ’une th ro m b o s e de
la g re ffe , m a is un g re ffo n a pu e tre
re c u p e re g ra c e a une th ro m b e c to m ie
re a lis e e a v e c un c a th e te r de Fogarty.
D e ux e c h e c s ta rd ifs s o n t su rv e n u s , un
a p re s 3 m o is e t I'autre a p re s 6 m o is.
T ous le s a u tre s g re ffo n s fo n c tio n n e n t
d e fa c o n s a tis fa is a n te .
L e s g re ffo n s de PTFE e tire e a s s u re n t
un a c c e s v a s c u la ire s a t is fa is a n t pour
I’h e m o d ia ly se d 'e n tre tie n c h e z d e s
p a tie n ts c h o is is e t le u r e m p lo i pe ut
s ’a v e re r i ’in te rv e n tio n de c h o ix c h e z
le s je u n e s e n fa n ts.

In any active hemodialysis unit there
are a substantial number of patients who
pose problems in vascular access. Such
patients often have already undergone
multiple vascular procedures and fre
quently will require a prosthetic graft
to create a satisfactory arteriovenous
fistula. The requirements of such a
graft are that it be inert, resistant to
clotting, of adequate size to permit
easy puncture and that it be placed in
an accessible location.
In May 1975 the Ottawa General
Hospital and Children’s Hospital of
Eastern Ontario began a trial of bovine

heterografts in patients on hemodialysis.
Although the initial results were satis
factory, the failure rate at the end of 1
year was so high that the use of bovine
grafts was discontinued.
Over the past 18 months the ex
panded polytetrafluoroethylene (PTFE)
(Teflon) prosthesis has become the sub
stitute of choice as a vascular graft.
Our experience with the use of this
material in patients on hemodialysis is
reported herein.
Patients and Methods
Between May 1, 1976 and Nov. 30,
1977, 25 fistulas were constructed in
22 patients using expanded PTFE
grafts. There were 9 male and 13
female patients whose average age was
41 years (range, 3 to 67 years). The
series included four children aged 12
years and under.
Sixteen grafts were placed as sub
cutaneous loops in the forearm between
the brachial artery and an adjacent
vein (Fig. 1). Seven straight grafts were
placed in the upper arm between the
brachial artery and distal axillary vein.
There was one straight forearm graft
between the radial artery and basilic

la p ro th e s e d e p o ly te tra flu o e th y le n e
(PTFE) e tire e e s t d e v e n u e le s u b s titu t
d e c h o ix p o u r la g re ffe v a s c u la ire .
A u c o u rs d e s 18 d e rn ie rs m o is , c e s
g r e ffo n s o n t e te p la c e s c o m m e f is t u le s
a r t e r io v e in e u s e s so u s -c u ta n e e s c h e z
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vein and one thigh loop between the
superficial femoral artery and saphe
nous vein. Grafts of 6-mm diameter
were used in all patients except in a 3year-old child in whom a 4-mm graft
was used.
Operations were performed under
local, regional, or general anesthesia,
with systemic heparinization which was
reversed by administering protamine
sulfate after completion of the vascular
anastomosis.
Anastomoses were performed with
6-0 Prolene or 7-0 Ethibond sutures.
They were usually end-to-side between
bevelled graft and vessel, although the
occasional venous anastomosis was per
formed in an end-to-end fashion if the
diameters of graft and vessel were com
parable. High flow rates were usually
achieved immediately as evidenced by
rapid distension of the graft and strong
pulsation in the recipient vein beyond
the venous anastomosis.
Postoperatively the arm was sus
pended for 48 hours to prevent edema
of the hand and forearm secondary to
venous overload. Grafts were not used
for dialysis until 4 weeks after opera
tion to allow adequate fixation and in
growth of fibrous tissue. Observance
of this rule reduced the risk of post
dialysis bleeding from the puncture site.
Results

Three fistulas failed within 48 hours
of operation. One of these was salvaged
by thrombectomy using a Fogarty ca
theter. Two late failures occurred, one

at 3 and one at 6 months. Two patients
died in the follow-up period, both from
cardiac causes unrelated to the opera
tion; in both the PTFE graft was patent
at the time of death. Nineteen grafts re
mained patent although at the time of
writing not all had been used for
dialysis.
Complications with PTFE grafts were
uncommon. In this series there was a
complication in only six patients. Graft
infection occurred once in a patient who
was a chronic carrier of staphylococci.
The infection was confined to a single
incision used in creating a subcutaneous
tunnel and was controlled by compres
ses to the wound and by antibiotics
without loss of the graft.
Skin loss with exposure of the un
derlying graft occurred in two patients.
In one case the graft was re-covered by
freshening the skin edges and resuturing
the wound. In the second the graft was
transplanted deep to the brachioradialis
muscle and covered by an advancement
skin flap.
Two patients had a cystic swelling
at the anastomotic site (Fig. 2). Arterio
graphy showed that there was no aneu
rysm and that the swelling lay outside
the graft; aspiration identified the swell
ing as a seroma. In both cases the
swelling persisted but did not interfere
with graft function or puncture.
Graft laceration during dialysis led
to the development of a false aneurysm
in one patient. This was repaired by
simple suture without loss of the graft.
In our series, limb ischemia, a “steal
syndrome”, true aneurysm and conges
tive heart failure were not encountered.
A comparison of the 1-year cumul
ative failure rates for bovine and PTFE
grafts shows that there is little to choose
between the two at 6 months, but after
this PTFE is definitely superior (Fig. 3).
After 6 months there was a progressive
loss of function in the bovine grafts due
to delayed sepsis or thrombosis and at
the end of 1 year, 14 of 22 grafts had
failed. Conversely there were no new
failures of PTFE grafts beyond the 6month period. Although the groups are
not truly comparable in that only 12
PTFE grafts were available for 1-year
follow-up, the difference is statistically
significant (P < 0.05).

m/22)
------BOVINE
----- PTFE

4 / 12)

FIG. 2— Perianastomotic seroma re
sembling true or false aneurysm. Angio
gram was normal and aspiration yielded
serum.
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FIG. 3— Comparison of 1-year cumul
ative failure rate for bovine and PTFE
grafts.

Discussion

The expanded PTFE prosthesis is
composed of nodules interconnected
with thin flexible fibrils. The extreme
porosity of the graft allows rapid and
thorough tissue ingrowth and formation
of a smooth pseudointima. Although the
graft is highly porous, the extremely
small pore size makes preclotting un
necessary. The literature contains sev
eral reports attesting to the value of
this material as a vascular substitute in
many clinical settings.1"3 In particular
the graft appears to tolerate repeated
puncture for hemodialysis over a long
period.4-5
Selection of the fistula site is im
portant. The radial artery is usually too
small to provide adequate flow through
the graft. In the single instance in
which this vessel was used, early throm
bosis occurred; however, the graft was
salvaged by thrombectomy and is still
functioning.
We have favoured graft placement
as a subcutaneous forearm loop since
it provides high blood flow, offers ade
quate length for easy puncture and is
accessible for patients on home dialysis
who “needle” their own grafts. Four of
the patients in our series were on home
dialysis.
Although our experience with thigh
loops is limited to one case of a 3-yearold child, this type of graft proved
highly satisfactory. The anastomosis of
the graft to the superficial femoral ar
tery provided adequate arterial input
while an end-to-end anastomosis be
tween graft and divided saphenous vein
was technically easy.
Analysis of failures reveals a variety
of possible causes. Two of three early
failures were probably due to technical
errors. In both cases the available ves
sels were small in size and anastomosis
was difficult. In addition, both patients
had a serum concentration of creatinine
that was lower than the concentration
in the average patient on dialysis. It
may be that the qualitative platelet
defect present in most uremic pa
tients, which inhibits thrombus forma
tion, was lacking in these two patients
thus explaining their comparatively
more coagulable state. In one patient
faulty graft puncture led to hypotension
and formation of a large hematoma,
both of which may contribute to throm
bosis.
One graft became thrombosed after
transplantation, coincident with restora
tion of normal renal function. In two
other patients who have successfully
undergone transplantation the fistulas
remain patent, which is highly advan
tageous in the event that the transplant
is rejected and dialysis becomes neces
sary.
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Complications other than thrombo
sis are uncommon. In particular, graft
sepsis is rare and when it occurs it usual
ly can be controlled by local therapy
and antibiotics without loss of the
prosthesis.

Skin loss with graft exposure can
usually be managed by freshening the
wound edges and resuturing, or, in the
case of larger defects, by transplanting
the graft deep to an adjacent muscle
belly and advancing a local skin flap.
Although true aneurysms have oc
curred with PTFE prostheses when
these are used as an arterial substitute,
they are unlikely to develop when the
graft is placed as an arteriovenous fis
tula and were not encountered in any
of our patients. Local perianastomotic
swellings resembling aneurysms may be
either seromas or lymphoceles and can
be differentiated by performing arterio
graphy and subsequent aspiration. If
they remain stationary in size and do
not interfere with puncture of the
prosthesis, they are probably best left
alone.
Finally, graft laceration can prob

ably be avoided if the prosthesis is not
used for at least 4 weeks after implan
tation and if appropriate caution is
shown by the dialysis technician in per
forming the puncture.
Our results indicate that PTFE grafts
are superior to bovine grafts for hemo
dialysis. After 6 months there is a
progressive failure of bovine grafts
from sepsis and late thrombosis where
as, to date, there have been no new
failures of PTFE grafts beyond the
6-month follow-up period.
Conclusions

Early results of the use of expanded
PTFE prostheses for patients on dialy
sis suggest that these are a useful sub
stitute in selected patients with prob
lems related to vascular access.
Although early results of bovine and
PTFE grafts are similar, PTFE grafts
appear distinctly superior at 1-year fol
low-up.
The single most obvious advantage of
this material is its ability to resist in
fection. When sepsis does develop it

usually responds to conservative meas
ures.
More lengthy follow-up is necessary
to determine accurately the role of
this material as a vascular substitute in
patients on dialysis.
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Radionuclide Test for Gastric Bile Reflux
I rving H. Koven,
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The authors conducted a study using
radioactive endogenous bile to detect
gastric bile reflux in healthy volunteers
and patients suspected of having bile
gastritis.
When 7 ixCi of pyridoxylideneglutamate
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or hydroxyiminodiacetic acid labelled
with technetium-99m is injected intra
venously it is excreted by hepatocytes,
and sequential gamma camera images
visualize the bile ducts and show
subsequent activity in the gut.
Following such an injection, the
authors determined the presence of
isotope-labelled bile in the stomach in
fasting subjects by assaying count rates
in serial gastric aspirates obtained by
means of a nasogastric tube positioned
in the antrum. The results were related
to the clinical history and gastroscopic
findings.
In normal persons only extremely low
counts were detected, possibly due to
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free activity; high counts (in excess
of 50 000/min) indicated abnormal reflux.
It is suggested that this test is a
useful adjunct, and is more physiologic
than endoscopy, in the assessment of
bile reflux.
Les auteurs ont mene une etude a
I’aide de bile endogene radioactive,
afin de deceler un reflux biliaire dans
I'estomac chez des volontaires normaux
et chez des patients soupconnes d’avoir
une gastrite d’origine biliaire.
Ouand 7 ij,Ci de pyridoxylidenegluta
mate ou d’acide hydroxyiminodiacetique
marque au technetium-99m est injecte
par voie intraveineuse, il est excrete
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par les hepatocytes, et des radiographies
gamma seriees mettent les canaux
biliaires en evidence et montrent
I'activite subsequente dans I'intestin.
Apres une telle injection, les auteurs
ont determine la presence de bile
marquee dans I'estomac des sujets a
jeun, par la mesure des comptages
isotopiques dans les echantillons
series du contenu gastrique obtenus
par aspiration au moyen d’une sonde
nasogastrique placee dans I'antre. Les
resultats ont ete relies aux antecedents
cliniques et aux observations de
gastroscopie.
Chez les personnes normales,
seulement des comptages tres bas
ont ete enregistres, possiblement dus
a I’activite iibre; des comptes eleves
(de plus de 50 000/min) ont indique
un reflux anormal.
II est propose que ce test constitue
une mesure d'appoint utile, et qu’il
est plus physiologique que I'endoscopie
dans 1'evaluation du reflux biliaire.

A simple, reproducible and quantitative
method to measure gastric reflux of bile
would be a useful adjunct in the diag
nosis of bile reflux gastritis and esopha
gitis. Until recently it was thought that
reflux of bile normally did not occur
into the stomach because of the sphinc
ter action of the pylorus.1 Esophago
gastric endoscopy now makes it pos
sible to observe the reflux of bile into
the stomach. When bile is detected in
the stomach of a patient with symptoms
of disease in the upper gastrointestinal
tract associated with hemorrhagic and
edematous changes in gastric mucosa,
the diagnosis of bile reflux gastritis is
often considered. Similarly, in patients
with symptoms of esophagitis the
finding of bile in the stomach tends to
support a diagnosis of alkaline esopha
gitis. The symptoms of bile reflux gas
tritis are postprandial pain, bilious
vomiting and weight loss.2-3 These are
nonspecific unless supported by more
objective findings. Changes observed
at endoscopy are only relatively ob
jective because the examination is done
during sedation and the presence of
the endoscopic instrument in the
stomach is unphysiologic.
This preliminary report describes a
new method of measuring bile reflux
into the stomach using a gamma-emit
ting radionuclide specific to bile ex
cretion.

7 fid
of pyridoxylideneglutamate
(PYG) or hydroxyiminodiacetic acid
(Hida) labelled with technetium-99m
("‘"Tc), sequential gamma camera ima
ges confirm the concentration of the
radiopharmaceutical within the intrahepatic and common bile ducts, the gall
bladder (when present) and the small
bowel. The images confirm that the
radiopharmaceutical is clearing from
the liver and entering the duodenum.
The total gastric content is aspirated
sequentially every 15 minutes, and after
its volume is recorded it is stored in
plastic cups. If the volume of aspirate
is insufficient the stomach is irrigated
with 50 mL of water.
Aspiration is continued for at least
2 hours and at least three samples are
obtained after presence of radioactivity
in the duodenum is confirmed by scan
ning. A fatty meal is given to stimulate
excretion if there is delayed emptying
of the gallbladder.
Radiation counts of the aspirates,
diluted with saline to a standard 20-mL
volume where necessary, are made in
duplicate under fixed geometric condi
tions using a scintillation probe with a
7.5-cm sodium iodide crystal (Fig. 1).
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Patients

This method was used in the study
of 3 healthy volunteers and 13 random
ly selected patients with symptoms of
gastrointestinal disease. Three patients
had clinical symptoms and radiologic
evidence of cholecystitis. Four patients
had symptoms of esophagitis related to
a diaphragmatic hiatus hernia. Six pa
tients suffered epigastric pain following
gastric operation; four of these had
had transabdominal vagotomy and pylo
roplasty and the other two had had gas
tric resection supplemented by either a
gastroduodenostomy or a gastrojejuno
stomy.
Before the bile reflux study each pa
tient had an esophagogastric endoscopic
examination performed by the same
gastroscopist (A.N.). The interpretation
of the findings with respect to bile re
flux was made without prior knowledge
of the endoscopic findings.
Results

FIG. 1—Excretion of administered ra
dionuclide, pyridoxylideneglutamate la
belled with technetium-99m (Tc PYG), by
means of biliary tree and its recovery from
stomach. IV = intravenous, gb = gall
bladder, duod = duodenum, NG tube =
nasogastric tube.

In the three patients with cholecys
titis severe bile reflux was demonstrated
that was not seen during endoscopy
(Table I).
Two of the four patients with symp
toms of esophageal hiatus hernia had
severe bile reflux as shown by the radio
nuclide method. In contrast, no bile re
flux was observed by endoscopy in
either of these two patients.
In four of the six patients who had
had a previous gastric operation bile
reflux was not demonstrated by the
radionuclide method, but in the other
two patients reflux was proved by both
methods.
Discussion

Method

In the fasting patient a radiopaque
nasogastric tube is positioned with its
tip in the antrum; this is confirmed by
fluoroscopy. The tube is taped to the
patient’s nose and cheek to prevent dis
placement.
Following an intravenous injection of

Under these conditions, 1 jj,Ci of 99mTc
corresponds to approximately 2000
counts/min.
Counts in each sample of aspirate are
plotted against time to determine their
maximum. This is necessary because
the counts intermittently alternate be
tween high and low (Fig. 2). The colour
of the aspirate is noted and recorded as
colourless, yellow or green. To minim
ize error in the counts due to free ac
tivity we selected 40 000 or more counts
per minute as indicating abnormal
reflux.

FIG. 2— Variations in activity of gastric
aspirates from same individual during
period of study (KF, FW and HG repre
sent three subjects).

Previous attempts to measure gastric
reflux of bile have proved unsatisfac
tory.4 In one study1 gastric regurgitation
of barium infused by an indwelling
duodenal tube was observed. This tech
nique is unphysiologic. Alkaline indi
cators such as polyethylene glycol and
phenol red have been introduced
directly into the stomach but these do
not exclude alkaline substances other
than bile. A radionuclide method using
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Table I— Results of Study in 13 Patients with Gastrointestinal Symptoms and 3 Healthy Volunteers
Reflux demonstrated by
Group
Cholecystitis
Hiatus hernia

Previous gastric
surgery

Sex
F
F
F
M
M

M
F
M
M
M

F
M

Healthy volunteers

F
IV!
M
M

Age,
yr
58
76
38
78
78
75
60
35
52
58
19
43
70
49
28
36

Endoscopy

Radionuclide activity
of aspirate,
counts/min

Colour of
aspirate

49 260
50 550
57 000
219
530
146 940
122 240
18 000
9 280
223 900
6 700
6 300
110 200
10 000
420
210

Y-G
G
Y-G
Y
Y
Y-G
Y
Y-G
Y
Y-G
Y
Y
Y
Y
Y
Y

—
—

+
—
—

+
+
—
—

Not done
Not done
Not done

+ = positive, — = negative, ± = equivocal.
Y = yellow, G = green.

bile salts labelled with carbon-14 has
been described by Rhodes and col
leagues.5 However, that method has an
inherent inconsistency due to low
activity of the isotope and the error
caused by bile discolouration and con
tam ination by stomach contents.
As a result of the introduction of
biliary scanning using gamma-emitting
radionuclides, a method of measuring
bile reflux is available that is accurate
and is reproducible in any department
of nuclear medicine. Originally, biliary
scanning using iodine-131 rose bengal
was proposed but was unsatisfactory due
to its high radiation dose and relatively
poor imaging characteristics. However,
99mTc pharmaceuticals such as 99mTc
PY G or 99mT c Hida, as used in our
study, have a rapid blood clearance,
early concentration in the liver and
rapid transit through the liver cell to
reach a high concentration in bile. F u r
therm ore, chromatographic analysis
with acetone indicates that the techne
tium is approximately 96% bound to
the pharmaceutical. Minimal in-vivo
unbinding (approximately 1% to 2% )
is suggested by the absence of activity
on scanning the thyroid and salivary
glands and low activity in gastric as
pirates from normal subjects.
Reflux of bile into the stomach and
esophagus is now considered a positive
factor in the production of gastritis and
esophagitis. Results of recent studies6
suggest that bile contributes to gastric
erosion by the destruction of the muco
sal barrier of the gastric epithelium.
The lack o f correlation in this pre
liminary study between symptoms, en
doscopic findings and the amount of
gastric bile reflux indicates the need
fo r an objective assessment in a patient
suspected of having bile reflux gastritis
or esophagitis.
424

It is of interest that each of the
patients with cholecystitis demonstrated
severe gastric reflux of bile. This was
an unsuspected finding. However, Cap
per and associates7 have described a
condition of “gallstone dyspepsia” and
suggest that it is caused by bile, not
stones, and is not corrected by chole
cystectomy.
The method we have described makes
possible the study of the excretion and
transit of bile under normal and pathol
ogic conditions. It may also be useful
in differentiating acid esophagitis and
alkaline esophagitis in patients with a
symptomatic hiatus hernia. Our find
ings suggest that this radionuclide meth
od is a useful adjunct, and is more
physiologic than endoscopy, in the as
sessment of gastric bile reflux.

P

-t

H .T.G . W illiams
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continued from page 419
merely be noted if they are recognized
during the dissection. Perzik believes that
a dissection to expose the glands might
well result in some damage to their blood
supply; in any event, the only certain
identification is achieved by biopsy and
histologic examination.
The author has very definite views on
surgery for malignant disease of the
thyroid. Total thyroidectomy is indicated
in patients with infiltrating cancer and
positive nodes in the neck, in those with
medullary carcinoma and when there is
a history of irradiation to the neck in
childhood. He does not subscribe to the
concept of multicentricity and therefore
does not advise total thyroidectomy for
the less malignant forms of thyroid car
cinoma; his own experience as well as
other evidence from the literature supports
the view that if the opposite lobe appears
normal a total lobectomy is adequate
treatment.
Residents in surgery have had com
paratively little exposure to thyroid sur
gery during the last 15 years but for a
number of reasons there are signs that
this may be changing. First, the success
of parathyroid surgery, requiring wide ex
posure and mobilization of the thyroid
gland, has increased the confidence of
medical endocrinologists in the ability of
their surgical colleagues. Second, the as
sociation between carcinoma of the thyroid
and irradiation of the neck in childhood
has raised serious doubts about the safety
of iodine-131 in the treatment of hyper
thyroidism. Third, a negative report on a
needle biopsy specimen from a thyroid
mass usually reassures the medical endo
crinologist, but many patients with a
palpable mass in the neck are less trusting
and seek a surgeon who will remove it
for them.
This is an important book, both for
surgeons with an interest in thyroid sur
gery and for medical endocrinologists. Its
publication may herald a new era in
thyroid surgery.
Professor and chairman,
Department of surgery,
The University of Alberta,
Edmonton, Alta.
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TEXTBOOK OF GYNECOLOGY. Edited
by Russell Ramon de Alvarez. 546 pp.
Illust. Lea & Febiger, Philadelphia; The
Macmillan Company of Canada Lim
ited, Toronto, 1977. $45. ISBN 0-81210515-X.

In the preface the editor states that this
book is to be a reference source with
emphasis on diagnosis and treatment for
those who deal with the gynecologic pa
tient. In spite of the brevity of this book,
he has succeeded. De Alvarez has as
sembled 29 writers; he has welded their
contributions into a uniform text that is
as up-to-date as possible.
The book is divided into six sections:
structure and development, function,
ectopic pregnancy and abortion, neo
plasms, special entities and gynecologic
surgery. The section on special entities
continued on page 468

THE CANADIAN JOURNAL OF SURGERY

-A

A

Ionized Hypocalcemia in Critically III Patients with Sepsis
md,* W.J. Sibbald, md, frcp [ c],* M.W. Edmonds, md , frcp [ c],+
R.L. Holliday, md, frcs[c]* and C. William s , md , F R C P [c ]f

B. T aylor,

Although total serum calcium (CaT)
concentrations are depressed in
critically ill patients with sepsis, the
ionized fraction (Ca2+), which represents
the active moiety of CaT, has not been
examined in depth in such patients.
In a prospective study, CaT and Ca2+
concentrations were measured in 75
healthy volunteers and 62 patients
with sepsis. Serum Ca2+ was measured
with an ionized calcium selective
electrode. The mean CaT value
in patients with sepsis was
significantly lower than in healthy
control patients (1.90 ± 0.18 mmol/L
vs 2.31 ± 0.09 mmol/L [7.62 ± 0.73
mg/dL vs 9.27 ± 0.35 mg/dL];
P < 0.001). Although the serum Ca2+
value in the patients with sepsis was
also significantly lower than in control
subjects (0.91 ± 0.09 mmol/L vs 1.09 ±
0.04 mmol/L [3.66 ± 0.38 mg/dL vs
4.36 ± 0.15 mg/dL]; P < 0.001),
the value of Ca2+ as a percentage of
Car was not significantly different in
the two groups (sepsis, 47.8 ± 5.3%
vs control, 47.5 ± 3.0%; P = 0.65).
In patients with sepsis both serum
albumin (P < 0.01) and total serum
protein concentrations (P < 0.001) were
also lower than in healthy volunteers.
The serum magnesium value in patients
with sepsis was 0.82 ± 0.16 mmol/L
(1.64 ± 0.32 meq/L) and was
0.92 ± 0.08 mmol/L (1.83 ± 0.16 meq/L)
in controls (not significant). Although
the patients with sepsis were
significantly more alkalotic than those
in the control group (pH, 7.45 ± 0.09 vs
7.40 ± 0.05; P < 0.05), this does not

From the critical care/ trauma unit,
Victoria Hospital, and the University
of Western Ontario, London, Out.
Presented at the 47th annual meeting of
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■Department of medicine, Wellesley
Hospital, Toronto, Ont.
Supported by Ontario Health grant
PR620C
Reprint requests to: Dr. W.J. Sibbald,
Department of medicine, Victoria Hospital,
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explain entirely the low Ca2+ value
found. Despite the low Ca2+ concen
tration, the serum parathormone value
in the patients with sepsis was
0.27 ± 0.14 ng/mL (normal, less than
0.5 ng/mL). Urinary cyclic AMP was
similar in both groups (2.45 ± 1.33
atnol/g creatinine vs 2.55 ± 1.25
y,mol/g creatinine; P = 0.85).
Ionized hypocalcemia is present in
patients with sepsis and may result
from failure of appropriate parathormone
secretion in response to low Ca2+
concentrations, as has previously been
described in patients with acute
pancreatitis.
Bien que les concentrations seriques
de calcium total (CaT) soient abaissees
chez les patients septiques dont I’etat
est tres grave, la fraction ionisee
(Ca2+), qui represente la partie active
du C ar, n'a pas ete etudiee en profondeur chez ces patients. Dans une
etude prospective, les concentrations
en Ca' et en Ca2+ ont ete mesurees
chez 75 volontaires sains et chez
62 patients septiques. Le serum Ca2+
a ete mesure avec une electrode
selective pour le calcium ionise.
La concentration moyenne de CaT chez
les patients septiques etait significativement plus basse que chez les sujets
temoins sains (1.90 ± 0.18 mmol/L
compare a 2.31 ± 0.09 mmol/L [7.62
0.73 mg/dL compare a 9.27 ± 0.35
mg/dL]; P < 0.001). Bien que la teneur
serique en Ca2+ chez les patients
septiques eut aussi ete significativement
plus faible que chez les sujets temoins
(0.91 ± 0.09 mmol/L compare a
1.09 ± 0.04 mmol/L [3.66 ± 0.38
mg/dL compare a 4.36 ± 0.15 m g/dL];
P < 0.001), la valeur du Ca2+ exprimee
en pourcentage du Ca1 n’etait pas
significativement differente pour les
deux groupes (groupe septique,
47.8 ± 5.3% et groupe temoin,
47.5 ± 3.0%; P = 0.65). Chez les patients
septiques, les concentrations seriques
en albumine et en proteine totale
etaient aussi plus faibles (respectivement, P < 0.01 et P <0.001) que
chez les volontaires sains. La valeur
magnesium serique des patients
septiques etait de 0.82 ± 0.16 mmol/L
(1.64 ± 0.32 meq/L) et celui des
temoins, de 0.92 ± 0.08 mmol/L
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(1.83 ± 0.16 meq/L) (une difference
non significative). Bien que les patients
septiques eussent ete significativement
plus alcalosiques que ceux du groupe
temoin (pH, 7.45 ± 0.09 compare a
7.40 ± 0.05; P < 0.05), ceci n’explique
pas completement la faible concen
tration de Ca2+ retrouvee. En depit
de cette faible teneur en Ca2+, la
concentration serique en parathormone
dans les patients septiques etait
de 0.27 ± 0.14 ng/mL (la normale est
de moins de 0.5 ng/mL). La concen
tration urinaire en AMP cyclique etait
semblable pour les deux groupes
(2.45 ± 1.33 ij.mol/g de creatinine,
compare a 2.55 ± 1.25 u.mol/g de
creatinine; P = 0.85).
L'hypocalcemie chez les patients
septiques est peut-etre le resultat de
I’echec des glandes parathyroi'des de
repondre a les concentrations en Ca2+
faible, comme les patients qui souffrent
de la pancreatite aigue.

In recent years the occurrence and
significance of hypocalcemia during
episodes of acute illness have been the
subjects of a number of articles in the
medical literature;1'3 as a result new
concepts of calcium metabolism in both
healthy and critically ill patients have
emerged. Calcium plays an important
role in both extra- and intracellular
physiology. Fine regulation of calcium
concentrations is necessary to modulate
nerve conduction, muscle contraction,
enzyme activity, membrane potentials,
blood clotting, and hormone release
and response, as well as bone meta
bolism.4
Until recently the concentration of
the biologically active ionized calcium
fraction (Ca2+) was inferred by methods
correcting for serum protein changes,
such as use of the formula described
by Parfitt.5 Moore6 developed a method
for measuring ionized calcium directly.
Using an electrode specific for ionized
calcium, he demonstrated that 30% to
55% of the total serum calcium
(CaT = 2.1 to 2.6 mmol/L [8.5 to
10.5 mg/dL]) is bound to plasma prote
ins (81% to albumin, 19% to globu
lins) (Fig. 1). From 5% to 15% of
CaT is bound in complexes and chelates
but is still diffusible. The remainder
is free ionized calcium, the biologically
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active fraction that directly inhibits
parathormone (PTH) secretion. PTH
in turn plays an important role in close
ly regulating the ionized calcium con
centrations. Ionized magnesium con
centrations also influence PTH, but to
a lesser extent, since it is the total
divalent cation concentration to which
PTH responds, and normally serum
Ca2i is far greater than serum mag
nesium.7
Previous observations by one of us
(W.J.S.) using indirect measurements
have supported the idea that ionized
hypocalcemia occurs in sepsis.8 In the
present study serum concentrations of
Ca2+ were measured by the direct
method in a broad group of patients
with severe bacterial infections (sepsis).
The function of the parathyroid glands
was investigated at the same time by
measurement of serum PTH and uri
nary cyclic AMP. Ionized hypocalcemia
would be expected to result in elevated
serum PTH values, which in turn
should augment urinary cyclic AMP
excretion.
Methods
A group of 75 healthy volunteers
served as controls. Venous blood was
drawn anaerobically (after overnight
fasting) into vacuum tubes for meas
urement of CaT, Ca2+, magnesium, al
bumin and total protein. The samples
were allowed to clot and were then
centrifuged. For measurement of Ca2+
the serum was withdrawn anaerobically
into syringes and frozen until analysed
in the Orion SS-20 flow-through elec
trode (Orion Research Inc., Cam
bridge, MA). Total calcium was meas
ured on the SMA-12/60 Auto Analyzer
(Technicon Instruments, Tarrytown,
NY) by the method of Gitelman;9 al
bumin was assayed by the method of
Dpumas, Watson and Biggs10 and total
protein by the method of Weichselbaum.11 Serum magnesium values were
measured by the method of Sunderman
and Carroll.12
Sixteen “healthy” patients who had
Bound to Albumin

FIG. 1— Composition of total serum
calcium. Serum calcium is composed of
several different fractions defined by trans
porting molecule.
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undergone minor urologic or gyne
cologic surgery served as a control
group for measurement of renal ex
cretion of cyclic AMP (patients with
impaired renal function were excluded).
These patients were ambulatory and
taking a regular hospital diet. All had
indwelling urinary catheters which per
mitted accurately timed 4-hour meas
urement of urine. Urinary cyclic AMP
was analysed in this group by a modi
fication of Gilman’s13 method. The
same serum components that had been
measured in the healthy volunteers
were assessed to verify that these 16
patients were, in fact, healthy.
The study group consisted of 62
patients with sepsis who were being
treated in the critical care/trauma unit
of Victoria Hospital, London. Sepsis
was defined as the presence of an in
fectious process as evidenced by an
identifiable site, a febrile response and
a leukocytosis with or without a posi
tive blood culture. A few patients were
in septic shock. Nine patients with renal
failure (serum creatinine concentration
greater than 133 /zmol/L [1.5 mg/dL])
were also studied. The same serum
constituents were measured in the con
trol group as in the study group; the
blood was drawn from indwelling cen
tral venous catheters. Capillary blood
gases were analysed in the patients
with sepsis using the standard Astrup
technique. In addition, venous blood
for measurement of PTH concentra
tions was collected from 17 patients
from the study group in heparinized
tubes, kept in ice, centrifuged and
separated, and measured by Dr. C.
Williams (Wellesley Hospital, Toronto)
using a radioimmunoassay technique
and the type 21132 antibody (Bur
roughs Wellcome & Co., Willowdale,
Ont.) to the amino-terminal region of
bovine PTH.
Observations
Results from the analysis of blood
and urine constituents are summarized
in Tables I and II. The mean serum
Ca2+ concentration in the healthy
volunteers was 1.09 ± 0.04 mmol/L
(4.36 ± 0 .1 5 mg/dL) and the CaT was
2.31 ± 0.09 mmol/L (9.27 ± 0.35
mg/dL). The value of Ca2+ was 47.5%
of that for CaT, which agrees with the
findings of others.14 These measure
ments were not significantly different
in the group of postoperative patients
also examined.
In the group with sepsis, which was
subdivided into patients with normal
renal function and those with acute
renal failure, both Ca2+ (0.91 ± 0.09
mmol/L [3.66 ± 0.38 mg/dL]) and
CaT (1.90 ± 0.18 mmol/L [7.62 ±
0.73 mg/dL]) were significantly de
creased; the difference was most marked
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in the patients with renal failure (Ta
ble I). The percentage of CaT repre
sented by Ca2+ (47.8%) was not signi
ficantly different from that in the con
trol group.
The constant overall Ca2+:CaT ratio
in the two groups suggests that one
could calculate Ca2+ knowing CaT.
However, this ratio did not apply to
patients with sepsis as evidenced by
the insignificant correlation coefficients
between Ca2+ and CaT (Fig. 2, Table
III).
Concentrations of both total protein
and albumin were low in the patients
with sepsis, as previously reported by
Deysine, Lieblich and Aufses15 and
Sibbald, Sardesai and Wilson.8 In both
groups, albumin values correlated well
with those for CaT (Fig. 3, Table III).
The Ca2+ concentration did not corre
late with that of albumin in either
group.
The group of patients with sepsis
had a borderline respiratory alkalosis
(Table II), likely because most of these
patients were maintained on ventilators.
Since the regression correlation of Ca2+
on pH was not significant, it is unlike
ly that the ionized hypocalcemia was
related to this alkalosis.
Serum phosphate (P04) in the pa
tients with sepsis was significantly
lower than in the volunteers (Table II),
thereby ruling out the possibility of in
creased binding of ionized calcium,
known to occur in hyperphosphate
mia.7,16 In the 16 patients with renal
failure the serum POt value was slight
ly elevated.
Serum magnesium concentrations
were slightly depressed in the patients
with sepsis who had normal renal func
tion (P = 0.03), although the value
was not outside the normal laboratory
range (0.55 to 1.15 m mol/L [1.1 to
2.3 meq/L]).
Urinary cyclic AMP concentrations
in the group with sepsis were not sig
nificantly different from those of
healthy volunteers, a surprising finding
considering that these patients had
ionized hypocalcemia and normally
should have manifested elevated values
secondary to increased PTH activity at
the renal tubular level.17
Serum PTH concentrations measured
in 17 patients with sepsis, 15 with nor
mal renal function and 2 with acute
renal failure, were well within normal
laboratory limits. This finding, to
gether with the “normal” cyclic AMP
excretion, would suggest a relative
deficiency of PTH in view of the low
value for circulating ionized calcium.
Although there seems to be an inverse
relation between Ca2+ and PTH (Fig.
4), this relation was not significant
(P > 0.1). The poor correlation may
be a consequence of the small number
of subjects in the study, or there may
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Table 1-Serum Total Calcium (Car) and Ionized Calcium Fraction (Ca2+) and Proteins in Patients with Sepsis

Group

Car, mmol/L

Ca2+, mmol/L

Controls
(n = 75)
All patients with
sepsis (n = 62)
Patients with sepsis
and normal renal
f unction (n = 53)
Patients with sepsis
a nd acute renal
failure (n = 9)

2.31 ± 0.09

1.09 ± 0.04

1.90 ± 0.18*

0.91 ± 0.09*

Total protein,
g/L

Albumin,
g/L

47.5 ± 3.0

70 ± 3

42 ± 2

47.8 ± 5.3 (NS)

56 ± 9*

28 ± 8*
28 ± 1*
30 ± 4f

Ca2+ as percentage
of Car

1.92 ± 0.02*

0.93 ± 0.01*

48.4 ± 0.7 (NS)

—

1.82 ± 0.08*

0.83 ± 0.05*

46.1 ± 1.2 (NS)

—

*P < 0.001.
fP < 0.05.
NS = not significant.

Table II -O ther Serum and Urine Constituents Measured in Patients with Sepsis

Controls
(n = 75)
All patients with
sepsis (n = 62)
Patients with sepsis
and normal renal
function (n = 53)
Patients with sepsis
and acute renal
failure (n = 9)

Parathormone,
ng/ml

Magnesium,
mmol/L

Phosphate,
mmol/L

0.92 ± 0.08

1.09 ± 0.05

0.82 ± 0.16

0.91 ± 0.07*

7.35 - 7.45
(lab)
7.45 ± 0.09

0.81 ± 0.02f

0.76 ± 0.045*

7.46 ± 0.01

0.88 ± 0.08
(NS)

1.53 ± 0.28
(NS)

Group

pH

Urinary cyclic AMP,
p.mol/g creatinine

<0.5
(lab)
0.27 ± 0.14
(n = 17)
0.26 ± 0.05
(n = 15)

2.55 ± 0.13

0.135 ± 0.05
(n = 2)

1.56 ± 0.48
(NS)
(n = 7)

2.45 ± 0.13
(NS)
3.01 ± 0.35
(NS)

*P < 0.001.
tP < 0.05.
NS= not significant.

Table III —Calcium Correlation Coefficients
Group
Controls
(n = 75)

2.50

3.00

3.50

C «2+

4.00

Patients with
sepsis (n = 62)

4.50

Bg/dL

Caf vs Ca2+

CaT vs albumin Ca2+ vs albumin pH vs Ca2+ Ca2+ vs PTH

0.47*

0.52

0.15 (NS)

0.17 (NS)

0.69*

0.11 (NS)

indeed be no correlation because of a
relative deficiency of PTH.

9.00

1

Ca
m g/dL 8.00

3 .0 0

Ca 2 +

4 .00

mg/dL

FIG. 4—Relation between serum para
thormone (PTH) and Ca2+ concentrations
in patients with sepsis. Inverse relation ap
pears to be present but is not significant
(r — 0.37, P = NS).

Albumin mg/dL

FIG. 3—Relation between serum albu
min and CaT concentrations in patients
with sepsis. Values correlated well despite
hypoalbuminemia (r = 0.69, P < 0.001).
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0.08 (NS)

0.37 (NS)

*P < 0.001.
NS = correlation nof significant.

FIG. 2— Serum ionized calcium fraction
(Ca2+) vs total serum calcium (CaT) in
patients with sepsis. N o significant corre
lation exists (r = 0.17, P = NS).

2 .0 0

—

/

D iscussion

Total and ionized hypocalcemia oc
cur in critically ill patients with sep
sis, and in no such individuals can the
value for Ca2+ be predicted from that
for CaT. Moore6 found that even in
normal individuals Ca2+ cannot be
predicted from CaT because albumin
concentrations vary from person to
person. In our control group the corre
lation coefficient of 0.47 supports a
weak relation between values for CaT
and Ca2+.
Trunkey, Carpenter and Holcroft4
demonstrated pronounced decreases in
Ca2+ as compared with CaT during
endotoxic shock in baboons and postu
lated that ionized hypocalcemia may
have contributed to the hypotension ob
served by impairing vascular tone. Drop

THE CANADIAN JOURNAL OF SURGERY

431

and Laver1 showed that Ca2+ decreased
markedly in comparison with CaT in
humans during cardiogenic and septic
shock and noted that large amounts of
calcium chloride were needed to re
store Ca2+ to its normal concentration.
Although the low concentrations of
CaT in our patients with sepsis may be
explained by hypoalbuminemia, it is
evident that ionized hypocalcemia is
due to other causes since ionized cal
cium concentrations are independent of
the concentrations of albumin (Table
III). Elevated or depressed magnesium
concentrations are known to cause low
Ca2+ values,7 but the borderline depres
sion of magnesium that we observed
does not appear to have been enough
to affect them.
Moore6 calculated that a 0.1-unit
increase in pH would cause a 0.04mmol/L (0.16 mg/dL) decrease in
Ca2+. In this study the slight alkalosis
present in the patients with sepsis
would not significantly affect the Ca2+
value, nor was there any significant
correlation between Ca2+ and pH in
this group of patients. Urinary calcium
losses accounting for the low serum
Ca2+ concentration may occur, but we
were unable to establish this in a pre
vious study.8
Ionized calcium may also have been
bound to anion complexes present in
the serum of these patients. Moore18
has demonstrated increased calcium
binding in patients with cirrhosis; how
ever, the ligand is unknown. Globulins,
lactate and pyruvate are all possible
binding substances. Denlinger and
Nahrwold2 have shown that massive
transfusions of whole blood cause low
Ca2+ concentrations by the complexing
of calcium ions with citrate; they re
ported a case of acute congestive heart
failure from low Ca2+ concentrations
during transfusion. Deysine, Lieblich
and Aufses15 and Trunkey, Carpenter
and Holcroft4 noted that hyperphospha
temia occurred in their subjects during
septic shock; here the phosphate could
have formed a complex with calcium
ions, thus causing a low Ca2+ con
centration. Hyperphosphatemia was not
observed in patients in this study (Ta
ble II).
In the patients with sepsis, the Ca2+
value was significantly depressed. The
parathyroid glands normally respond to
ionized hypocalcemia, so serum PTH
concentrations should have increased
in order to mobilize calcium from bone
and to increase reabsorption from the
renal tubules to correct the deficit. In
the patients with sepsis the PTH con
centrations were not increased in the
presence of ionized hypocalcemia. The
only patient in the group with an
elevated PTH value was a young man
with pancreatitis and lobar pneumonia
(PTH = 0.62 ng/mL, Ca2+ = 0.93
432

mmol/L). This patient had an elevated
PTH value appropriate for his degree
of hypocalcemia. Serum PTH con
centrations are known to increase in
chronic renal failure,19 probably be
cause of hypocalcemia. In two patients
with sepsis and acute renal failure the
Ca2+ value was indeed low, but the
PTH value was within the expected
normal range (Table II). Normal values
for urinary cyclic AMP in the patients
with sepsis also supported the finding
of “normal” serum PTH concentra
tions. These data suggest hypofunction
of the parathyroid glands in sepsis, with
or without renal failure.
Robertson and colleagues20 demon
strated inappropriately low concentra
tions of PTH in nine patients with
acute pancreatitis and a low Ca2+ value
and concluded that inadequate para
thyroid response was the cause of the
hypocalcemia. Condon and associates21
demonstrated that 75% of patients with
hypocalcemia secondary to pancreatitis
had undetectable concentrations of
PTH. In contrast, Weir and associates22
found that PTH was elevated in five of
eight patients with pancreatitis and a
low Ca2+ value and in one patient with
a low-normal Ca2+ value. The con
flicting results may be due to the immunoheterogenicity of antibodies to
PTH used in different laboratories.
The failure of elevation of PTH
secretion might have several causes.
Fischer, Blum and Binswanger23 have
shown that stimulation of (i receptors
with exogenous catecholamines results
in increased concentrations of serum
PTH. In sepsis, plasma norepinephrine
and epinephrine are increased24 which,
according to Fischer and associates,
would increase serum PTH and hence
Ca2+. The lack of elevation of the se
rum PTH concentration in response to
known elevation of endogenous cate
cholamines may be an indicator of a
generalized “sick cell syndrome” in
sepsis wherein cellular receptors are
incapable of a normal response to cir
culating cathecholamines.
The glands may also have been “re
set” to respond with PTH secretion to
lower concentrations of Ca2+.
A third possible cause of the pro
longed ionized hypocalcemia is endorgan failure, but if this were the case
serum PTH concentrations would be
elevated. Our patients were not given
PTH extract to assess the response, but
Robertson and colleagues20 showed an
increase in Ca2+ concentrations in pa
tients with hypocalcemia secondary to
pancreatitis who were given the extract.
Finally, Robertson and associates20
stated that a possible cause of the low
PTH concentrations in pancreatitis
could be catabolism of the hormone in
the serum by trypsin. A similar mechan
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ism may operate in patients with sepsis
as they are extremely catabolic.
In summary, patients with sepsis
have hypocalcemia resulting not only
from decreased amounts of calcium
bound to protein, but also from low
concentrations of ionized calcium. The
reason or reasons for the low Ca2+
value are not clearly defined at present
but relative hypoparathyroidism may
be involved.
Conclusions

Ionized and total hypocalcemia exist
in critically ill patients with sepsis and
the low value for CaT is secondary to
hypoalbuminemia. Low Ca2+ concen
trations may result from relative hypo
parathyroidism, due either to “reset
ting” of the glands to lower concentra
tions of Ca2+ or to inability of the
glands to secrete appropriate amounts
of PTH in the presence of sepsis.
The fact that ionized calcium con
centrations cannot be predicted ac
curately from the value for CaT in the
individual patient with sepsis empha
sizes the need for direct measurement
of Ca2+ on the flow-through electrode.
The therapy of hypocalcemia in
critically ill patients depends upon the
clinical situation. Patients with ful
minant septicemia or those receiving
large amounts of citrated blood will
have a marked decrease in the Ca2+
value2 and should immediately be given
free calcium supplements intravenously.
Patients with sepsis who are critically ill
but whose condition is more stable re
quire a number of therapeutic proce
dures: removal of the septic focus,
introduction of hyperalimentation to
reverse the protein catabolism and
administration of free calcium supple
ments to raise the Ca2+ concentration.
We are currently assessing the hemo
dynamic response of these patients to
calcium infusion to determine the im
portance of ionized hypocalcemia.
We thank R. Weir, RT, for his careful
measurements of ionized calcium, W. Ballantyne for his expert technical assistance,
S. Woolcock for typing the manuscript,
and the nurses and residents in the critical
care/trauma unit, Victoria Hospital, Lon
don, for their kind cooperation.
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Effect of Wheat Bran on Serum Lipoproteins and
Biliary Lipids
R oderick M. M cD ougall, m sc,
K eith Walker, m b , ch b, FRCP[c]f

In this study nine patients with
gallstones and nine healthy volunteers
were given a high bran diet for 4 weeks.
At the outset and at 4 weeks bile
specimens were obtained for deter
mination of biliary lipid values, size
of the bile-acid pool and bile-acid ratios,
and blood specimens were drawn to
determine the serum concentration of
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triglycerides and of lipoprotein-bound
cholesterol. Three patients with
gallstones remained on the high bran
diet for 6 months or more and
samples were analysed again. The
high bran diet produced a substantial
decrease in biliary cholesterol values
in patients with gallstones after 4
weeks, and a significant increase in
the concentration of high density
lipoprotein-cholesterol in the serum of
patients whose course was followed
for 6 months or longer.
Dans cette etude, neuf patients
souffrant de calculs biliaires et neuf
volontaires sains ont recu pendant
4 semaines un regime alimentaire a
forte teneur en son. Des echantillons
de bile ont ete preleves au commen
cement et apres 4 semaines, pour la
determination des teneurs en lipides
biliaires, le volume du pool d’acide
biliaire et les rapports d’acide biliaire,
et des echantillons de sang ont ete
pris pour determiner la concentration
des triglycerides et celle du cholesterol

lie aux lipoproteines. Trois patients
souffrant de calculs biliaires ont ete
maintenus sur le regime riche en son
pendant 6 mois et plus, et ont eu des
determinations sanguines additionnelles.
Le regime alimentaire a forte teneur
en son a produit, apres 4 semaines,
une importante diminution des
concentrations de cholesterol biliaire
chez les patients ayant des calculs
biliaires, et une augmentation signi
ficative de la concentration du complexe
cholesterol-lipoproteine de haute
densite dans le serum des patients
dont 1'evolution a ete suivie pendant
6 mois ou plus.

Cholesterol cholelithiasis and athero
sclerosis have been linked, by their
world-wide geographic incidence, to the
low fibre diet characteristic of Western
countries.1'2 The metabolic relation be
tween these entities and dietary fibre
is unclear but cholesterol is the main
constituent of both gallstones and
atheromas. Moreover, the synthesis of
bile acids from cholesterol, in the
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liver, constitutes the metabolic pathway
whereby cholesterol may be lost from
the body.3 The metabolic link between
cholesterol, bile acids and dietary fibre
is the bile-acid-binding property of fibre
and its effect on intestinal transit time.4
In order to investigate the relation be
tween dietary fibre, biliary lipids and
serum lipids, we ascertained lipid meas
urements in nine patients with radiolucent gallstones and in nine healthy
volunteers, before and after the subjects
were placed on a high bran (fibre) diet.
Patients and Method

Nine patients with radiolucent stones
in radiologically functioning gallblad
ders and nine healthy control subjects
with no history of biliary tract disease
were admitted to the study after we
had obtained the informed consent of
each subject. At the beginning of the
study a bile sample was obtained from
each subject, through a duodenal tube
positioned radiologically, to determine
the size of the total bile-acid pool,
the proportion contributed by individ
ual bile acids (cholic acid [CA],
chenodeoxycholic acid [CDCA], deoxycholic acid [DCA] and lithocholic acid
[LCA]) and the amounts of biliary
lipids (cholesterol, phospholipid and
total bile acids). At the same time a
blood sample was obtained by vene
puncture to determine the concentration
of serum lipids (cholesterol and trigly
cerides). The subjects were instructed
to eat 50 g of a wheat bran cereal
daily in addition to their normal diet.
This amount of bran altered the bowel
habit of every subject, usually from
one stool daily to two or three bulky
stools each day. At the end of 4 weeks
bile and blood samples were again anal
ysed. Three of the subjects in the group
of patients with gallstones remained on
the high bran diet for 6 months (one
patient) to 1 year (two patients) and
their serum lipid concentrations were
measured again at the end of these time
periods.
The amounts of biliary cholesterol,
lecithin and total bile acids in the col
lected bile specimens were determined
by methods described previously.5 Bile
acids were measured by the method of
Engert and Turner6 using a 3-a-dehydroxysteroid dehydrogenase extracted
from Pseudomonas testosteroni, phos
pholipid by the method of Bragden7
and cholesterol by the method described
by Abell and associates8 using the Liebermann Burchard reaction. From the
data obtained we determined the lithogenic or saturation index (SI) of
Metzger, Heymsfield and Grundy9 for
each bile sample, taking the cholesterol
solubility line of Admirand and Small10
as a reference point. Individual bile
acids in bile were measured by gas434

liquid chromatography as described pre
viously,11 and the size of the total bileacid pool was determined by isotope
dilution using 4 /xCi of cholic acid
labelled with carbon-14, administered
intravenously 14.5 hours before col
lection of bile samples.12
High density lipoprotein (HDL) was
separated from low density lipoprotein
(LDL) and very low density lipoprotein
(VLDL) by precipitation of LDL and
VLDL with heparin and manganese
chloride, according to the method of
Burstein, Scholnick and Morfin,13 and
the LDL plus VLDL precipitate was
solubilized with sodium citrate.14 Choles
terol concentrations were measured di
rectly in both fractions and in the native
serum by the cholesterol-esterase/
cholesterol oxidase reaction,15 using a
commercial kit (Boehringer Mannheim
Biochemicals, Indianapolis, IN). Native
serum triglyceride values were estimated
enzymatically by the lipase-esterase-glycerokinase reaction.16 The Abbott bichromatic analyzer (Abbott Diagnostics,
South Pasadena, CA) was used for both
types of assay.
Results

Determinations of biliary cholesterol,
phospholipid and total bile acids, with
subsequent calculation of SI showed
that the bile of the nine patients with
gallstones was initially saturated, or
supersaturated, with cholesterol (SI =
1.43 ± 0.16, mean ± SEM). Biliary
cholesterol fell to unsaturated concen
trations in all patients but one after 4
weeks of a high bran diet (SI = 0.76 —
0.07, P < 0.01 by Student’s paired ttest); in the patient who was the ex
ception the SI fell from 2.1 to 1.2
(Fig. 1). In nine control subjects bile
was unsaturated with cholesterol initial
ly (SI = 0.70 ± 0.1) and remained un
saturated during the period they were
on a high bran diet (SI = 0.50 ± 0.06).

The total bile-acid pool in nine con
trol subjects initially was 2.37 ± 0.36 g
(mean ± SEM) and remained essential
ly unchanged at 2.32 ± 0.16 g after 4
weeks of a high bran diet. The pool
was slightly smaller initially in the nine
patients with gallstones (1.75 ± 0.6 g)
and did not increase significantly during
the period of the diet (2.03 ± 0.21 g).
Analysis of the individual bile acids
showed the proportion of DCA to be
greater in the bile of patients with gall
stones than in that of control subjects.
DCA formed 31.3% of the total bileacid pool in patients with gallstones
and only 19.0% in control subjects
(P < 0.02, Fig. 2). The proportion of
DCA in the bile-acid pool of patients
with gallstones decreased to a mean
value of 23.3% after 4 weeks of
high bran diet (P < 0.05, Fig. 3) but
did not change significantly in control
subjects. The proportion of CDCA in
the bile-acid pool in control subjects was
40.4% and in patients with gallstones
28.8% (P < 0.01) before bran was
included in the diet but did not change
significantly in either group after 4
weeks of the diet. The proportions of
CA and LCA were not significantly dif
ferent in the two groups either before
or after the high bran diet.
The serum cholesterol concentration
in nine control subjects prior to in
gestion of the diet was 161 ± 9.4
mg/dL (4.16 ± 0.24 mmol/L) (mean
± SEM); after 4 weeks it was essen
tially unchanged at 168 ± 12.0 mgd/L
(4.34 ± 0.31 mmol/L). By comparison,
the serum cholesterol concentration was
significantly elevated in the nine pa
tients with gallstones before the high
bran diet was instituted (219 ± 15.1
mgdL [5.7 ± 0.39 mmol/L], P <
0.01), and was unchanged after 4
6 0 -,
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FIG. 1— Biliary saturation index in nine
patients with gallstones before institution
of high bran (fibre) diet and after 4 weeks
(P < 0.01).

Controls

Gallstones

Mean 19%

Mean 313%

FIG. 2— Proportion of deoxycholic acid
(DCA) in bile-acid pool of nine control
subjects and nine patients with gallstones
(P < 0.02).
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(3.8 ± 0.41), but did decrease signif
icantly in the three patients who stayed
on the diet for 6 to 12 months (2.5 ±
0.07, P < 0.05). The serum lipid data
are set forth in Table I.
Discussion

Bile from the nine patients with
radiolucent gallstones was supersat
urated with cholesterol initially. The
biliary cholesterol concentration fell
significantly in all after 4 weeks’ intake
of increased dietary fibre in the form
of wheat bran. Dietary bran acts as
a weak bile-acid binding agent4 and
decreases intestinal transit time, prob
ably causing increased excretion of bile
acids in the feces and thus effecting a
partial interruption of the enterohepatic
circulation of bile acids. In this situa
tion, hepatic synthesis of primary bile
acids (CA and CDCA) is increased, and
newly synthesized cholesterol in the
liver is converted into primary bile
acids instead of being secreted un
changed into bile. Additional support
for this hypothesis is to be found in the
change in the proportion of the second
ary bile-acid DCA in patients with gall
stones that was brought about by in
gestion of a high bran diet. Initially the
proportion of DCA in the bile-acid pool
of patients with gallstones was high, and
fell after 4 weeks of a high fibre diet.
This change may indicate binding and
excretion of DCA by bran, and replace
ment of DCA in the bile-acid pool by
the primary bile acids CA and CDCA.
A change in the serum lipoproteins
transporting cholesterol in the blood of
patients with gallstones was not ap
parent after 1 month on a high bran
diet but appeared in three patients
whose course was followed for 6 to 12
months. The VLDL + LD L/H D L
ratio fell in these three patients, in
dicating an increase in the concentra
tion of HDL cholesterol (i.e., the cho
lesterol being transported from the
tissues to the liver).17 It is possible that
the long-term drain of hepatic choles

% DCA

FIG. 3—Proportion of DCA in bile-acid
pool of 9 patients with gallstones before
and after high bran diet (P < 0.05).

weeks (211 ± 17.4 mg/dL [5.46 ±
0.45 mmol/L]) and in three patients
after 6 to 12 months (211 ± 24.7 m g/
dL [5.46 ± 0.64 mmol/L]).
Serum triglyceride concentrations in
control subjects initially were 113 ±
14.7 mg/dL (1.28 ± 0.17 mmol/L) and
did not change after bran was included
in the diet (112 ± 16.5 mg/dL [1.26 ±
0.19 mmol/L]). In patients with gall
stones they were significantly higher in
itially (195 ± 23.9 mg/dL [2.20 ±
0.27 mmol/L], P < 0.01) and did not
change when bran was added to the
diet (219 ± 34.2 mg/dL [2.47 ± 0.39
mmol/L]).
The lipoprotein-cholesterol ratio
(VLDL + LDL/HDL) in control sub
jects was unchanged after they had
been on a high bran diet for 1 month
(2.5 ± 0.31 and 2.4 ± 0.28). The ratio
was significantly elevated initially in
patients with gallstones when compared
with controls (3.9 ± 0.39, P < 0.01)
and did not change after 1 month of
administration of a high bran diet

Table I— Serum Lipid Data (Mean ± SEM) in Control Subjects and Patients with Gallstones
Control subjects
(n = 9 )

terol by its conversion into primary bile
acids, caused by ingestion of bran,
stimulates the observed increase in HDL
cholesterol, which indicates that more
cholesterol is being transported to the
liver for metabolism. This chain of
events may also indicate a possible me
tabolic link between atherosclerosis,
cholesterol cholelithiasis and fibre de
ficiency.
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an urgent problem
postoperative anaerobic
in gynecological
infections

'■• ■clindamycin is an important antibiotic in the
therapy of such [gynecological] infections.’ ’
Swenson, R.M., et al. (1974). Obstet. & Gynecol., 44:699.

in abdominal
infections

This study suggests " ... clindamycin is an excellent
and relatively safe antibiotic for treatment of
[abdominal] infection caused by anaerobes when
combined with surgery (when indicated) or other
antibiotics active against aerobic gram-negative
bacilli, if present.”
Levison, M.E.,etal.(M ar., 1974).
Antimicrob. Agents & Chemother., p. 276-280.

an accepted solution
Dalacin C Phosphate S.S.
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Indications: Dalacin C Phosphate (clindam ycin phosphate in je c tio n N.F.) Dalacin C Phosphate S terile S o lu tio n is in dica te d fo r the tre£
m ent of in fectio ns where the oral route is not in dicated or feasible.
C lindam ycin phosphate is indicated in the treatm ent o f serious in fe c tio n s due to sensitive anaerobic bacteria, such as Bacteroide
species, pep tostre pto coccus, anaerobic strep tococci, C lo s trid iu m species and m icro-aero philic stre p to co cci.

infections
in pulmonary
.anaerobic infections

C lindam ycin phosphate is also indicated in serious in fe c tio n s due to sensitive G ram -positive organism s s ta p h y lo c o c c i (in clu d in g penic
linase-producing staphylococci), strep tococci and pne um o cocci when the patient is in tolerant of, or the o rganism resistant to, oth
appropriate antib iotics.
Contraindications: The use of Dalacin C Phosphate is c o ntraind icated in p atie nts previously found to be h ype rsen sitive to th is com poun
the parent com pound, clindam ycin , or clindam ycin palm itate. A lth ough cro ss-se n sitisa tio n w ith Linc o c in (lin co m ycin ) has not be«
dem onstrated, it is recom m ended that Dalacin C Phosphate not be used in p atie nts w ho have dem onstrated lin c o m y c in sensitivity. Un
further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (infants below 30 days of age), or in pregnant wom e
Warnings: Some cases of severe and persistent diarrhoea have been reported durin g or a fte r therapy w ith D alacin C Phosphate. Th
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Mediastinoscopy for Diagnosing Diseases of the Lung
Other than Primary Carcinoma
R.A. F o rse ,

md,

Mediastinoscopy is an efficient method
of assessing lymphatic spread in
carcinoma of the lung. It is also
valuable in providing a definitive
diagnosis of other lung diseases. At
the Montreal Chest Hospital Centre
diagnostic mediastinoscopy was
performed in 60 patients with diseases
of the lung other than primary
carcinoma. All had preoperative
radiologic evidence of hilar adenopathy.
A definitive diagnosis was obtained
in 91.7% of cases. Nonspecific adenitis
was diagnosed in four patients and in
none was there evidence of serious
intrathoracic disease subsequently.
Morbidity was minimal and there were
no deaths.
Mediastinoscopy is a safe, accurate
and efficient aid in the evaluation of
primary or secondary disease of the
anterior intrathoracic lymphatic system.
La mediastinoscopie est une methode
efficace d'evaluer I'envahissement
lymphatique du cancer du poumon.
Elle est aussi utile pour arriver a un
diagnostic definitif dans d'autres
maladies du poumon. Au Centre Hospitalier Thoracique de Montreal, la
mediastinoscopie diagnostique a ete
effectuee chez 60 patients souffrant

From the department of surgery,
Montreal Chest Hospital Centre,
Montreal, PQ
Presented at the annual meeting of the
Canadian Thoracic Society, Moncton, NB,
June 13-15, 1977
Reprint requests to: Dr. D.D. Munro,
Department o f surgery, Montreal Chest
Hospital Centre, 3650 St. Urbain St.,
Montreal, PQ H2X 2P4
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de maladies pulmonaires autres qu'un
carcinome primaire. Tous presentaient
des signes radiologiques preoperatoires
d’adenopathie hilaire.
Un diagnostic definitif a ete obtenu
dans 91.7% des cas. Une adenite
nonspecifique a ete diagnostiquee chez
quatre patients et aucun n’a subsequemment montre de signes d'une
maladie thoracique serieuse. La mor
bidity est demeuree minimale et il
n’y a eu aucun deces.
La mediastinoscopie est un moyen
sur, precis et efficace servant a
revaluation des maladies primaires ou
secondaires du systeme lymphatique
thoracique anterieur.

Since its introduction by Carlens1 in
1959 mediastinoscopy has become well
established as a diagnostic procedure.
It enables the surgeon to obtain lym
phatic tissue from the anterior medi
astinum for direct microscopic and
bacterial evaluation. It is the most
accurate method of assessing the lym
phatic spread of primary carcinoma of
the lung.2 It is also valuable in diag
nosing other primary or secondary dis
eases affecting the paratracheal and
parabronchial lymph nodes. The pur
pose of this report is to outline our
experience with mediastinoscopy in the
diagnosis of diseases of the lung other
than primary carcinoma.
Clinical Material
Sixty patients underwent mediastino
scopy at the Montreal Chest Hospital
Centre during the period Jan. 1, 1966
to Dec. 31, 1975 for the diagnosis of
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diseases of the lung other than carci
noma. Thirty-five were men and 25
were women and their ages ranged
from 16 to 66 years (mean, 37.5 years).
Mediastinoscopy was performed when
tissue specimens obtained by broncho
scopy, gastric lavage, needle biopsy, or
peripheral node biopsy did not permit
a definitive diagnosis. Involvement of
the anterior mediastinal lymph nodes
in the underlying disease process was
suggested by chest roentgenography or
mediastinal tomography in all patients.
When clinical examination did not re
veal evidence of peripheral adenopathy,
particularly in the supraclavicular area,
mediastinoscopy was performed in
preference to biopsy of a clinically un
involved scalene node.
Results
The pathological diagnosis in the 60
patients following mediastinoscopy is
shown in Table I. Tissue was obtained
for histologic and bacteriologic evalua
tion in all cases. A definitive diagnosis
was established in 55 (91.7%) cases.
Sarcoidosis was the most common
diagnosis; it was present in 45 patients.
Hodgkin’s lymphoma involving para
tracheal or parabronchial nodes was
found in four patients. Secondary ade
nocarcinoma, arising from the breast
in each case, was discovered in four
patients. One patient had tuberculous
adenitis, confirmed by the presence of
caseation necrosis and positive culture
of lymphoid tissue. Normal thymic tis
sue was determined to be the cause
of apparent hilar adenopathy in an
other patient.
There were four cases of nonspecific
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Table I— Pathological Diagnosis following Mediastinoscopy
Diagnosis

No. of cases

%

45
4
4

75.0
6.7
6.7

Sarcoidosis*
Lymphoma (Hodgkin’s disease)
Metastatic carcinoma (breast)
Normal thymic tissue causing apparent hilar adenopathy
Tuberculosis
Nonspecific adenitis
Granulomatous adenitis

1
1

1.6
1.6

4
1

1.6

6.7

‘ Consistent with Boeck’s sarcoid.

Table II— Clinically Suspected Cases vs. Pathological Findings

Disease
Sarcoidosis
Lymphoma
Metastatic carcinoma

Clinically
suspected

Pathologically
confirmed
38
3
4

41
3
4

adenitis and one of granulomatous
adenitis. Samples of tissue from these
five patients showed no evidence of
tuberculosis by direct culture and
guinea pig inoculation.
A comparison of the clinical pre
operative diagnosis and the result of
mediastinoscopy is presented in Table
II. The clinical preoperative diagnosis
was remarkably accurate, particularly
in patients with sarcoidosis. In three of
the four cases of Hodgkin’s lymphoma
the disease was suspected preoperatively. In all four patients with meta
static breast cancer, the diagnosis was
suspected clinically; however, a tissue
diagnosis was indicated before further
therapy could be recommended.
There were two complications— a
postoperative air leak from the right

Not clinically suspected
but pathologically suggestive

bronchus, which healed spontaneously,
and nonfatal pulmonary embolism
which occurred 7 days postoperatively.
We describe three typical cases.
Case Reports

Case 1.—A 20-year-old man had a
2-week history of left-sided precordial
chest pain. There were no associated
respiratory symptoms. The patient denied
experiencing fever, chills or night sweats
and had no known contact with tuber
culous persons.
The physical findings were normal.
There was no adenopathy and the chest
was clear. Results of laboratory investiga
tions including biochemistry, hematology
and sputum tests were inconclusive. The
chest roentgenogram (Fig. 1) revealed
enlargement of paratracheal and broncho
pulmonary lymph nodes bilaterally and

FIG. 1—Case 1. Hilar lymph nodes are enlarged bilaterally and superior media
stinum is widened.
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a widened superior mediastinum. Medi
astinoscopy was performed and specimens
of lymphatic tissue were obtained. The
pathological diagnosis was consistent with
sarcoidosis.
Case 2.—A 48-year-old man had a
2-month history of persistent cough,
wheezing and occasional night sweats. He
had lost 10 kg in weight during that
time. He was a nonsmoker.
The physical findings were within nor
mal limits. Results of hematologic and
biochemical investigations and sputum
tests were not diagnostic. The chest ro
entgenogram (Fig. 2) demonstrated a left
hilar mass with normal lung parenchyma.
Bronchoscopy findings were normal. The
patient underwent mediastinoscopy. The
pathological diagnosis was Hodgkin’s
lymphoma, nodular sclerosing type.
Case 3.—A 46-year-old woman had
had progressive shortness of breath over
a 7-month period. Seven years earlier she
had undergone a radical mastectomy on
the right side for infiltrating duct carci
noma. Routine follow-up chest roentgeno
grams had been normal. On her admission
the chest roentgenograms (Fig. 3) revealed
an ill-defined density in the hilar region
on the right, which compressed the right
main-stem bronchus, and distal atelectasis.
The diaphragm on the right was elevated
and immobile.
Physical examination demonstrated a
well-healed mastectomy scar and de
creased breath sounds over the right side
of the chest. There was no lymphadenopathy. Other investigations, including
lung and bone scanning, gave normal
results. Mediastinoscopy was performed
and resulted in a diagnosis of infiltrating
duct carcinoma.
Discussion

Mediastinoscopy is m ost commonly
used for the clinical staging of prim ary
carcinoma of the lung.3 Its value in
managing bronchogenic carcinom a has
been reviewed in a num ber of papers.2,4
Ashbaugh,5 Tucker,6 Provost, Oliver
and Schwaber7 and Foster, M unro and
Dobell8 have presented excellent re 
views of the anatomic considerations,
complications and results of m ediastino
scopy.
In this series of 60 patients lym phoid
tissue was obtained for bacteriologic
and pathological assessment in all cases.
Lym ph nodes were considered to be
involved in the disease process in all
cases as demonstrated by enlargem ent
on preoperative roentgenograms.
Sarcoidosis: was the postoperative
diagnosis in 75% of these cases. M it
chell and Scadding,9 in a recent review,
pointed out the difficulty in securing
a firm diagnosis of sarcoidosis. A t the
International Conference on Sarcoidosis
in Washington, D C,10 it was stated that
sarcoidosis could not be defined on
the basis of histopathology alone be
cause the characteristic histologic ap
pearance of sarcoidosis is not patho-
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gnomonic. Similar noncaseating granu
lomas m ay be seen in a wide variety
of diseases including leprosy, syphilis,
fungal infections, foreign body reac
tions and C rohn’s disease. Mitchell and
Scadding9 believed that in a patient
with clear clinical features of sarcoido
sis and without discordant symptoms
or signs, a positive Kveim test or his
tologic confirmation was sufficient
to establish the diagnosis. Kent and
associates,11 however, have warned of
the high frequency of other diseases,
particularly tuberculosis, in patients
with a clinical picture of sarcoidosis.
As we have shown, with mediastino
scopy the surgeon can obtain tissue for
direct culture and guinea pig inocula

tion to eliminate tuberculosis as a
cause of symptoms.
In the past, relatively high diagnostic
accuracy has been Obtained for sar
coidosis by “blind” biopsy of the
clinically uninvolved scalene fat pad.
Elliott and colleagues,12 however, have
shown that mediastinoscopy is more
likely to produce a definitive diagnosis
of sarcoidosis or other intrathoracic
disease. In view of their findings it has
been our practice to use mediastino
scopy primarily when there is no
clinical supraclavicular adenopathy.
A malignant condition involving the
anterior mediastinal nodes was docu
mented in eight (13.3%) cases in this
series; four were cases of Hodgkin’s

lymphoma. The treatment regimen used
for Hodgkin’s disease today13 is based
on the anatomic extent of the disease.
Using mediastinoscopy we were able
to provide definite pathological evi
dence of supradiaphragmatic involve
ment in these cases and morbidity was
minimal.
Four postmastectomy patients were
found to have metastatic spread of dis
ease to mediastinal nodes from 9
months to 7 years after the initial op
eration. Radiotherapy, or chemo
therapy, or both, could be instituted
immediately following diagnostic medi
astinoscopy without retarding wound
healing or prolonging postoperative
convalescence.
In none of the six patients who had
a diagnosis of nonspecific adenitis did
tuberculosis or a malignant condition
develop during the follow-up period.
Thus, while a specific diagnosis was
not made in this group, serious under
lying disease does not appear to have
been overlooked.
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FIG . 2— Case 2. Left hilar mass is present. Lung parenchyma is normal.

FIG . 3— Case 3. There is right hilar mass, right upper lobe atelectasis and elevated
diaphragm on right side.
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Peripheral Arterial Insufficiency Due to Giant Cell Arteritis
P.K. O’B rien ,
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Progressive peripheral arterial insuf
ficiency developed in a 53-year-old man
who was referred for investigation of
fever of unknown origin. Angiograms
showed a smooth beaded appearance to
both deep femoral arteries and biopsy
of an occluded popliteal artery disclosed
the lesions of giant cell arteritis. An
excellent clinical response was obtained
with steroid therapy.
Une insuffisance arterielle peripherique
progressive est apparue chez un
homme de 53 ans recu en consultation
pour I'investigation d'une fievre
d’origine inconnue. Les angiogrammes
ont montre un aspect en chapelet lisse
pour les deux arteres femorales
profondes et la biopsie d’une artere
poplitee obliteree a revele les lesions
d'une arterite a cellules geantes. Une
excellente reponse clinique a ete
obtenue avec un traitement steroi'dien.

It has long been known that the m or
phologic lesions of giant cell arteritis
are not confined to the arteries of the
carotid system.1’2 The occurrence of
symptoms due to peripheral arterial in
volvement, however, has only recently
been emphasized.3 We report a case in
which intermittent claudication with
progression to pregangrenous change
developed in a patient with clinical,
radiologic, and pathological evidence
of involvement of the femoropopliteal
system by giant cell arteritis.
Case Report

A 53-year-old man was first seen on
Dec. 6, 1974. He gave a history of fever
and sweating, mainly in the mornings and
evenings, of 2 to 3 weeks’ duration accom
panied by a 2.3-kg weight loss. Physical
examination prior to referral had revealed
no clinical abnormality but abnormal findFrom the departments of pathology and
surgery, The Etobicoke General Hospital,
Rexdale, Ont.
*Department of pathology, The
Etobicoke General Hospital

t Department of surgery, The Etobicoke
General Hospital
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ings of laboratory tests included an
erythrocyte sedimentation rate of 108
mm/h and a leukocyte count of 11 X
109/L. The patient had smoked up until
2 months before his initial attendance. He
had a history of left retinal detachment in
1941 and of allergy to sulphonamides.
The patient was 168 cm in height and
weighed 81 kg. The blood pressure was
120/70 mm Hg. No murmur was noted
over the precordial area. The carotid pul
ses were normal and all peripheral pulses
were palpable. There was slight hepatosplenomegaly. Findings on urinalysis were
normal and culture of urine and blood
produced no growth of organisms.
On Dec. 18 the patient complained of
pain in both calves; the pain began after
he had walked about 100 m and ceased
when he rested. The pain was present to
an equal degree bilaterally. The anterior
tibial pulses were now not palpable and
the dorsalis pedis pulses were difficult to
feel. Carotid and femoral pulses were
normal. The popliteal pulse was palpable
bilaterally but less so than on the previous
examination. There was good tissue capil
lary refill and venous return. The blood
pressure was 120/80 mm Hg. A tentative
diagnosis of collagen vascular disease or
vasculitis was made. No treatment was
instituted.
The patient was admitted to hospital on
Dec. 30. Femoral pulses were present and
normal and no bruits were heard over the
femoral arteries. Popliteal pulses were
diminished and the pedal pulse was absent
on both sides. Abnormal findings of labo
ratory studies were as follows: leukocyte
count, 13 X 109/L (polymorphonuclear
cells 68%, lymphocytes 26%, monocytes
6%); erythrocyte sedimentation rate, 104
mm/h; serum <*2 globulin value, 11 g/L
(normal, 4 to 8 g/L ); serum albumin
value, 3 g/L (normal, 38 to 50 g/L); 2-hr
pc blood glucose value, 150 mg/dL (8.3
mmol/L). The following measurements
or tests gave normal or negative results:
hemoglobin concentration, platelet count,
test for rheumatoid factor, VDRL, routine
urinalysis, cultures of blood, urine and
stool, antinuclear factor, concentrations of
serum electrolytes, blood urea nitrogen,
serum creatinine, BjA/ILC complement,
uric acid, serum acid phosphatase, serum
alkaline phosphatase, serum glutamic oxa
loacetic transaminase, serum bilirubin (total
and conjugated), serum cholesterol and
serum triglycerides, lipoprotein electro
phoresis and chest roentgenogram. While
the patient was in hospital the erythrocyte
sedimentation rate settled down to 9 mm/h
and on discharge the patient was taking no
medications but was on a modified diet.
In April 1975 he began to complain of
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increasingly severe intermittent claudica
tion, particularly in the right leg, accom
panied by severe pain in the right fifth
toe. Incipient gangrene of the right foot
was evident. Hepatosplenomegaly was
present. There was bilateral loss of the
popliteal pulse and a decrease in the
femoral pulse on both sides. A translumbar aortogram on Apr. 17 showed com
plete obstruction of the right superficial
femoral artery and both deep femoral
arteries had a smooth beaded appearance.
Little evidence of collateral flow was
noted (Fig. 1).
A right translumbar sympathectomy was
performed on Apr. 22 and resulted in some
clinical improvement. On May 2 the right
femoropopliteal artery was explored. The
artery was bound down to the vein. It was
dissected free and a longitudinal arteriotomy was performed. Virtually total occlu
sion of the lumen was evident and no flow
was observed. It was impossible to intro
duce a Fogarty catheter into the vessel
lumen. A 1-cm portion of the popliteal
artery was excised.
Histologic examination of the excised
portion of vessel showed the lumen to be
almost totally occluded by proliferating
fibrous tissue undergoing collagenization.
Revascularization was evident. Examina
tion under high power showed extensive
disruption of the internal elastic lamina
associated with foreign-body giant cells
and spotty calcification. There was a
round cell panarteritis with adventitial
fibrosis. Occasional granulomatous foci
were noted in the tunica media.
Treatment with prednisone, 60 mg/d,
was started without delay. The diabetes
was controlled with diet and chlorpropa
mide. Subjective improvement was noted
soon after the patient started taking
steroids. There was a notable improvement
in his clinical status. The pregangrenous
changes noted in the right foot gradually
disappeared and he was discharged on

FIG. 1—Translumbar aortogram show
ing complete obstruction of right super
ficial femoral artery and smooth beaded
appearance of both deep femoral arteries.
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May 20 on a regimen of prednisone, 5 mg
qid. At follow-up on Sept. 23, 1975 both
lower limbs were warm and the femoral
pulses were normal; faint bruits were
audible over the femoral arteries. However,
the pulses below the knees were impal
pable although both feet were warm and
slightly flushed.
Repeat translumbar aortography on
Sept. 24, 1975 showed complete obstruc
tion of both superficial femoral arteries
from the point of origin. The deep femoral
arteries still showed the smooth beaded
appearance previously noted (Fig. 2).
Numerous collateral branches were present
throughout both legs. The superficial
femoral artery on the left side was patent
below the level of the adductor hiatus.
Discussion

The combination of fever, malaise,
weight loss, high erythrocyte sedimen
tation rate and an elevated serum a l
globulin concentration in this patient is
consistent with the presence of giant
cell arteritis, which was confirmed by
the almost pathognomonic histologic
changes in the right popliteal artery. At
no time in the course of the illness did
the patient have symptoms referable to
the temporal arteries and no signs of
disease affecting these vessels were
elicited on clinical examination at any
time. However, careful questioning
revealed that jaw pain on chewing had
been present in the months preceding
initial examination and had led to
dental treatm ent. This symptom was
probably due to claudication of the
masseter muscles. The patient had
never experienced polymyalgic symp
toms.
Large-artery lesions in giant cell ar
teritis are accompanied by appreciable
mortality and morbidity. The emphasis
that has been given to the cranial
aspects of the disease has tended to
overshadow the fact that serious symp
toms due to involvement of large ar
teries are often found if looked for in
patients with the more classical forms
of presentation.3 Claudication of an arm
or leg can be the presenting symptom.4

Lesions of giant cell arteritis have been
found in the arteries of limbs that have
been amputated for gangrene,5 and the
disease has caused the aortic arch syn
drome,3 subclavian artery occlusion,6 Prescribing Information
aortic rupture3 and dissecting aneurysm
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Massive Lower Gastrointestinal Bleeding: An Unusual
Complication of Crohn’s Disease
J.C. H arvey, md,* L. R otstein , md ,* M. Steinhardt, md , FRCP[c],f M.M. R eingold, md, frcs[c ],*

E. R ubin ,

Massive rectal bleeding may complicate
Crohn’s disease at any stage and tends
to be persistent. Limited experience
gained with this complication supports
the use of selective angiography followed
by conservative resection as the
management of choice. Results of
experimental studies suggest that
selective infusion of vasopressors may
be safely attempted when hemorrhage
complicates Crohn’s disease in its early
stages but is probably too hazardous
in cases in which the disease is more
advanced.
Une hemorragie rectale massive peut
venir compliquer une maladie de Crohn,
a n'importe quel stade clinique, et elle
tend a persister. Une experience limitee
obtenue avec cette complication,
soutiens I’emploi d'une angiographie
selective suivie d'une resection
conservatrice comme le traitement de
choix. Les resultats d'etude experimentales indiquent que I’infusion
selective d'agents vasopresseurs peut
etre tentee avec securite quand une
hemorragie vient compliquer une maladie
de Crohn dans ses stades initiaux mais
cette pratique est probablement trop
dangereuse dans les cas oil la maladie
est plus avancee.

Massive lower gastrointestinal bleeding
is an unusual complication of Crohn’s
disease. In the most recent review of
this subject, Homan, Tang and Thorbjarnarson1 reported seven cases collected
over a 43-year period at New York
Hospital—Cornell Medical Center and
reviewed 19 other well-documented
cases in the literature. There was suf
ficient data to justify comment upon
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the frequency of repeated episodes of
Case 2.—A 23-year-old woman was ad
bleeding in 24 patients; 12 had recur mitted to Mount Sinai Hospital on Jan. 29,
rent massive bleeding while 5 others had 1977 after passing a large amount of bright
at least one episode of less serious re red blood per rectum. Two years earlier
she had complained to her family doctor
bleeding. Four patients received no sur of crampy abdominal pain, but no diag
gical treatment;2,3 two died and a third nosis had been made. Except for occasional
suffered another massive hemorrhage.4 diarrhea and recent blood-streaked stools
Thus, present knowledge of the course she had been well. There was no family
of Crohn’s disease indicates that once history of inflammatory bowel disease.
She was a pale, tremulous young woman.
massive bleeding occurs it is highly
likely either to persist or to recur.1'5,6 Her blood pressure was 90/60 mm Hg and
The purpose of this report is to place pulse rate was 138 beats/min. Abdominal
examination revealed no tenderness or
on record two additional cases and to masses.
Prothrombin time was 12.5 sec
provide recommendations for manage onds (control, 11.5 seconds) and her hemo
ment.
globin value was 10.2 g/dL. She continued
to pass bright red blood mixed with clots
per rectum and 3500 mL of whole blood

Case Reports
Case 1.—A 55-year-old woman was ad
mitted to Mount Sinai Hospital, Toronto,
on Mar. 25, 1975 with a diagnosis of deep
vein thrombophlebitis. Results of routine
laboratory investigations were normal ex
cept for anemia (hemoglobin value, 8.1
g/dL) and prolongation of prothrombin
time (13 seconds, control 11 seconds). Al
though she denied symptoms of gastro
intestinal disease, a full investigation was
planned because of her anemia. Sigmoidoscopic examination was normal to 22 cm.
Gastrointestinal barium studies revealed
that changes consistent with Crohn’s di
sease were present in a 15-cm length of
the distal ileum (Fig. 1). The stomach and
duodenum appeared normal. The patient
was treated orally with anticoagulants for
her deep vein thrombophlebitis and re
ceived supplemental iron, vitamin B,, and
folate. Her recovery was uneventful and
the anticoagulants were discontinued 3
months later.
She was well until Mar. 20, 1976 when
she was admitted with bloody diarrhea. On
admission her blood pressure was 120/90
mm Hg, pulse rate 120 beats/min and
hemoglobin value 11.4 g/dL, but over the
next 3 days transfusion of 5000 mL of
blood was required to maintain vital
signs. Superior mesenteric arteriography
disclosed a bleeding point in the distal
ileum within an area of inflammatory
bowel disease (Fig. 2). At laparotomy the
right colon and distal 20 cm of ileum were
resected. Gross and microscopic examin
ation of the specimen confirmed the diag
nosis of Crohn’s disease. The postoperative
course was complicated by an enterocutaneous fistula which closed after a 5-week
course of total parenteral nutrition. Since
that time the patient has been well and
there has been no further bleeding.
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FIG . 1—Case 1, March 1975. Crohn's
disease of distal 15 cm of ileum with
marked narrowing of bowel lumen and
separation of loops due to thickened me
sentery.

FIG . 2— Case 1, March 1976. Superior
mesenteric arteriogram demonstrates con
trast extravasation in area of Crohn’s di
sease in distal ileum. Vasculature is tor
tuous with loss of normal tapering and
terminal coiling of rectal arteries. Bowel
wall is thickened.
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tive radiographic and pathological
was required to maintain vital signs. To colon as well as the small bowel. In a
study of intestinal vaso-architecture in
Crohn’s disease and in ulcerative
rule out upper gastrointestinal bleeding a study of patients in the hyperemic stage
colitis. Gut 11: 928, 1970
nasogastric tube was inserted; there was of Crohn’s disease, Erikson and col
9. L underquist A, L underquist A,
no evidence of blood in the aspirate. Sig- leagues11 demonstrated a response to
K nutsson H: Angiography of Crohn’s
moidoscopic examination to 15 cm was vasopressors, but to our knowledge no
disease of the small bowel and colon.
obscured by blood and clots. Emergency report has described the successful man
Am J Roentgenol 101: 338, 1967
angiography revealed a bleeding point in agement of bleeding Crohn s disease by
10. K nutsson H, L underquist A, L un 
the terminal ileum. The pattern of the
derquist A: Vascular changes in
vessels in the region was consistent with selective infusion of vasopressors. Bleed
Crohn’s disease. Am J Roentgenol 103:
Crohn’s disease (Fig. 3). At laparotomy ing in advanced stages of the disease,
380, 1968
11. E rikson U, F agerberg S, K rause U,
an inflammatory mass was found involving although it may be less common because
et
al: Angiographic studies in
the ileocecal region. There was “creeping of cicatrization and decreased blood
Crohn’s disease and ulcerative colitis.
fat” over the surface of the serosa with a flow , 0 does occur. Massive bleeding has
Am J Roentgenol 110: 385, 1970
thickened mesentery and palpable mesen been the initial presentation5' 1 2 1 5 as well
12. C orona FE, D yck WP: Massive gas
teric lymph nodes. Approximately 18 cm as a later complication of Crohn’s ditrointestinal hemorrhage as the sole
of ileum and 8 cm of ascending colon
clinical manifestation of regional en
sease
. 3 -5' 6' 10
Because
of
the
decreased
were resected. Gross and microscopic
teritis. Am J Dig Dis 18: 1001, 1973
number
of
collateral
vessels
in
advanced
examination confirmed the diagnosis of
13. H orwitz F, Baronofsky ID: Regional
stages of Crohn’s disease, such infusion
enteritis presenting as gross rectal
Crohn’s disease.
bleeding. J Mt Sinai Hosp N Y 27: 19,
The patient’s postoperative course was therapy may be hazardous and probably
1960
.
. .
complicated by a superficial wound in should not be used.
fection which was treated by drainage. She
Massive lower gastrointestinal bleed 14. Sauter KE: Massive gastrointestinal
hemorrhage
due
to
regional
enteritis.
was discharged on the 10th postoperative
ing due to Crohn’s disease is life-threat
Am J Surg 112: 91, 1966
day. On follow-up examination 2 months ening. Angiographic localization of the
15. Sunkwa-M ills HNO: Life-threatenmg
later she was asymptomatic except for site of bleeding followed by conserva
haemorrhage in Crohn’s disease. Br
mild wound discomfort.
Surg 61: 291, 1974
tive resection of the involved bowel is 16. JBarber
KW j r , W augh JM, B eahrs
the recommended management. A brief
OH, et al: Indications for and the
Discussion
results of the surgical treatment of
trial of selective vasopressor infusion
regional enteritis. Ann Surg 156. 472,
Massive lower gastrointestinal bleed may be employed when bleeding occurs
1962
T „
in
the
early
hyperemic
stages
of
the
17 de D ombal FT, Burton I, G oligher
ing is an indication for arteriography
disease
but
should
not
be
attempted
in
JC: The early and late results of
whenever the patient’s condition per
surgical treatment for Crohn s disease.
mits. In cases of diverticulosis selective cases of advanced disease where total
Br J Surg 58: 805, 1971
infusions of vasopressors may be used flow is known to be decreased and col 18. Albo RJ, G rimes OF, D unphy JE:
Management of massive lower gastro
to control the hemorrhage; surgery is lateral flow is probably inadequate.
We agree with Homan, Tang and
intestinal hemorrhage. Am J Surg 112:
reserved for use when arterial infusion
264, 1966
has failed. When the source of bleeding Thorbjarnarson1 that all involved bowel
19. F reedman P: Regional ileitis present
should
be
resected,
if
practicable,
when
is a lesion for which conservation man
ing as recurrent intestinal haemor
rhage. Br Med / 2: 268, 1952
agement is not considered to be ap the surgeon has to operate without pre
propriate, arteriography will allow the operative angiographic localization of
surgeon to operate with the knowledge the bleeding site. This recommendation
of the source of bleeding, thus avoiding is based on the fact that a few patients
the problems and frustration of a have had recurrence of massive
“blind” search for the source of hemor bleeding following conservative resec- This list is an acknowledgement of
tion , 1' 4 ,5 ’1 7 1 9 but it is emphasized that books received. It does not preclude
rhage.
Early in the course of Crohn’s di preoperative angiography was not done review at a later date.
sease the arteriographic pattern in the in any of these cases.
American Academy of Orthopaedic Sur
small bowel is that of hyperemia with
geons. Symposium on Reconstructive
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Orthopedic Outpatient Surgery
J ohn W. H azlett ,

Changes in provision of health care
by the province of Ontario have included
forced reduction in the number of
hospital beds. In this situation the needs
of patients with orthopedic disabilities
have been m et by a dramatic increase
in outpatient surgery.
A t the Hotel Dieu Hospital, Kingston,
the total number of surgical procedures
increased from 5516 in 1970 to 7260 in
1975. During this period the number of
outpatient surgical procedures performed
under general anesthesia rose from
820 in 1970 to 2927 in 1975, an increase
of 264%.
O f 1197 orthopedic procedures
performed in 1975, 632 (52% ) were
performed on an outpatient basis.
In the author’s personal experience
of outpatient surgery, which in 1975
included 38 meniscectomies, 10 major
shoulder repairs, 28 foot reconstructions,
11 nerve releases, 14 tendon releases
and 4 elbow arthroplasties, patient
acceptance has been good. Adequate
clinic facilities, trained nurses, appro
priate anesthesia and patient education
are essential if management in this
locale is to be successful.

Des modifications dans la distribution
des soins de sante en Ontario ont inclus
la diminution forcee du nombre de lits
d hopitaux. Devant cette situation, les
besoins des patients ayant une incapacity
d ordre orthopedique ont ete rencontres
par une importante augmentation de la
chirurgie en externe.
A I'Hotel-Dieu Hospital de Kingston,
le nombre total des interventions
chirurgicales est passe de 5516
en 1970 a 7260 en 1975. Durant cette
periode, le nombre des interventions
chirurgicales pratiquees en externe
sous anesthesie generate a augmente
de 820 en 1970 a 2927 en 1975, soit une
augmentation de 264%.
Sur 1197 operations d’orthopedie
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realisees en 1975, 632 (52%) ont ete
effectuees en externe.
Selon ('experience de I’auteur en
chirurgie en externe, laquelle, en 1975,
comprend 38 meniscectomies, 10 re
parations majeures de I’epaule, 28
reconstructions du pied, 11 liberations
d'un nerf, 14 liberations d’un tendon et
4 arthroplasties du coude, I’acceptation
des patients est bonne. Des installa
tions cliniques adequates, des infirmieres
entrainees, une anesthesie appropriee
et I’education du patient sont essentielles
si le traitement dans ce champ doit
avoir du succes.

waiting lists and to offer prompt service
to patients with orthopedic disabilities,
more and more operative procedures
were undertaken on an outpatient basis.
This was possible because the hospital
had a separate surgical outpatient clinic
with adequate facilities and personnel
able to handle 15 to 20 patients a day
for “in and out” surgery.
The total number of operations per
formed at the Hotel Dieu Hospital,
Kingston, in 1970 was 5516; by 1975
this number had increased by 31% to
7260, in spite of the loss of 15 to 20
beds to the surgical service in 1973.
The volume of outpatient surgery in
When the Government of Canada Med creased by 264% from 820 operations
ical Care Act became operative in the in 1970 to 2927 in 1975. During this
province of Ontario on Oct. 1, 1969 time the percentage of outpatient opera
residents of the province were provided tions increased from 15% to 40% of
with complete ward-type inpatient and the total number of operations per
outpatient services in hospitals with formed. This increased volume of out
coverage of about 95% of health care patient surgery affected all the divisions
of surgery. With respect to orthopedic
costs.
Following the implementation of the surgery, there was a notable shift of
act a number of events resulted in operative procedures from an inpatient
greatly increased costs of health care to an outpatient basis; between 1974
coverage in the province: nurses and and 1975, there was an increase in the
hospital employees received large salary number of operative procedures per
increases, physicians and patients made formed by two orthopedic surgeons of
greater use of hospital services, the 157 (from 1040 to 1197), but the num
provincial government extended its ber of outpatient procedures performed
health care coverage and persons over by these surgeons increased by 276
65 years of age were exempted from (from 356 to 632). By 1975, 53% of
the orthopedic operative procedures
paying premiums.
In 1973, because of concern about were performed under general anesthe
mounting health care costs, the Ontario sia on an outpatient basis.*
government attempted to avoid duplica
Personal Experience
tion of health services in neighbouring
In 1970, out of a total of 576 oper
hospitals, by amalgamating obstetric and
pediatric units. By such means a num ations performed, 73 (13%) were done
ber of hospital beds were eliminated. in the outpatient department. In 1975
The pressure of increased use of pre the percentage performed on an out
paid hospital services was instrumental patient basis increased to 46% (292
in bringing about a number of changes of 627 operations).
An analysis of the number of closed
in medical practice, particularly with
regard to admission of patients to hos procedures performed (Table I) in
dicates that they formed about 40% of
pital.
The orthopedic service of the Hotel the total outpatient operations in 1975.
Dieu Hospital, Kingston, which served There was a particular increase in the
as a teaching unit for Queen’s Univer number of neck manipulations.
sity medical school, was a self-contained
unit of 16 beds situated in one of the ’"This figure is higher than the correspond
oldest parts of the hospital. It was ing one for general surgery and reflects
closed by the hospital authority in 1973, the greater difficulty of orthopedic sur
geons in obtaining hospital admission for
and orthopedic patients were obliged their patients and the better adaptation of
to share the accommodation on a larger orthopedic patients to the reduction of
general surgical service. To avoid long inpatient facilities.
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Open procedures were undertaken
much more commonly on an outpatient
basis in 1975 (Table II). In particular,
there were increases in the number of
median and ulnar nerve releases, knee
meniscectomies, shoulder repairs and
foot procedures.
Meniscectomy of the knee is a com
mon orthopedic procedure. In 1970
this operation was performed 27 times
and in all instances the patient was
admitted to hospital. In 1975 this oper
ation was done on an outpatient or “in
and out” basis in 38 patients—more
than half the total of 63 patients who
underwent this procedure. It is notable
that the inpatient meniscectomies were
performed on those persons who were
elderly, who lived a long distance from
the hospital, who had bilateral disease,
or who had other disorders. Of the 38
subjects who underwent meniscectomy
as outpatients, 32 were men and 6 were
women; their average age was 38 years.
Other outpatient procedures included
10 shoulder repairs for recurrent dis
location or rotator cuff tears, on nine
men and one woman (average age, 47
years), and 28 foot and ankle proce
dures such as metatarsal osteotomy,
Keller arthroplasty, excision of acces
sory tarsal navicular bone and arthrotomy of the ankle. Of the 76 patients
in whom meniscectomy, shoulder re
pair, or a foot or ankle procedure was
planned for an “in and out” attendance
at hospital, 8 eventually had to be ad
mitted because of excessive pain or
disability. With added experience in

Table 1—Outpatient Orthopedic S u rg eryClosed Procedures
1970

1975

Neck
Back
Shoulder
Knee
Fracture*

51
—
4
3
3

84
11
14
6
1

Total

61

116

Manipulation

*Local anesthesia was used for most frac
tures.

Table II—Outpatient Orthopedic S u rg eryOpen Procedures
Procedure

1970 1975

Removal of pin, screw, etc.
Ganglion or cyst
Incision and drainage
Nerve release
Amputation
Meniscectomy
Shoulder repair
Foot procedures
Miscellaneous

3
4
2
i
2
---—
—

11
4
2
11
6
38
10
28
64

Total

12

174

patient selection and more complete
preoperative instruction, the number of
failures to carry through the original
plans has decreased.
Patients who required admission after
knee surgery included a 37-year-old
man who had had both medial and
lateral menisci removed, a 28-year-old
man who had had a medial capsular
repair, a 45-year-old man with asso
ciated arthritis and probable gout of
his knee and a 31-year-old man with
associated ligament derangement.
Two patients were admitted after a
shoulder repair: a 38-year-old man who
was operated upon 8 months after he
had sustained a grossly displaced frac
ture of the greater tuberosity of the
humerus and a 28-year-old man who
was poorly prepared psychologically to
accept outpatient surgery.
Of the two patients admitted after
foot surgery one was a woman who
had undergone bunionette and sesam
oid removal, and the other was an
elderly man who had had bilateral
Keller procedures.

therapist but this seemed to create more
difficulties than it solved because of the
varied personnel involved, the excessive
sympathy extended to the patient and
the frequent use of hypodermic injec
tions of narcotic agents. Since these
factors could not be ^controlled, home
care was discontinued early in the pro
gram, which has been more successful
in consequence.
Conclusions

Increased use of orthopedic outpa
tient surgery has been prompted by re
duced hospital inpatient facilities in
Ontario and long waiting lists for hos
pital admission.
Inpatient care has been reserved for
complicated problems and for the care
of patients with back and hip disabil
ities.
Patient acceptance of outpatient sur
gery and the interest and help of re
latives and friends have allowed de
velopment of a successful program.
Procedures have included knee menis
cectomy, major shoulder repair and
various foot reconstructions.
An understanding and cooperative
Needs for Outpatient Surgery
nursing staff in the outpatient depart
A patient who wishes to have surgery ment, operating room and recovery
such as knee meniscectomy performed room has greatly aided the safe, prompt
on an outpatient basis must have a firm and acceptable discharge of patients
desire to avoid hospitalization and must who have undergone major orthopedic
be able to secure the assistance of an procedures.
other person. A large number of stairs
at home or the need to obtain meals
outside the home pose difficult prob continued from page 445
lems for a patient on crutches after
La correction instrumentale des scolioses
surgery.
par voie anterieure. M. Onimus. 87 pp.
The patient is confidently advised
Illust. Expansion Scientifique Fran?aise.
about the procedure to be followed at
Paris, 1978. $24.24, broche. ISBN 2the hospital, the need for fasting, for
7046-0970-5.
hemoglobin estimation and urinalysis, Genitourinary Problems in Women. Jack
and the use of analgesics. Allergies,
R. Robertson. 149 pp. Mpst. Charles
C Thomas, Publisher, Springfield, 1L,
other health problems and medications
1978. $16.75. ISBN 0-398-03668-3.
taken by the patient are carefully docu
Handbook
of Ultrasonic B-Scanning in
mented.
Medicine. R.M. Lunt. 172 pp. Illust.
The hospital must supply a suitable
Cambridge University Press, Cam
outpatient and waiting area and have
bridge; Cambridge University Press.
New York, 1978. Price not stated. ISBN
nurses who are familiar with the con
0-521-21753-9, clothbound; ISBN 0cepts of outpatient surgery. Halothane
521-29264-6, paperbound.
anesthesia and a cooperative anesthetic
Advances in Surgical On
staff are helpful to the patient in avoid International
cology. Volume 1. Edited by Gerald P.
ing postoperative nausea and other
Murphy. 228 pp. Illust. Alan R. lass,
complaints. Recovery room staff must
Inc., New York, 1978. $36. ISBN 08451-0500-0.
avoid the use of hypodermic injections
Manuel de chirurgie orthopedique et du
and should offer reassurance.
reeducation du pied. H. Voutey. 313
For lower limb surgery, the likelihood
pp. Illust. Masson, Paris, 1978. Pnx
of wound discomfort, the type of ban
non mentionne. ISBN 2-225-48147-4.
dage or cast and its adjustment or care, A Manual of Thoracic Surgery. Arndt von
the need for limb elevation and the type
Hippel. 247 pp. Charles C Thomas,
Publisher, Springfield, IL, 1978. $13.75,
of exercise program are all explained
clothbound; $8.75, paperbound. ISBN
to the patient.
0-398-03689-6, clothbound; ISBN 0Generally, a friend or relative takes
398-03690-X, paperbound.
the patient to his home or apartment Nephrolithiasis. Pathogenesis and Treat
and follow-up care is available from the
ment. Fredric Lawrence Coe. 235 pp.
Illust Year Book Medical Publishers,
doctor by phone or through the hospital
Inc., Chicago, 1978. Price not stated.
emergency department. Initially, in this
ISBN 0-8151-1799-X.
program, we provided home care
continued on page 467
through a visiting nurse and a physio
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In treating any serious infection involving gram-negative or anaerobic organisms,
PYOPEN makes a lot of sense.
.
Because PYOPEN is a penicillin, it provides the traditional margin of safety
common to all penicillins.
.. ,
. . .. .
PYOPEN is free from dose-related toxicities, yet it provides bactericidal
effectiveness against Pseudomonas aeruginosa and other gram-negative organisms
includinq Proteus species often resistant to other antibiotics. Moreover, in vitro and
clinical studies have shown that PYOPEN is active against anaerobic organisms,
includinq most strains of Bacteroides fragilis, at concentrations usually achieved
with therapeutic doses. If a gram-negative or anaerobic infection is suspected,
make sure you request a PYOPEN sensitivity test.
CONTRAINDICATIONS: Carbenicillin should not be used in patients with “ ^ S ^ a c tO T a a e producing s°aphylococci9ypRECAUTIONS: The same as for penicillin G.

beta-lactamase and is, therefore, contraindicated in' m'eb>lons causecI byL
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cardiac disease One g of PYOPEN contains 6.5 mEq of sodium ion.
PYOPEN the concomitant administration of sodium may be.hazardous, patlems with' “ ™ u*
or edema. ADVERSE REACTIONS:
Therefore, large doses of the drug should beladminlsterecIwith caution to P ^e n ts w d h conges d
thrombophlebttis after prolonged administration; pruritus;
Similar to those reported with penicillin G. Also reported pain and .raahas « she'or i_m■ '"1“ " ° ^
in hemoglobin level; one case of seizure in hemiplegic
eosinophilia; nausea; occasional rise in SGOT and alka ine Ph° sP*a ase
°J?h^ a s th e n ia gravis have been reported. Prolonged bleeding time has been reported
patient on high doses and one case of increased muscle
' dai?v ' ?PYOPEN K g 14 d°ays (giving blood levels of 200-400 pg / ml). Aggregation of platelets by
in 22 of a series of 30 patients receiving between 500 and 750 mg / kg dai^i=ot PYOPtN aunngi i4 aays tgi y
disappear after disconadenosine diphosphate was decreased I n . a l l ^ p a t i e n t s f and“
S S w a s s i u m levelswere 2 and 1.5 mEq / 1. Oral
tinuing the drug. Two women receiving * 5 “ ™ ^ N d?' y DOSAGE- Relartve^y high doses of carbenicillin are required in the treatment of severe Pseudomonas

information and references available on request.

Only regular sensitivity testing will tell
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in treating:
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Compression Treatment of Hypertrophic Scars
in Burned Children
M. G a rcia -V e l a s c o ,

md,

R. L e y ,

The formation of hypertrophic scars is
common following healing of the burn
wound, particularly in children. The
control of scar formation is an important
part of overall treatment in these cases
and this paper describes a newer
method that applies compression to the
burn scar in an attempt to improve the
ultimate appearance. The 35 patients
treated by this method included some
with partial-thickness and others with
full-thickness burns. The results of
treatment with compression garments
were assessed at 6 months and at 12
months, using a grading system based
on colour, consistency and thickness
of the scar. The design of facial moulages
and their use in compression of facial
scars are dealt with. Overall there was
a 75% to 80% improvement in the
state of burn scars. The reasons for
this improvement are discussed.

Suite a la guerison d’une brulure, la
formation d'une cicatrice hypertrophique
est frequente, particulierement chez
les enfants. Dans ces cas, le controle
du processus de cicatrisation constitue
une partie importante du traitement
d ensemble, et cette communication
decrit une methode plus nouvelle qui
consiste a exercer une compression
sur la cicatrice du tissu brule dans une
tentative pour en ameliorer I’apparence
finale. Les 35 patients traites de cette
facon incluent certains patients ayant
une brulure de profondeur partielle
et d autres de pleine epaisseur. Les
resultats du traitement avec des
vetements compression ont ete evalues
apres 6 et 12 mois, a I’aide d’un
systeme de classification reposant sur
la couleur, la consistance et I'epaisseur
de la cicatrice. On discute du modele
des moulages faciaux et de leur
emploi pour la compression des
cicatrices faciales. Pour I’ensemble,

From the division of plastic and re
constructive surgery, Montreal Children’s
Hospital and McGill University
Montreal, PQ
Reprint requests to: Dr. H.B. Williams,
Department of surgery, The Montreal
General Hospital, 1650 Cedar
Ave., Montreal, PQ H3G 1A4
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on a observe une amelioration de 75%
a 80% de I’etat des cicatrices de
brulures. Les raisons de cette
amelioration sont discutees.

The formation of hypertrophic scars
and contractures in children who have
suffered partial- and full-thickness
burns is a well-known problem to any
one who attends these patients. The
functional disabilities from scar con
tractures and their grotesque appear
ance have been viewed as the normal
outcome of healing of burn wounds.
The scarring may be reduced by proper
use of split-thickness skin grafts but
extensive scar contractures may develop
even at the margin of these grafts. In
recent years compression applied in a
variety of ways has been used in an
attempt to control and reduce such ex
tensive scarring. Cronin1 described the
use of splints to prevent anterior neck
contractures after skin grafting. Fuji
mori, Hiramoto and Ofuji2 reported a
method of treating burn scars using
self-adhesive sponges and pressure on
the burn area. Larson and associates3-6
introduced a program for the preven
tion and treatment of hypertrophic
scars and contractures that combined
splints and pressure with custom-made
elastic garments (Jobst Elastic Gar
ments, Toledo, OH). These garments
are worn day and night to provide con
stant, even pressure to the burn scars.
This compression method with some
modifications has been used at the
Montreal Children’s Hospital in 35
burned children. In this paper we de
scribe the technique and the results we
obtained.
Patients

Thirty-five patients with hypertrophic
scars that developed after partial- or
full-thickness burns were studied in the
18-month period from Jan. 1, 1975
through June 30, 1976. There were 20
boys and 15 girls whose ages ranged
from 1 to 16 years.
Fifty scars were studied, of which
35 were randomly treated by compres
sion methods and 15 were left un
treated and considered as the control
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group. The estimated depth of the burn
wound at the time of admission was of
partial thickness in 20 of the scarred
areas and of full thickness in the re
maining 30 areas. All burns had been
caused by either flame or scalds.
Grading

All patients were followed up by
clinical examination and with serial
photographs at a special clinic for burn
scars which was held once monthly.
Personnel from a number of health care
fields, including plastic surgeons, occu
pational therapists, physiotherapists,
clinic nurses and social workers, were
involved in the assessment process. A
consensus was reached in grading the
scars on a scale of 1 to 3 according to
colour, consistency and thickness (Ta
ble I).
The compression garments were ad
justed or changed as necessary during
the course of treatment.
Results

The overall improvement seen in
the compression group was of a much
greater degree than in the control group
(Table II).
Improvement in the colour of the
scar was evident in all the patients by
the end of 12 months but was seen
earlier in the treated patients than in
the controls. Also, the scar in the
treated patients was much softer after
6 months, particularly when treatment
had been continued for a year. With
respect to the thickness of the scar,
the percentage of the treated group in
grades 1 and 2 rose from 77% to 92%
after 6 to 12 months of treatment;
only 50% of the control group were
in the latter category after 12 months.
Improvement was noted after a few
weeks of treatment in most patients
and the improvement in the appearance
and consistency of the scar continued
even up to 1 year after treatment was
started. Some areas of the body, such
as the presternal region and axillary
webs, respond better to compression
treatment, and the use of additional
measures, such as rubber foam fitted
under the garment, is helpful in in-
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Discussion
Table 1— Grading of Scars by Colour, Consistency and Thickness
Grade

Colour

Consistency

1

White or mildly
pigmented
Pink or purple
Red

Soft

2
3

Thickness
Flat
Slightly raised
Prominent

Moderately hard
Hard

Table I I - Evaluation of Scar Colour, Consistency and Thickness at 6 and 12 Months*
12 months

6 months
Characteristic
Colour
Grade

Compression
(n = 35)

Control
(n = 15)
1

Compression
(n = 30)

Control
(n = 10)

1
2
3

20
70
10

55
45

68
32
0

25
75
0

Consistency
Grade 1
2
3

23
62
15

20
80

80
20
0

0
75
25

23
54
23

13
87

50
42
8

50
50

Thickness
Grade

1
2
3

Hypertrophic scars have several
characteristics evident on m icroscopic
examination: the collagen is arranged
in a whorl-like pattern, is m ore vascu
lar and contains a greater number o f
fibroblasts than does usual scar tissue.
T he ground substance consists mainly
o f chondroitin sulfate A which is
present in greater amounts than in ma
ture scar tissue.7,8 Compression causes
the collagen pattern to break dow n
bringing about the linear appearance
characteristic o f mature scar and a
decrease in the amount o f chondroitin
sulfate A (Fig. 6). Electron m icro
scopic study o f sections showed the
presence o f intracellular fibrils in some
o f the fibroblasts in the hypertrophic
group. These specialized cells, known
as myofibroblasts, may well play a role
in the form ation o f contractures as

‘ Figures are percentages.

creasing localized pressure in specific
areas. Splinting o f webs and other sites
o f contractures is an integral part o f
the treatment. Light moulded splints
are used for patients in whom joint
areas are involved in the burn.
In the application o f pressure to
scars in the facial region custom-made
silicone facial masks fitted from plaster
impressions have been very useful
(Figs. 1 and 2). A facial moulage is

made and a negative silicone mask is
fashioned with built-up areas corre
sponding to the scarred region (Larsofl
D : personal communication, 1976).
This method is used in the case o f
irregular scars in the nasolabial folds
and on the lips, side o f the nose and
the chin. Usually the mask is worn
under a standard elastic garment (Fig.
3). Our results with this method have
been very encouraging (Figs. 4 and 5).

FIG. 1— Facial moulage (left) with silicone facial mask (centre) which is moulded
im negative impression (right).

FIG. 2— Mask placed on face.

FIG. 3— Mask is usually worn under
standard elastic compression garment.
451
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FIG. 4—Severe facial burn scars.

described by Gabbiani, Ryan and
Majno9 (Fig. 7).
There is no adequate explanation of
the changes in scars brought about by
pressure. They might be attributed to
the direct effect on collagen of pres
sure alone or acting through ischemia,
since in order to be effective the elastic
devices must exert a pressure above
20 mm Hg which is higher than the
intercapillary pressure.
Control of scars is better achieved
if treatment is started in the early
phases of the scarring process. Hence
the measurements for the custom-made
garments should be taken as early as
possible, even before the wounds are
healed. Open and granulating areas
still present may be covered with small
dressings. The parents are informed of
the importance of the treatment method
and the necessity of wearing the gar
ments both day and night. In some
cases superficial skin breakdown re
quires local dressings and it is often
necessary to change the elastic garments
every 2 to 3 months owing to reduction
in their elasticity. Some children com
plain of pruritus and discomfort dur
ing hot weather; nevertheless the treat
ment should continue for at least 6
months and preferably up to 1 year
following the burn.
Summary

Thirty-five children with burn scars
and scar contractures were treated by
compression with an elastic garment.
After 6 months of therapy 75% to
80% showed a definite improvement
when compared with patients in a
control group who were not so treated.
The improvement continued for up to

12 months after treatment was insti
tuted. Adequate splinting of associated
contractures is an important part of
the overall management. Compression
garments and splints used together are
highly valuable for controlling scarring
due to burn wounds.
We thank Dr. T.A. Seemayer, pathol
ogist, Montreal Children’s Hospital, for
the electron microscopy.
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FIG. 5— Improvement in scars after 2
months of treatment, using facial mask
and compression.

Hypertrophic

Scar

Compression
+20mm

Hg

FIG. 6—Schematic representation of
change seen in collagen under compression.
Whorl-like pattern is gradually changed to
linear pattern with clearer orientation.

c
V ;.
Pnotomicrograph of myofibroblast found in hvnert
scar, Note intracellular myofibrils (arrow) (reduced by 29% from X2500).
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Critique of Items 465-468
(SESAP II)
Hirsrhsnrunfz’s disease (aeanelionic megacolon) is characterized by a congenital absence of the myen“ rk S t o n cells of th fd lta l segment of the intestine; symptoms of obstruction are noted shortly
liter birth. Depending on the length of colon involved and the delay in diagnosis, varying degrees of
anemia, malnutrition, and other complications may occur.
Psvchoeenic or functional constipation is the most common cause of megacolon in children. It
frequently begins in early childhood, and fecal soiling is common. Children with functional constipation arc Seldom undernourished and do not have symptoms of intestinal obstruction. Digital exammation of such patients demonstrates the rectal vault to be grossly dilated by fecal impaction. This symp
tom complexes extremely difficult to treat and constitutes a major portion of the severe constipation
problems of children.

465 0

466 [B] 467 (c) 468 [H

Reference

465-468/1. Santulli TV: Constipation, in Mustard WT, Ravitch MM, Snyder WH Jr, et al: Pediatric
Surgery, ed. 2. Chicago, Year Book Medical Publishers Inc, 1969, vol 2, p 1014

The Royal College of Physicians and Surgeons of Canada

THORACIC SURGERY — EXAMINATIONS
The first examinations leading to the Certificate of Special Competence in the specialty of Thoracic Surgery will be held in
September, 1979. Prospective candidates should note the following:
1. Only candidates who are Royal College Certificants in General Surgery are eligible to take the examinations in Thoracic Surgery.
2 Candidates who wish to take the examinations in 1979 should send a documented account of their training in Thoracic Surgery to the
address below as soon as possible, and, in any case, not later than December 1,1978. Only candidates whose assessment of crede
tiais is complete will be eligible to take the examinations. There is no charge for this assessment.
3. Further information may be obtained from:
Division of Training and Evaluation,
Royal College of Physicians and Surgeons of Canada,
74 Stanley Avenue,
Ottawa, Ontario, Canada, K1M 1P4.

Le College Royal des Medecins et Chirurgiens du Canada

EXAMENS -

CHIRURGIE THORACIQUE

Le premier examen en vue du certificat de competence particulibre en chirurgie thoracique aura lieu a I’automne de 1979. Tous les
candidats qui sont int6ress6s a se presenter a cet examen devront prendre connaissance de ce qui suit.
1. Les candidats qui dbsirent se presenter aux examens en chirurgie thoracique doivent etre detenteurs du certificat de spbcialiste en
chirurgie generate du College royal.
2 Les candidats qui dbsirent se presenter aux examens en 1979 doivent envoyer les details de leur formation en chirurgie thoracique,
avec p re u v T fl^ p p S a I’adresse ci-dessous, le plus tot possible et au plus tard le 1er decembre 1978. Les candidats ne peuvent etre
admisd I’examen avant que l’appr<§ciation de la formation soit terminee. II n y a pas de frais a payer pour cette appreciation.

*

3. On peut obtenir de plus ampies renseignements a I’adresse suivante:
Division de la Formation et de I’Evaluation,
College royal des M6decins et Chirurgiens du Canada,
74, avenue Stanley,
Ottawa, Ontario, K1M 1P4.
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To lower
blood pressure
during
anesthesia

reduces excessive
blood loss

Precautions

for controlled hypotension during anesthesia
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not tor direct injection.
Indications
'Nipride’ is indicated for producing controlled hypotension during
anesthesia to reduce bleeding in surgical procedures where deemed
appropriate. Benefit-risk ratio should be carefully considered on an
individual basis.
Contraindications
In the treatment of compensatory hypertension, e.g. arteriovenous
shunt or coarctation of the aorta. It is also contraindicated in physically
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia
or hypovolemia or in those with known inadequate cerebral circulation.
In patients with liver disease, severe renal disease, Leber’s optic
atrophy and disease states associated with vitamin B 12 deficiency.
Warnings
'Nipride' is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection. Infusion rates
greater than 8 mg/kg/minute are virtually never required. If at this
rate an adequate reduction in blood pressure is not obtained within
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium
nitroprusside administration. One factor is common to all known
cases, namely that large amounts of nitroprusside were infused at
high rates. Since detoxification relies upon enzymatic action, the
rare possibility of deficient or atypical enzymes occurring in humans
should always be considered. Patients most apt to run into difficul
ties are those who are resistant to the hypotensive effect or those
in whom maintenance at the selected blood pressure level is difficult
or impossible.
, .
Constant attention to the patient’s dose-response characteristics
is mandatory. If infusion rates are in excess of 8 m g/kg/minute deter
mine the nature of the response (effective constant response at
higher dose; tachyphylactic; resistant - none or less than expected).
As soon as either tachyphylaxis or resistance is determined the infu
sion of ‘Nipride’ should be discontinued immediately. In abnormal
responders it has been noted that metabolic acidosis may occur
at higher doses.
Caution should be exercised in using ‘Nipride’ in patients with hypo
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 m g /100 ml, it is
probably safe to continue with the infusion. Peritoneal dialysis can
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect
of sodium nitroprusside than are normotensive subjects. Patients
receiving concomitant antihypertensive medications (especially
hydralazine or hexamethonium) are more sensitive to the hypotensive
effect of sodium nitroprusside and the dosage of 'Nipride' should
be adjusted downward accordingly.
The following Warnings apply to the use of ‘Nipride’ for controlled
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin
ished. If possible, preexisting anemia and hypovolemia should be
corrected prior to employing controlled hypotension.
3 Hypotensive anesthetic techniques may alter pulmonary ventilation
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen
partial pressure.
4 Resistance and tachyphylaxis occur more frequently in normoten
sive patients infused with sodium nitroprusside. Induction of delib
erate hypotension in healthy young individuals may prove to be
more difficult than in other segments of the population.
5 Upon discontinuance of the sodium nitroprusside infusion for the
purpose of controlled hypotension during anesthesia a rebound
hypertension has been observed on rare occasions.

Adequate facilities, equipment and personnel should be available
for frequent and vigilant monitoring of blood pressure. When the infu
sion is slowed or stopped, blood pressure usually begins to rise imme
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly
patients, since they may be more sensitive to the hypotensive effects
of the drug.
If, in the clinical situation, stress induced by pain or manipulation
is reduced or eliminated during 'Nipride' infusion, the patient could
experience a greater than expected reduction in blood pressure
unless the rate of infusion is adjusted downward as required.
‘Nipride’ tends to deteriorate in the presence of light. Therefore, the
infusion bottle should be wrapped with aluminum foil or other opaque
material. Solutions of 'Nipride' should not be kept or used longer
than four hours. 'Nipride' in aqueous solution yields the nitroprusside
ion, which reacts with even minute quantities of a wide variety of
organic and inorganic substances to form usually highly coloured
reaction products (blue, green or dark red). If this occurs, the infusion
should be replaced as quickly as possible.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache,
restlessness, agitation, muscle twitching, retrosternal discomfort and
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo
minal pain, confusion and somnolence have been noted with too
rapid reduction in blood pressure. These symptoms rapidly disap
peared with slowing of the rate of infusion or temporary discontinua
tion of infusion and did not reappear with continued slower rate
of administration.
Irritation of the injection site may occur. Methemoglobinemia and
one case of hypothyroidism following prolonged therapy have been
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing
deliberate hypotensive surgery must be restricted to carefully
selected cases. There is a possibility of an abnormal response
occurring in normotensive patients. In this event, the infusion of
'Nipride' should be discontinued immediately. (See Warnings).
The contents of a 50 mg 'Nipride' vial should be dissolved in 3 ml
of sterile dextrose in water without preservatives. No other diluent
should be used. Depending on the desired concentration, all of the
prepared stock solution should be diluted in 500 or 1000 ml of 5 per
cent sterile dextrose in water and promptly wrapped in aluminum
foil or other opaque material. Both stock solution and infusion solu
tion should be freshly prepared and any unused portion discarded.
The freshly prepared solution for infusion has a very faint brownish
tint. If it is highly coloured, it should be discarded. (See Precautions).
The solution should not be kept or used longer than four hours from
initial reconstitution. The infusion fluid used for the administration
of 'Nipride' should not be employed as a vehicle for simultaneous
administration of any other drug.
‘Nipride’ dosage varies considerably from patient to patient, hence
the need for individual titration. The infusion should be started at
the lower dosage range, 0.5 mg/kg/minute and increased by
0.2 mg/kg/minute every 5 minutes until the desired reduction in
blood pressure is obtained. The blood pressure usually starts to drop
immediately or at least within a few minutes. Continuous monitoring
of the blood pressure is necessary. Blood pressure should not be
allowed to drop at too rapid a rate and systolic pressure should not
be lowered below 60 mm Hg.
Infusion rates greater than 8 mg/kg/minute should rarely be used.
The maximum recommended dose is 800 mg /minute.
‘Nipride’ should be administered by an infusion pump, micro-drip
regulator or any similar device that will allow precise measurement
of the flow rate. Avoid extravasation. The rate should be adjusted
to maintain the desired hypotensive effect, as determined by frequent
blood pressure determinations.
For the use of 'Nipride’ in the treatment of hypertensive crises please
refer to the Product Monograph.
Supply
‘Nipride’ is supplied in 5 ml amber-coloured vials containing the
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
* Reg. Trade Mark for sodium nitroprusside 'Roche'
®Reg. Trade Mark

Can. 8042

(sodium nitroprusside)

Usage in pregnancy
The safety of 'Nipride' in women who are or who may become preg
nant has not been established; hence, it should be given only when
the potential benefits have been weighed against possible hazard
to mother and fetus.
Usage in children
The safety of Nipride’ in children has not been established. Clinical
experience is limited.

Hoffm ann-La Roche Limited
Vaudreuil, Quebec
J7V6B 3

PAAB
CCPP

Major Amputation following Vascular Reconstructive
Procedures (Including Sympathectomy)
G ordon H unter , m b , frcs, frcs [c] and Pam H olliday, b sc ( p t ), mcpa *

To study the effects of vascular
reconstruction or sympathectomy, or
both, on the level of amputation, the
number of revision procedures
performed and the mortality following
amputation, the authors reviewed the
records of 504 patients from three
Toronto teaching hospitals who had one
or both limbs removed at or above
the below-knee level. It appears that
(a) previous vascular surgery or
sympathectomy, or both, actually
increases the number of patients in
whom a below-knee amputation is
successful, (b) the number of revision
procedures necessary is increased after
failed vascular surgery or sympathec
tomy, or both, and (c) revision
procedures following amputation do
not affect the mortality from lower limb
amputation.
Dans le but d’etudier les effets de
la reconstruction vasculaire ou de ia
sympathectomie, ou des deux, sur le
niveau de I'amputation, le nombre
d'interventions de revision effectuees
et la mortalite consecutive a I'amputation, les auteurs ont passe en revue
les dossiers de trois hopitaux
universitaires de Toronto ou 504 patients
ont eu un membre ou les deux membres
amputes sous le niveau du genou ou
au-dessus. II semble que (a) une
chirurgie vasculaire ou une sympa
thectomie precedent, ou les deux,
augmentent le nombre de patients pour
qui une amputation sous le niveau
du genou est reussie, (b) le nombre
de revisions necessaires est augmente
apres echec de la chirurgie vasculaire,
de la sympathectomie, ou des deux,
et fc) les interventions de revision
apres une amputation n’affectent en
rien la mortalite reliee a I’amputation
des membres inferieurs.
From the Amputee Research Centre,
Toronto, Ont.
'"‘Amputee unit, University of Toronto,
West Park Hospital, Toronto
Reprint requests to: Dr. G.A. Hunter,
Amputee Research Centre, West Park
Hospital, 82 Buttonwood Ave., Toronto
Ont. M6M 2J5
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Because arteriosclerosis, with or with
out diabetes, accounts for 70% to 86%
of all lower limb amputations,1-4 vascu
lar reconstructive procedures (endarter
ectomy, bypass by vein or synthetic
implant, and aortoiliac surgery) and
sympathectomy have been used to im
prove circulation to the lower ex
tremity. The aims of such procedures
are:
1. To treat intermittent claudication
and rest pain.
2. To avoid the necessity for am
putation when there is impending
necrosis.
3. To allow a distal amputation with
preservation of as much as possible of
the patient’s own tissue.
Hunter5 suggested that the results of
amputation of one or more toes were
enhanced if vascular reconstruction had
been performed during the preceding
month. However, this was not the case
for patients who underwent transmeta
tarsal amputation or Syme’s amputation.
Kihn, Warren and Beebe8 showed
that previous arterial reconstruction
did not influence the eventual healing
of below-knee amputations but it did
affect healing of above-knee amputa
tions. In the latter group the wound
from a recent reconstructive procedure
lowered the rate of primary wound
healing.
Burgess and Marsden7 reported that
the level of initial lower extremity am
putations does not differ greatly in pa
tients who have previously undergone
vascular surgery and in the amputees
who have not had vascular reconstruc
tion. They also noted that delayed heal
ing and local wound complications
were more frequent in the former
group, especially when the amputation
had been performed within 4 weeks of
the last attempted vascular procedure.
There is still uncertainty about the
value of sympathectomy; of the 142
patients on whom these workers had
based their conclusions, 36 had had
lumbar sympathectomy alone. We be
lieve that the effect of vascular surgery
on wound healing should be assessed
less than 6 months after the perform
ance of the last vascular procedure.
Pedersen stated that if reamputation
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was necessary, it did not significantly
affect the mortality.8
Our clinical impression had not con
firmed these earlier reports and there
fore we conducted our own study of
the effect of vascular reconstruction
on subsequent major amputations of
the lower limb. Our purpose was to
analyse the effect of previous vascular
procedures or sympathectomy, or both,
on the level of amputation, the number
of revision procedures required and the
mortality following amputation.
We reviewed the results of major am
putations of the lower limb from three
University of Toronto teaching hospi
tals over a 5-year period from 1970 to
1975.
Clinical Material

There were 504 patients for whom
adequate records were available. In
this group all amputations were carried
out for severe peripheral vascular dis
ease. In 407 patients the amputation
was unilateral and in 97 it was bila
teral. There were 366 women and 138
men. Diabetes was a complicating fea
ture in 166 (33%) of the 504 patients.
Primary wound healing was defined
as healing within 3 months of the in
itial amputation.
Results and Discussion

Level of Amputation in Relation to
Previous Vascular Surgery
When there was no history of pre
vious vascular reconstruction 140
(46%) of 304 limbs demonstrated
primary wound healing at the belowknee level. Vascular reconstruction,
often combined with lumbar sympathec
tomy and performed at any time prior
to amputation, resulted in primary
wound healing in 114 (52%) of 220
limbs. The corresponding figure for
patients who had undergone sympa
thectomy alone any time before am
putation was 37 (48%) of 77 limbs.
These results were not significantly
different when submitted to yf analy
sis. However, when they were further
analysed in relation to the timing of
vascular surgery and the exact proce-
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within 6 months after final amputation.
Of these 60 patients, 17 (28%) required
revision to one or both limbs. In the
patients who survived for 6 months the
Revision Procedures following Vas rate of revision was similar— 127
cular Reconstruction or Sympathec (29%) of 444 patients required revi
tomy, or Both
sion procedures.
The mortality following amputation
In our series we found that when no
vascular reconstruction had been per in the dysvascular amputee is high. An
formed, revision of the amputation to editorial from The Lancet15 stated that
a more proximal level was necessary in one quarter of patients will probably
62 (20%) of 304 limbs. When vascular be dead within 1 year, half within 3
reconstruction, with or without sym years and two thirds within 5 years,
pathectomy, had been performed prior and a patient surviving for 5 years has
to amputation, such revision was neces an almost 50% chance of losing his
sary in 90 (41%) of 220 limbs. Fol other leg.
Our results support the views of
lowing sympathectomy alone at any
time before amputation, revisions were Pedersen8 and of Kihn, Warren and
Beebe.6 Although dysvascular amputees
necessary in 23 (30%) of 77 limbs.
When these figures were analysed to do not live long after their amputation,
take into account the timing of vascu an aggressive attempt at preserving the
lar surgery prior to amputation and the knee joint and acceptance of a higher
exact procedure performed (Table II), revision rate is justified even after un
the rate of revision at or above the successful vascular surgery or sympa
below-knee level appeared to be in thectomy, or both.
We would stress16 that the only con
creased after failure of vascular surgery
or sympathectomy, or both, especially traindications to below-knee amputa
when amputation was necessary within tion in patients with vascular disease,
4 weeks of the vascular surgery. These whether or not they have had recent
results confirm the views of Burgess vascular reconstructive procedures, are:
and Marsden.7 The risks accompanying
1. Necrosis up to or above the level
below-knee amputation after vascular
reconstruction must be compared with of the knee joint, usually associated
the greater chances of preserving the with an acute thrombotic or embolic
knee joint (Table I) and should not occlusion of the femoral artery.
2. Fixed flexion contracture of more
deter the surgeon from attempting be
low-knee amputation whenever possible. than 30° at the knee joint and more
than 20° at the hip joint.
Effect of Increased Number of
3. Absence of skin bleeding at trial
Revision Procedures on Mortality
amputation (hence the importance of
Of the 504 patients, 60 (12%) died avoiding a tourniquet at the time of
surgery). Lack of bleeding from the
muscle at the time of amputation is
worrying but should not deter the sur
Table 1— Healing of Below-Knee Amputations in Relation to Tim e Period and Procedure
geon from proceeding at the belowknee level provided that the skin itself
Vascular reconstruction,
bleeds.
with or w ithout

dure performed (Table I), prior vascu
lar reconstruction or sympathectomy,
or both, appeared to increase signifi
cantly the number of patients in whom
a below-knee amputation was success
ful, provided the amputation was car
ried out between 1 and 6 months after
the last vascular procedure.
Bickel and Ghormley9 first suggested
use of a long posterior skin flap in
below-knee amputations done for peri
pheral vascular disease, and Burgess
and colleagues10 popularized the tech
nique. Ultimate healing after this pro
cedure has been reported in 75% to
80% of patients.7-11'12
In spite of the obvious success of
below-knee amputations, Waterhouse
(personal communication, 1975) re
ported that in Ontario in 1972, only
50% of amputations for peripheral
vascular disease were at the belowknee level. We were surprised and dis
appointed to find that such amputa
tions were successful in under 50%
of patients in three major teaching cen
tres where there is an aggressive atti
tude towards preservation of the knee
joint. These results confirm the views
expressed by Kihn, Warren and Beebe6
and Burgess and Marsden.7
Information concerning the value of
sympathectomy before amputation var
ies from the views of Pedersen, who
believed that sympathectomy was of no
value,8 to the opinions of Perlow13 and
Paloschi and Lynn,14 who claimed that
lumbar sympathectomy was an impor
tant adjunct to healing and would per
mit a more distal amputation. The
results from our series suggest that

Tim e between last
vascular procedure
and amputation, mo
< 1
1 -3
3 -6
> 6

sympathectomy may help to preserve
the knee joint in the dysvascular am
putee.

sympathectomy, no. of
patients/total no.
(and % )
40/97
23/38
20/24
31/61

Sympathectomy alone,
no. of p a tien ts /to tal no.
(and % )
13/29
10/15
8/10
6/23

(41)
(60)
(83)*
(51)

(45)
(67)
(8 0 )f
(26)

*P = 0.01.
|P = 0.05.

Table II— Incidence of Revision at Any Level in Relation to Tim e Period and Procedure

Tim e between last
vascular procedure
and amputation, mo

< 1

1 - 3
3 - 6

>6

Vascular reconstruction
with or w ithout
sympathectomy, no. of
patients/total no.
(and % )
42/97
10/38
5/24
33/61

(43)*
(26)
(21)
(54)

*P = 0.001.
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Sympathectomy alone,
no. of pa tien ts /to tal no.
(and % )
10/29 (34)
3/15 (2 0 )

1/10 ( 10)
9/23 (39)

Conclusions
This survey justifies the following
statements with respect to the decision
on the level for major amputations in
patients following vascular reconstruc
tion or sympathectomy, or both:
1. Too many above-knee amputations
are being performed in Ontario.
2. Prior vascular reconstruction or
sympathectomy, or both, appears to
increase the number of patients in
whom a below-knee amputation is suc
cessful, provided the amputation is car
ried out between 1 and 6 months after
the last vascular procedure.
3. The rate of revision procedures at
all levels is increased after failure of
vascular surgery or sympathectomy,
especially when amputation is neces
sary within 4 weeks of the vascular
surgery.
4. Revision procedures do not appear
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to affect the mortality following lower
limb amputation.
5. A below-knee amputation should
be attempted,
whenever possible,
whether or not the patient has had
recent unsuccessful vascular recon
structive procedures.
We thank the surgeons of Toronto Gen
eral Hospital, Toronto Western Hospital
and St. Michael’s Hospital, Toronto, who
allowed us access to their records, and
we are extremely grateful to the Ontario
March of Dimes who financed this in
vestigation. Mrs. Csima from the Uni
versity of Toronto carried out the statis
tical analysis and Miss Marie Dennis typed
the manuscript.
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Bilateral Carcinoma of the Breast:
Frequency and Mortality
C. Barber M ueller , md , frcs[ c] and F rances A mes

Of 3558 women with cancer of the breast,
129 were found to have bilateral primary
cancers, in approximately one quarter
(33) of these women the two cancers
developed synchronously; in the re
mainder (96) the second cancer de
veloped metachronously, more than
6 months after the appearance of the
first primary tumour. In two thirds (64)
of the women in the latter group the
second cancer made its appearance
within 4 years after the first was
detected.
The 15-year survival curve for the
129 patients shows a 50% mortality at
approximately 10 years, slightly better
than that for the total group of 3558.
At the time of our study (April 1975)
70 were alive and 59 were dead;
53 died as a result of their breast
cancer and 6 from other causes. Only
3 of the 48 women in whom the first
cancer developed before the age of
70 years died of causes other than
breast cancer, giving a mortality due
to breast cancer of 90%.
The clinical stage, the recorded
histopathology, the type of operation
and the duration of time at risk after
the first diagnosis did not differ signif
icantly between those who lived and
those who died. The authors conclude
that age, stage or type of growth,
operative therapy or time at risk do not
determine the time of death or alter the
90% certainty that death will be due
to carcinoma of the breast.
Sur 3558 femmes atteintes de cancer
du sein, 129 ont presente un cancer
primaire bilateral. Chez environ un quart
(33) d’entre elles les deux cancers se
sont developpes de maniere synchronisee; chez les autres (96), le deuxieme
cancer a evolue en asynchrone, plus
de 6 mois apres I'apparition de la
premiere tumeur primaire. Chez deux
tiers (64) des femmes de ce dernier
groupe, le deuxieme cancer a fait son

From the department of surgery, McMaster University, Hamilton, Ont.
Reprint requests to: Dr. C. Barber
Mueller, Department of surgery, McMaster
University Medical Centre, 1200 Main
St. W, Hamilton, Ont. L8S 4J9
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apparition moins de 4 ans apres
que le premier eut ete detecte.
La courbe de survie a 15 ans pour
les 129 patientes montre une mortalite
de 50% apres approximativement 10 ans,
ce qui est un peu mieux que pour
I’ensemble des 3558 patientes. Au
moment de notre etude (avril 1975),
70 patients vivaient et 59 etaient
decedees; 53 sont mortes de leurs
cancers du sein et 6 d'autres causes.
Seulement 3 des 48 femmes dont le
premier cancer s’est developpe avant
I’age de 70 ans sont mortes de causes
autres que le cancer du sein, ce qui
donne un taux de mortalite due au
cancer du sein de 90%.
Le stade clinique, I'histopathologie
observee, le type d’operation et la duree
du temps d’exposition apres le premier
diagnostic n'etaient pas significativement
differents entre celles qui ont survecu
et celles qui sont mortes. Les auteurs
concluent que I'age, le stade ou le type
de tumeur, le traitement operatoire ou
le temps d'exposition ne determinent
pas le temps du deces ou n'alterent
la probability a 90% que le deces sera
du au carcinome du sein.

Bilateral breast cancer is of continuing
interest to surgeons, partly because it
raises the question of whether prophy
lactic contralateral mastectomy is in
dicated1-3 and partly because it is a
biologic curiosity, due to its apparent
rarity in a breast supposedly subject
to the same influences that induced
cancer in the first breast.4'5 A precise
method of defining the incidence of
bilateral breast cancer is difficult to
find;6 groups under observation are not
always similar, the time between diag
nosis of the first carcinoma and the
detection of the second is variable, the
depletion of the original group at risk
is difficult to ascertain, follow-up is
frequently incomplete and results may
be inexactly reported.2 The average
time to the diagnosis of a second
primary tumour has been reported as
7.4 years by Robbins and Berg,7 6.3
years by Kilgore, Bell and Ahlquist,8
6.1 years by Watanatittan and Ram,9 6
years by Lewison and Neto'° and 5
years by Farrow.5 All state an “average”

time to a second primary cancer in
survivors of the original cancer without
disclosing the decreasing numbers at
risk as death depletes the initial group.
Slack and associates11 described pro
bability of a second cancer as a func
tion of patient-years at risk. Using data
collected during the National Cancer
Institute breast II study they showed
a gradually decreasing incidence of a
second primary tumour per patientyear at risk, from 5/1000 to 1/1000
during the 6 years of the study.
McCredie, Inch and Alderson12 sug
gested that the rate of development of
a second carcinoma is 1% per year,
remaining constant for 20 years.
The study reported herein derives
from a larger study of 3558 unselected
women who have been followed up
after the development of carcinoma
of the breast. Of this group, 129
women developed bilateral breast can
cer, either synchronously (simultaneous
ly) or metachronously (nonsimultaneously). (We have excluded two cases
of bilateral inflammatory carcinoma of
the breast.) We examined the data to
compare the two sides with respect to
the type and stage of growth and the
operation performed. We relate the oc
currence of the second tumour to the
number of patients at risk and the
survival curve of the bilateral cases to
that for the total group. We report the
cause of death in those women who
died after bilateral breast cancer de
veloped.
Data Utilized

Data for this study were collected by
the Upstate Medical Center Cancer
Registry, Syracuse, NY, which has
been in operation since 1956. Every
cancer patient in the Syracuse catch
ment area is registered. The accession
information includes name, address and
age, the site, stage and type (histopa
thology) of tumour, the method of
treatment and the name of the re
sponsible physician. Each patient in the
register or her physician is contacted
annually. The source of contact is
recorded and the annual status is shown
as one of the following:
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Alive, without breast cancer.
Alive, with breast cancer.
Alive, status unknown.
Dead, due to breast cancer.
Dead, due to other causes.
Dead, cause unknown.
Lost to follow-up.

Note is made of all admissions to
Syracuse area hospitals and charts are
reviewed upon discharge. When a pa
tient dies, physicians are contacted,
hospital records or autopsy reports, or
both, are reviewed and the cause of
death is recorded. Our study of the
records of women with bilateral breast
cancer began in April 1975. Every
registrant had been contacted annually
to the time of death or to Dec. 31,
1974 and no patient was lost to followu p .

Since this report is based on a review
of cancer registry records, not on data
for individual patients, we do not apply
the rigorous criteria of Robbins and
Berg7 for an unequivocal diagnosis of
bilateral mammary carcinoma. The
Syracuse registry maintains a registra
tion card for each separate carcinoma,
so that two cards are kept for the
single patient in whom bilateral breast
carcinoma develops.
Methods

Information from the registry cards
was transferred to sorting cards accord
ing to a code that listed year of ac
cession, age at diagnosis, stage of
tumour, histopathology, primary treat
ment and type of operation upon each
breast. The interval between the first
appearances of the two tumours, the
age at death, cause of death and autop
sy findings were also coded. Hospital
charts were not reviewed or tumour
specimens re-examined since this study
was concerned more with frequency of
occurrence, cause of death and death
rates than with type of tumour or
specific management. In accordance
with the practice in prior publica
tions1310 we used three age categories
(21 to 50 years, 51 to 70 and 71 to 100
years). The cause of death specified as
breast cancer on the registry card was

considered reliable: (a) if an autopsy cancer was first noticed between 5 and
had been performed; (b) if the individu 20 years after the development of the
al had died in a Syracuse area hospital first. There appears to be a consistent
and the chart had been reviewed; (c) annual percentage of occurrence of a
if, prior to the time of death, a letter second tumour when account is taken
from the responsible physician had of the decreasing numbers at risk with
indicated that the patient was alive the passage of time.12 The depletion
with the disease; or (d) if the registry curve for the 3558 patients was affected
card showed that therapeutic proce by death as well as by reduction in
dures for breast cancer such as chemo numbers at risk due to recent entrance
therapy, irradiation and hormone into and insufficient time in the registry
ablative therapy had been carried out files, that is, the group considered
during previous hospital admissions.
withdrawn alive ' in the calculation of
For seven cases that did not satisfy life tables.16
these criteria, the registry personnel
Stage of the Disease
reinstituted a search to determine the
cause of death by once again contact
The stage of the cancer at the time
ing the physician, family or other in of diagnosis was determined by clinical
dividuals acquainted with the patient examination, supplemented by the pa
at or near the time of death. Table I thologist’s report whenever axillary
sets forth, according to the three age nodes were examined. The staging was
groups, the status (alive or dead) of as follows: stage I—tumour limited to
the 129 patients and also indicates the the breast; stage II—tumour known to
cause of death.
be present in the axillary lymph nodes;
stage III—disseminated carcinoma; and
Accession Data
stage IV—unspecified. The initial car
cinoma and the second carcinoma were
Age at Diagnosis
staged as shown in Table II. There was
Fig. 1 shows the age of the 129 pa no significant difference in the stage
tients at the time of first diagnosis. observed between the first and the sec
There was no significant difference be ond appearance of the disease or be
tween those who lived (“alive group”) tween the alive and the dead groups.
and those who died (“dead group”) in
H istopathology
regard to age at diagnosis or whether
Brief notes made on the registry cards
the two breast cancers appeared syn
chronously or metachronously. This permitted identification of the histopa
group of 129 patients was substantially thologic type in accordance with diag
noses made by pathologists of the
younger than the group of 3558 from
whom this subset is drawn.12'15
Timing of Bilaterality
Fig. 2 shows the time distribution of
occurrence of the second cancer. Two
cancers developed in 33 of these 129
patients within an interval of less than
6 months (an incidence of slightly less
than 1% [0.93%] in the entire series
of 3558 patients) and these were con
sidered synchronous. In 96 women the
second cancer developed after a longer
interval—metachronously. In 48 pa
tients with metachronous tumours the
second carcinoma developed within 3
years, in 16 the second cancer occurred
in 3 to 4 years and in 32 the second

T a b le 1— N u m b e r o f C a s e s o f B ila te r a l M a m m a ry C a rc in o m a in E ach o f T h r e e A g e G roups

Age
g ro u p ,
yr

N o. of
p a tie n ts
61

51 - 70

46

T o ta ls

462

3

Z Q

2

O
FIG. 1— Age distribution of 129 women
m whom bilateral breast carcinoma de
veloped. Age is shown as age at time of
diagnosis of first carcinoma. Distribution
suggests slightly higher incidence of syn
chronous breast cancers in older women.

C a u s e o f d e a th

21 - 50

71 - 100

UJ
>
<

Zi

22
129

S ta tu s
A liv e
D ead
A liv e
D ead
A liv e
D ead
A liv e
D ead

28
33
31
15
11
11
70
59

S y n c h ro n o u s

M e ta c h ro n o u s

4
6
8
7
3
5
15
18

24
27
23
8
8
6
55
41

B re a s t
cancer

O th e r

N o . on w ho m
a u to p s y w as
p e rfo rm e d

32

1

14

13

2

2

8

3

i

53

6

17
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FIG. 2— Annual occurrence of second
cancers in 129 patients shown in relation
to number at risk derived from total group
/
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Table I I — The Three Age Groups Showing Stage a t Tim e of Diagnosis of
First and Second Cancers According to Age Group
Stage

I
No. of
patients

Age group,
yr

Status

Dead

4
1
2
4

2

2

3

0

2

5
17

12

26

16

25

27

Dead

15

0

5

41

37

71

71

2

2

21

46

44

A live

129

Totals

1

5

5

Dead

1
3

2

0

0
2

3

2

13

13

1

1

8

8

A live

22

71 - 100

7

2

0

0

10

3

2

1

0

8

4

5

1

0

10

2

3

2

2

20

21

21

23

2nd
tum our

10

3

14

13

17

18

A live

46

51 - 70

1

0
2

18
7

16

17

Dead

4

7
14

37

35

1st
tum our

2nd
tum our

1st
tum our

2nd
tum our

1st
tumour

21

18

A live

61

21 - 50

2nd
tumour

1st
tumour

IV
Unspecified

III
Disseminated

Axilla

Breast only

2
7

11

Table III— Histopathologic Type of First and Second Cancers in Three Age Groups
Scirrhous
carcinoma

Duct cell
carcinoma
Age group,
yr
21 - 50
51 - 70
71 - 100
Totals

1st
tumour

Status
Alive
Dead
Alive
Dead
A live
Dead
Alive
Dead

28
33
31
15
11
11
70
59

2nd
tumour

14
15
15
8
5
6
34
29

1st
tumour

19
19
14
9
3
4
36
32

-

4
-

1
-

5
~

2nd
tumour
5
3
9
4
7
4
21
11

Adeno
carcinoma

Anaplastic
carcinoma
1st
tumour
2
-

1
-

3

1st
tum our

2nd
tumour

1st

2nd

2nd

1st

2nd

t

10

i
6
4
1
1
2
6
9

4
8
8
2
1
1
13
11

Unspecified

O ther

5

8
5
3
2

21

12

'

Table IV — Frequencies w ith Which Both Breasts Had
Sim ilar or Dissimilar Histopathologic Findings
Age group,
yr
21 - 50
51 - 70
71 - 100
Totals

Status
Alive
Dead
Alive
Deac
Alive
Dead
Alive
Deac

28
33
31
15
11
11
70
59

Syracuse area. In reviewing the entire
registry effort, we noted15 wide varia
tions in the classification of breast car
cinoma among the various pathologists,
but by the late 1960s the influence of
the United States Armed Forces Insti
tute of Pathology fascicle was apparent
and histopathologic typing became
more uniform. Disparities among the
several pathologists were not examined
and this study reports only the recorded
diagnoses. Table III lists the types of
tumour diagnosed in the initial and sec
ond cancer. There was no appreciable
difference in type of tumour observed
between the first and the second ap
VOLUME 21, NO. 5, SEPTEMBER 1978 /

Both sides
sim ilar

No.
sim ilarity

14
16
13
8
4
6
31
30

14
17
18
7
7
6
39
29

pearances of the disease or between the
alive and the dead groups. Table IV
notes the presence or absence of histo
logic similarities between the tumours
on each side.
Primary Treatment
The primary treatment for 124 of
the 129 women was ablation of the
breast. The five women who did not
undergo a breast resection were con
sidered to have stage III disease when
first seen and underwent radiation
therapy, oophorectomy and chemo
therapy, variously combined. When the
women were divided into the three

age groups, it was apparent that radical
mastectomy was the treatment of choice
for the younger women and slightly
less so for the group over 70 years of
age (Table V). It is also apparent that
radical mastectomy, although accept
able treatment for the first manifesta
tion of cancer, was employed far less
frequently for the second tumour, a
difference that is highly significant
(P < 0.001). There was no difference
in the mode of primary treatment be
tween patients in the alive group and
those in the dead group.
Outcome
Rate of Death
The survival curve for the 129 pa
tients, plotted by life-table analysis
(Fig. 3),16 shows a half-death (T/2)
time (i.e., 50% of patients are dead)
of approximately 10 years, compared
with 7.5 years for the women in the
unselected group of 3558. When per
centage survival is plotted semi-logarithmically (Fig. 4) a slow death rate is
demonstrated in the first 5 years, then
there is a decay curve that appears
reasonably close to a single exponential
from the 7th to the 15th years.17 This
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1
Table V—Operative Treatment Employed for First and Second Cancers
R a d ic a l
m a s te c to m y
no. (a n d % )
A g e g ro u p ,
yr
21 - 50
51 - 70
71 - 100
T o ta ls

S ta tu s
A liv e
D ead
A liv e
Dead
A liv e
D ead
A liv e
D ead

28
33
31
15
11
11
70
59

M o d ifie d
ra d ic a l
m a s te c to m y

1st
tu m o u r

2nd
tu m o u r

24
28
27
12
5
6
56
46

19
19
14
9
3
4
36
31

(8 5 )
(8 5 )
(8 7 )
(8 0 )
(4 5 )
(5 5 )
(8 0 )
(7 8 )

(6 8 )
(5 8 )
(4 5 )
(6 0 )
(2 8 )
(3 6 )
(5 2 )
(5 2 )

1st
tu m o u r
2
1
3
1
2
1
7
3

S im p le
m a s te c to m y

2nd
tu m o u r

1st
tu m o u r

4
8
8
2
1
1
13
11

1
2
1
2
4
2
6
6

U n s p e c ifie d

2nd
tu m o u r
5
3
9
4
7
4
21
11

1st
tu m o u r
1
2

2
1
4

2nd
tu m o u r

1
v«

3

V
4

2

-4

5
*

line, when its points are calculated by
the method of least squares, shows a
T /2 of approximately 7 years, a fig
ure also slightly in excess of that seen
in an unselected population of women
with breast cancer.13"18 The figures for
our curves were terminated at 15 years
because only six women were at risk
for the 16-year computation.

Cause o f Death

Fifty-nine patients from our group
were dead and 70 were still alive at the
time this review was compiled. Fiftythree deaths were from breast can
cer and six were from other causes.
Table I shows that only 3 of 48 women
in whom the cancer developed before
the age of 70 years died of other
causes, representing a 94% mortality
due to cancer of the breast in the two
younger age groups.
Discussion

FIG. 3—Survival curve constructed by
life-table method16 showing that half of
women survived for 10 years. This group
of patients with bilateral breast carcinoma
cannot be identified at time of diagnosis
of first cancer.

TIG. 4—Survival curve constructed by
life-table method and presented as logarith
mic plot, suggesting that rate of dying is
constant between Sth and 15th year.15'17
464

The reported frequency of bilateral
carcinoma varies from 1% to 12% of
all women in whom breast cancer de
velops. 1"“'18,19 -phis frequency is ob
viously difficult to determine, because
in order for the second primary breast
cancer to develop, the women must
survive the first and have sufficient
time at risk for the second to develop
while others in the same group at risk
are dropping out because of the mor
tality induced by the first carcinoma.
In the total group of 3558 women with
breast cancer, bilateral carcinoma had
developed synchronously in 33, but 6
months to 4 years elapsed before the
appearance of the second carcinoma in
64 of the remaining 96. During this
time the basic population at risk (3558
women) was being depleted owing to
death before sufficient time at risk had
elapsed for a contralateral tumour to
develop. The ultimate rate of occur
rence for bilateral disease is therefore
difficult, if not impossible, to determine
with any finality. It is probably in the
range of 2.5% to 5% of all women in
whom unilateral breast cancer develops.
A better means of expressing bila
terality seems to be a statement of its
annual incidence among those at risk.
From Fig. 2 bilaterality appears to
have an occurrence rate of 0.8% to
1.0% per year in the population at risk
(3558 patients), continuing for at least
15 years.12 This figure is probably use
less except to remind the clinician that
second cancers do occur. Sufficient
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survival time from the diagnosis of the
first cancer is required for a second
primary to appear. This occurs by the
end of the fifth year in 75% of such
cases. The basic group (3558 patients)
from which this review is drawn con
sisted of all women with cancer of the
breast and included a number in whom
the diagnosis was made at or just be
fore death, as well as others destined
to die early (i.e., those classified as
stage III). Since this total group of
women is used as the reference base,
the percentage with bilateral carcinomas
should be, and is, somewhat lower than
that reported in studies conducted only
upon women subjected to curative ef
forts on one side.12
In the absence of a specific review
of the histopathology by examining the
actual microscopy specimens, the pre
cise definition of pathologic type was
not possible in this study. In 50% of
cases the tumour type of the second
lesion was the same as in the first and
this similarity did not seem to affect
the outcome. This leads to speculation
that the histopathologic features may
be of minimal importance in determin
ing the ultimate outcome—the time and
cause of death.
The stage of the disease at the time
of diagnosis was similar in both the
initial and the second breast tumours,
a fact that must reflect both on the
vigilance of the physicians who treated
these women and on the eagerness with
which the women appeared for follow
up examination. It is somewhat sur
prising that in these women, who had
already had one primary breast tumour,
the second tumour was not detected at
an earlier stage and tumours classified
as stage I were not found with increas
ing frequency in the second breast.
With regard to the ultimate outcome,
the therapeutic effort employed seemed
to have little effect upon the cause of
death (i.e., these women died of their
cancer), although a delay of death is a
possibility not measured in this study.
Mastectomy should probably be used
only to rid the patient of a mass on
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the chest wall and should not be con
sidered an effort to avert the death that
is caused by distant metastases. We
found nothing in this study to permit
the claim that one operative procedure
more than another can delay death or
produce a cure.
There is reason to suppose that, as
more time elapses, in those women who
are still alive death will probably result
from the same causes as were operative
in those who have died, since the initial
data are similar. Analysis showed that
the duration of time at risk was the
same for both the alive and dead
groups, so that the force of mortality
is not expressed simply in terms of time
at risk. Each year some of the women
at risk die of their disease. This frac
tion is fairly constant through the years
and seems to remain so for at least 15
years.15 The alive/dead ratio of total
registrants reflects the continuous entry
into and departure (by death) from
the register of women who have breast
carcinoma.
Carcinoma of the breast is a lethal
disease. There is little evidence in this
study that the initial stage, histopa
thologic features, age at diagnosis, or
treatment alters the outcome when
measured as cause of death. One is left
with the unsatisfying explanation that
some vague element designated as
“host-tumour relationship” is probably
the significant variant. If it is assumed
that both breasts are subjected equally
to the forces of carcinogenesis, one
may wonder why so few women have
bilateral breast cancer, rather than why
so many women do. The time to T /2
is longer for the group with bilateral
cancer than for the group with uni
lateral disease, probably partly because
the time required for expression of the
disease in the second breast is suffi
ciently long that mortality due to the
primary disease must be delayed. Also
it is partly a function of the patient’s
age at the time of diagnosis. The bila
teral group contains a greater propor
tion of younger women, in whom the
decay curve15 is slower than in the
older women.
There was nothing in the information
from the register (i.e., stage, histologic
type, operation, or time at risk) that
distinguished the alive group from the
dead group, and the inevitable conclu
sion is that the forces defining the time
of death are not measurable in the
clinical setting at the time of initial
diagnosis. Pearlman20 has recognized
this and has approached the problem
by attempting to measure cancer ag
gressiveness, which relates to the time
of first appearance of metastases. The
nonspecific term “host-tumour relation
ship” is an immunologic term today
and may be an important determinant
of the outcome. Even though treatment

may delay the apparently inevitable
death due to breast cancer (in 90%
of patients with the disease) and may
influence the quality of life either
adversely or favourably, it appears that
cancer of the breast must be viewed as
a systemic disease in which surgical re
moval of the initial manifestation is
unrelated to the ultimate expression of
the disease, namely, death. Bilateral
disease is another illustration of the
lethal enigma of breast cancer.
Conclusions

Carcinoma of the second breast oc
curs at a steady rate of slightly less
than 1% per year among women at
risk.
Ninety percent of the women in
whom bilateral carcinoma of the breast
develops die of this disease.
Development of the second carcino
ma does not significantly enhance the
lethality of the first breast cancer and
survival curves do not show an increased
rate of dying due to the second cancer.
Half of the women who have bila
teral! carcinoma are dead within 10
years after diagnosis of the first carci
noma.
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Esophagoatrial Fistula
K evin Cunnane ,

The author describes a case of eso
phagoatrial fistula— an extremely rare
condition. A 79-year-old man had had
epigastric pain for 4 weeks. Physical
and roentgenographic examinations
disclosed atrial fibrillation with a systolic
murmur and an ulcer of the lower
esophagus which, on histologic examin
ation, was benign. No specific treatment
was recommended. The patient died
suddenly 3 months later from massive
gastrointestinal hemorrhage which, at
autopsy, was found to be due to an
esophagoatrial fistula. A review of the
literature showed that this case differed
from others previously reported in that
the duration of symptoms up to the
tim e of death was only 4 months and
the patient had no embolism.
L auteur decrit un cas de fistule
oesophagoauriculaire, une affection
extremem ent rare. Un homme de 79
ans s etait plaint de douleur epigastrique
d'une duree de 4 semaines. Les
examens physiques et radiologiques
ont revele une fibrillation auriculaire
avec murmure systolique et un ulcere
de I’oesophage inferieur qui, a I’examen
histologique s’est revele benin. Aucun
traitem ent specifique n'a ete recommande. Le patient est decede
soudainement, 3 mois plus tard, d’une
hemorragie gastrointestinale massive
qui, a I’autopsie, s’est avere etre due
a une fistule oesophagoauriculaire.
Une revue de la litterature a montre
que ce cas differait des autres signales
precedemment, par la duree des
symptomes jusqu’a la mort, qui n’a
ete que de 4 mois, et par le fait que
le patient n’a pas eu d’embolie.

A fistulous communication between the
esophagus and left atrium is extremely
rare. Six cases have previously been re
ported.1'6 An additional case is de
scribed.
Case Report
A 79-year-old man was admitted to
From the department of pathology,
Chedoke Hospitals, Hamilton, Ont.
Reprint requests to: Dr. K. Cunnane,
Pathology department, County Hospital
Mullingar, Co. Westmeath, Ireland
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hospital for investigation of epigastric pain covered by a grey slough on the anterior
of 1 month’s duration. The pain was de wall of the lower esophagus. The lumen
scribed as a constant dull ache located of the esophagus did not appear constricted
high in the epigastrium. It was not influ and the stomach appeared normal. His
enced by taking food but was partly re tologic examination of a biopsy specimen
lieved by antacids. There were no other from the ulcer identified only necrotic
symptoms (e.g., nausea, vomiting, dyspha debris and granulation tissue. Smears
gia). The patient was a nonsmoker and a showed mixed gram-positive cocci and
teetotaller.
bacilli but no fungi. The patient was given
On physical examination he was found no specific treatment and was discharged
to have atrial fibrillation and a loud sys following some alleviation of symptoms.
tolic murmur maximal at the apex and
He continued to experience intermittent
transmitted to the left axilla. The other attacks of epigastric pain for which he
findings were normal. An electrocardio took a variety of antacids. Three months
gram confirmed the presence of atrial after discharge he collapsed suddenly at
fibrillation and showed no evidence of home. On admission to the emergency de
infarction.
partment of the nearest hospital the patient
Results of laboratory investigations was unconscious and his blood pressure
were essentially within normal limits. could not be recorded. He vomited fresh
Chest roentgenograms showed normal blood and died while resuscitative proce
lung fields. Roentgenography of the upper dures were being instituted.
gastrointestinal tract showed an ulcer in
the lower part of the esophagus; the
Autopsy Findings
stomach and esophagogastric junction were
normal. Endoscopy revealed a flat ulcer
The stomach and proximal small
bowel contained about 2000 mL of
partly clotted blood. An oval ulcer
measuring 3 X 2 cm was present on the
anterior wall of the esophagus at the
junction of the middle and lower thirds
(Fig. 1). The esophagus at this point
was densely adherent to the pericar
dium. A small opening (diameter, 0.1
cm) was discovered in the centre of the
esophageal ulcer leading to a tract that
penetrated the esophageal wall and the
posterior wall of the left atrium. The
remainder of the esophagus appeared
normal apart from glycogenic acantho
sis.7 The pericardial cavity was obliter
ated by fibrous adhesions. When the
heart was opened, a small ulcer (dia
meter, 0.1 cm) was found on the pos
terior wall of the left atrium about 1
cm above the mitral valve. There was
calcific aortic stenosis with left ventri
cular hypertrophy.
Histologic sections and smears of the
esophageal ulcer had an appearance
similar to that observed in the initial
investigation (Fig. 2). Sections from the
centre of the ulcer showed a fistulous
tract penetrating the esophageal wall
(Fig. 3). Necrotic atrial myocardium
was present on the cardiac aspect of
the fistula. None of the sections showed
evidence of neoplasia or of granulomas.
Numerous sections taken from the
esophagus distal to the ulcer showed
normal squamous epithelium with no
FIG. 1—Oval ulcer on anterior wall of
lower third of esophagus.
evidence of glandular metaplasia. Hy-
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cers.9 This squamous epithelium did not
show the basal hyperplasia and elong
ated submucosal papillas described in
reflux esophagitis by Behar and
Discussion
Sheahan.19 There was no evidence of
Nontraumatic fistulas have been de carcinoma or of granulomas. No fungi
scribed between the esophagus and were seen on sections stained with Gropericardium,8 esophagus and left ven cott’s stain. McManus and Webb11 de
tricle,1 and esophagus and left atrium.1'6 scribed an esophageal ulcer in a 67Sixteen cases of esophagopericardial fis year-old woman caused by Lactobacillus
tula were found by McDaniel and acidophilus following therapy with oral
Knepper8 in a review of the literature ly administered tetracycline. Although
and they described an additional case. some gram-positive bacilli were seen in
Prolla, Taebel and Kirsner1 discovered the necrotic debris covering the ulcer
in the literature accounts of seven cases in the present case, there was no sem
of perforation of the left ventricle by a blance of a mycelial arrangement as
benign gastric ulcer. Six cases of eso- described by McManus and Webb.11
phagoatrial fistula have been de Furthermore, the bacilli were mingled
scribed.1'6 Like the case described here with gram-positive cocci suggestive of
these opened into the left atrium and colonization of the ulcerated surface
were diagnosed at autopsy. Five of the by mixed bacteria.
Esophageal ulceration has been as
patients had long-standing peptic eso
phagitis ranging in duration from 2 sociated with various drugs12'14 but this
years2 to 20 years.3 One patient had patient was not taking any medication
achalasia and esophageal carcinoma.4 prior to the onset of symptoms. Ulcera
Hematemesis was a prominent feature tion of the esophagus has also been de
of the terminal episode in three of these scribed in Behcet’s syndrome,15 but no
cases;1'3,5 particles of vegetable matter other features of the syndrome were
and debris were observed in the cere present.
The presumed terminal event in this
bral vessels in two of them.3,5
The case reported here differed from patient was erosion of the fistula into
those previously described in that the the lumen of the left atrium resulting in
duration of symptoms before the ter massive hemorrhage, syncope and
minal episode was only 4 months. The death. Unlike patients from some pre
cause of the esophageal ulcer was un viously described cases,3,5,6 this patient
known. There was neither endoscopic had no findings indicative of embolism.
nor roentgenographic evidence of pep
tic esophagitis. Distal to the ulcer the
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Plastic and Reconstructive Surgery of the
Face and Neck. Proceedings of the Sec

ond International Symposium. Volume
1: Aesthetic Surgery. Edited by George
A. Sisson and M. Eugene Tardy, Jr.
236 pp. Illust. Grune & Stratton, Inc.,
New York; Longman Canada Limited,
Don Mills, 1977. $45.65. ISBN 0-80890941-X.
Plastic and Reconstructive Surgery of the
Face and Neck. Proceedings of the Sec

ond International Symposium. Volume
2: Rehabilitative Surgery. Edited by
George A. Sisson and M. Eugene T ar
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Inc., New York; Longman Canada
Limited, Don Mills, 1977. $59.40. ISBN
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The Second International Symposium on
Malignant Hyperthermia. Proceedings
FIG.
showing
necrotic
reduced

2—Esophageal surface of ulcer
granulation tissue covered by
debris (hematoxylin and eosin,
by 37% from X200).
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FIG. 3— Fistula penetrating esophageal
wall. Detached strip of atrial muscle is
present at bottom of illustration (Hemato
xylin and eosin, reduced by 37% from
X20).
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continued from page 424
includes discussions on pediatric and
adolescent gynecology, diseases of the
vulva, infections, endometriosis, inconti
nence of urine and shock.
In the first section there is an interest
ing and clinically oriented chapter on
anatomy that was a pleasure to read.
Other chapters are devoted to cytology,
genetics and developmental anomalies;
these are clinically oriented and helpful.
The section on function contains the
usual chapter on ovulation, menstruation
and ovarian function. There is a detailed
discussion on dysfunctional uterine bleed
ing and another on the polycystic ovary;
the latter includes material on androgen
production in the female and an evalua
tion of hirsutism. This section also in
cludes long, well-referenced chapters on in
fertility and family planning and two short
er chapters on the menopause and psychosexual and psychosomatic gynecology.
Under the heading of neoplasms there
is an entire chapter devoted to radiation
therapy; this includes not only an ex
planation of the nature and effects of
ionizing radiation but also details of
radiation treatment for each form of
gynecologic cancer. Radiation therapy is
also described in the chapters on carcino
ma of the cervix and carcinoma of the
endometrium and, as is inevitable in a
multiauthored book, there is some du
plication and disagreement. It was sur
prising to read in the chapter devoted to
radiation that in-situ carcinoma can be
treated with one radium insertion and in
the same paragraph, “for microinvasive
carcinoma of the cervix, two radium in
sertions of 48 hours for a total of 8000
mg-hrs of radium are adequate”. Therapy
for carcinoma in situ is becoming more
conservative and this conservatism is re
flected in the chapter on carcinoma of the
cervix. It therefore does not seem reason
able that radium should ever be con
sidered. Treatment is surgical; the deci
sions should only have to do with how
much surgery is necessary. Treatment for
microinvasive carcinoma may be a little
more controversial, but surely milligramhours as a measurement of radiation is
obsolete.
In the management of endometrial car
cinoma, surgery with preoperative radia
tion, surgery with postoperative radiation
or vaginal irradiation and even irradiation
alone for the poor-risk patient are all
compared. Unfortunately, the authors have
not described which patients should be
treated with surgery alone. Many patients
whose disease is diagnosed very early and
who have a well-differentiated tumour may
well be spared the discomfort and mor
bidity of radiotherapy.
Again, because of the multiple authors
involved in the preparation of this text,
there is some duplication and omission.
The physiology of menstruation is dis
cussed at least three times; on the other
hand, no outline is provided for the in
vestigation of the adolescent with delayed
menarche or secondary amenorrhea.
Included in the book is a good discus
sion on predisposing factors and the role
of estrogen in the development of endo
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metrial carcinoma, but the factors that
may play a role in the etiology of cervical
cancer are not included.
Most of the book is well written and
easy to read. The print is clear and
“boxed” headings stand out well on the
page. Nearly all the chapters have biblio
graphies and some of these are lengthy.
The index is adequate. I think that this
book is small enough to be convenient
and detailed enough to be useful.
One closing point: after all the criticism
the feminists have heaped on the gyne
cologists for their patronizing attitude to
women, it is a little disconcerting to read
in the chapter on pediatric gynecology, “It
is often valuable to comment favorably
on her appearance and dress because, like
many women, the young girl will usually
respond.” More fuel for the fire^
E m il y

J.

G ear

Department of obstetrics and gynecology,
Ottawa Civic Hospital,
Ottawa, Ont.
THE YEAR BOOK OF PLASTIC A N D
RECONSTRUCTIVE SURGERY. 1977.
Edited by Frederick J. McCoy, Reed
O. Dingnian, Dwight C. Hanna and
others. 405 pp. Illust. Year Book Medi
cal Publishers, Inc., Chicago, 1977.
Price not stated. ISBN 0-8151-5818-1.

The format of the 1977 year book of
plastic and reconstructive surgery fol
lows previous patterns and represents ma
terial published up to luly 1976.
The book is divided into sections deal
ing with congenital anomalies, neoplastic,
inflammatory and degenerative diseases,
trauma, aesthetic surgery, grafts and trans
plantation, and general topics. The editors
have included articles of special interest
to the plastic surgeon from the allied spe
cialties and the related basic sciences. At
the beginning of the text is a series of
55 questions related to the material
furnished in the review. It is the reader’s
task to seek the correct answers in the
various sections of the book.
The editorial panel has selected pro
vocative and fairly relevant articles. A
conscientious reader of Plastic and Re
constructive Surgery, the British Journal
of Plastic Surgery and the Scandinavian
Journal of Plastic and Reconstructive Sur
gery will recognize that the bulk of the
material in the year book comes from
these sources.
There are numerous reviews of the
European literature; the editors offer a
quick recapitulation of articles and refer
ences to the important papers. Most ab
stracts of the material have already ap
peared in Plastic and Reconstructive Sur
gery, however, the material is presented
here in greater depth, with carefully re
produced illustrations.
As in previous issues, the editorial con
sultant has included personal comments
on the impact and interpretation of some
of the articles. These will be of special
value to the younger surgeon.
Paul

R . B e n o it

Ste. 104,
340 McLeod St.,
Ottawa, Ont.
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